,drug_name,section_name,gpt_output
0,XEOMIN,adverse reactions,"hypersensitivity, dysphagia, breathing difficulties, spread of effects from toxin, neck pain, muscle weakness, injection site pain, musculoskeletal pain, eyelid ptosis, dry eye, dry mouth, diarrhea, headache, visual impairment, dyspnea, nasopharyngitis, respiratory tract infection, facial paresis, injection site hematoma, eyelid edema, facial pain, injection site swelling, sensation of pressure, blepharospasm, eye disorder, immunogenicity, eye swelling, nausea, flu-like symptoms, injection site reaction, allergic dermatitis, localized allergic reactions, swelling, edema, erythema, pruritus, rash, herpes zoster, muscle spasm, dysarthria, myalgia, hypersensitivity"
1,XEOMIN,boxed warnings,"asthenia, generalized muscle weakness, diplopia, blurred vision, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence, breathing difficulties, death"
2,XEOMIN,warnings and precautions,"respiratory difficulties, speech difficulties, swallowing difficulties, compromised respiratory function, dysphagia, neuromuscular disorders, exacerbate clinical effects, corneal exposure, corneal ulceration, ulceration, perforation, diplopia, ptosis, asthenia, generalized muscle weakness, blurred vision, dysphonia, dysarthria, urinary incontinence, breathing difficulties, anaphylaxis, serum sickness, urticaria, soft tissue edema, dyspnea, respiratory failure, aspiration, peripheral motor neuropathic diseases, amyotrophic lateral sclerosis, neuromuscular junctional disorders, myasthenia gravis, Lambert-Eaton syndrome, severe dysphagia, respiratory compromise, persistent epithelial defect, VII nerve disorders, ectropion, narrow angle glaucoma, ecchymosis"
3,QUTENZA,adverse reactions,"application-associated pain, increase in blood pressure, application site erythema, application site pain, application site pruritus, application site papules, application site edema, application site swelling, application site dryness, nasopharyngitis, bronchitis, sinusitis, nausea, vomiting, pruritus, hypertension, application site urticaria, application site paresthesia, application site dermatitis, application site hyperesthesia, application site excoriation, application site warmth, application site anesthesia, application site bruising, application site inflammation, application site exfoliation, peripheral edema, headache, burning sensation, peripheral sensory neuropathy, dizziness, dysgeusia, hyperesthesia, hypoesthesia, cough, throat irritation, abnormal skin odor"
4,QUTENZA,warnings and precautions,"coughing, sneezing, irritation of eyes, irritation of airway, transient increases in blood pressure, procedural pain, increases in blood pressure"
5,ZYTIGA,adverse reactions,"hypertension, hypokalemia, fluid retention, mineralocorticoid excess, adrenocortical insufficiency, hepatotoxicity, fatigue, joint swelling, discomfort, edema, hot flush, diarrhea, vomiting, cough, dyspnea, urinary tract infection, contusion, anemia, elevated alkaline phosphatase, hypertriglyceridemia, lymphopenia, hypercholesterolemia, hyperglycemia, elevated AST, hypophosphatemia, elevated ALT, muscle discomfort, dyspepsia, upper respiratory tract infection, urinary frequency, nocturia, fractures, arrhythmia, chest pain, chest discomfort, cardiac failure, pyrexia, groin pain, constipation, insomnia, falls, nasopharyngitis, hematuria, rash, hypernatremia, non-infectious pneumonitis, myopathy, rhabdomyolysis"
6,ZYTIGA,warnings and precautions,"mineralocorticoid excess, cardiovascular disease, LVEF < 50%, NYHA Class III or IV heart failure, hypertension, hypokalemia, fluid retention, adrenocortical insufficiency, hepatotoxicity, grade 3 to 4 hypertension, grade 3 to 4 hypokalemia, grade 3 to 4 edema, heart failure, myocardial infarction, ventricular arrhythmia, adrenal insufficiency, ALT or AST increases, liver enzyme increases, liver test elevation, serum transaminases elevation, bilirubin levels increase"
7,TOVIAZ,adverse reactions,"dry mouth, constipation, angina, chest pain, gastroenteritis, QT prolongation on ECG, dyspepsia, nausea, abdominal pain upper, urinary tract infection, upper respiratory tract infection, dry eyes, dysuria, urinary retention, cough, dry throat, edema peripheral, back pain, insomnia, ALT increased, GGT increased, rash, diverticulitis, irritable bowel syndrome, blurred vision, palpitations, hypersensitivity reactions, angioedema with airway obstruction, face edema, dizziness, headache, somnolence, urticaria, pruritus"
8,TOVIAZ,warnings and precautions,"angioedema, urinary retention, severe constipation, narrow-angle glaucoma, headache, dizziness, somnolence"
9,STRIBILD,adverse reactions,"Peripheral Neuropathy, Anaphylaxis, Infusion Reactions, Hematologic Toxicities, Infections, Opportunistic Infections, Tumor Lysis Syndrome, Increased Toxicity, Hepatotoxicity, Lactic Acidosis, Severe Hepatomegaly with Steatosis, Severe Acute Exacerbations of Hepatitis B, New Onset or Worsening Renal Impairment, Bone Effects of Tenofovir DF, Immune Reconstitution Syndrome, Nausea, Diarrhea, Ocular Icterus, Flatulence, Fatigue, Jaundice, Somnolence, Headache, Dizziness, Insomnia, Abnormal Dreams, Rash, Suicidal Ideation, Suicide Attempt, Depression, Abdominal Pain, Dyspepsia, Vomiting, Fever, Pain, Nasopharyngitis, Pneumonia, Sinusitis, Upper Respiratory Tract Infection, Arthralgia, Back Pain, Myalgia, Paresthesia, Peripheral Neuropathy, Anxiety, Increased Cough, Rhinitis, Skin Discoloration, Hyperpigmentation, AST Elevation, ALT Elevation, Amylase Elevation, Creatine Kinase Elevation, Hematuria, Proteinuria, Serum Creatinine Increase, Estimated Creatinine Clearance Decrease, Bone Mineral Density Decrease, Bone Fractures, Allergic Reaction, Angioedema, Lactic Acidosis, Hypokalemia, Hypophosphatemia, Dyspnea, Pancreatitis, Increased Amylase, Hepatic Steatosis, Hepatitis, Increased Liver Enzymes, Rhabdomyolysis, Osteomalacia, Muscular Weakness, Myopathy, Acute Renal Failure, Renal Failure, Acute Tubular Necrosis, Fanconi Syndrome, Proximal Renal Tubulopathy, Interstitial Nephritis, Nephrogenic Diabetes Insipidus, Renal Insufficiency, Polyuria, Asthenia"
10,STRIBILD,boxed warnings,"lactic acidosis, severe hepatomegaly with steatosis, fatal cases, severe acute exacerbations of hepatitis B"
11,STRIBILD,warnings and precautions,"renal impairment, acute renal failure, Fanconi syndrome, lactic acidosis, severe hepatomegaly with steatosis, fatal cases, exacerbations of hepatitis B, liver decompensation, liver failure, renal adverse reaction, proximal renal tubulopathy, renal replacement therapy, bone pain, pain in extremities, fractures, muscular pain, weakness, decreases in bone mineral density, redistribution/accumulation of body fat, central obesity, dorsocervical fat enlargement (buffalo hump), peripheral wasting, facial wasting, breast enlargement, ""cushingoid appearance"", immune reconstitution syndrome, inflammatory response, Mycobacterium avium infection, cytomegalovirus, Pneumocystis jirovecii pneumonia (PCP), tuberculosis, autoimmune disorders, Graves' disease, polymyositis, Guillain-Barre syndrome"
12,FARXIGA,adverse reactions,"hypotension, impairment in renal function, hypoglycemia, genital mycotic infections, increases in LDL-C, bladder cancer, nasopharyngitis, urinary tract infections, back pain, increased urination, male genital mycotic infections, nausea, influenza, dyslipidemia, constipation, discomfort with urination, pain in extremity, volume depletion, dehydration, hypovolemia, orthostatic hypotension, renal failure, blood creatinine increase, bone fractures, hypersensitivity reactions, angioedema, urticaria, anaphylactic reactions, severe cutaneous adverse reactions, increase in hematocrit, increase in serum inorganic phosphorus, increase in low-density lipoprotein cholesterol"
13,FARXIGA,warnings and precautions,"hypotension, impairment in renal function, hypoglycemia, genital mycotic infections, increased LDL-C, bladder cancer"
14,VICTRELIS,adverse reactions,"'anemia, neutropenia, pancytopenia, hypersensitivity, fatigue, nausea, headache, dysgeusia, anemia, neutropenia, diarrhea, vomiting, dry mouth, fatigue, chills, asthenia, decreased appetite, arthralgia, dizziness, insomnia, irritability, dyspnea exertional, alopecia, dry skin, rash, agranulocytosis, thrombocytopenia, mouth ulceration, stomatitis, pneumonia, sepsis, angioedema, urticaria, drug rash with eosinophilia and systemic symptoms (DRESS) syndrome, exfoliative rash, exfoliative dermatitis, Stevens-Johnson syndrome, toxic skin eruption, toxicoderma'"
15,VICTRELIS,warnings and precautions,"'embryofetal toxicity, birth defects, fetal death, anemia, decrease in hemoglobin concentrations, neutropenia, worsening of neutropenia, hypersensitivity, serious acute hypersensitivity reactions, urticaria, angioedema, pancytopenia, thromboembolic events, pulmonary embolism, acute myocardial infarction, cerebrovascular accident, deep vein thrombosis, severe or life-threatening infections, life-threatening neutropenia'"
16,VIMIZIM,adverse reactions,"'anaphylaxis, hypersensitivity reactions, pyrexia, vomiting, headache, nausea, abdominal pain, chills, fatigue, immunogenicity, anti-drug antibodies, neutralizing antibodies'"
17,VIMIZIM,boxed warnings,"anaphylactic reactions, cough, erythema, throat tightness, urticaria, flushing, cyanosis, hypotension, rash, dyspnea, chest discomfort, gastrointestinal symptoms, nausea, abdominal pain, retching, vomiting, hypersensitivity reactions"
18,VIMIZIM,warnings and precautions,"'anaphylaxis, hypersensitivity reactions, cough, erythema, throat tightness, urticaria, flushing, cyanosis, hypotension, rash, dyspnea, chest discomfort, gastrointestinal symptoms, nausea, abdominal pain, retching, vomiting, peripheral edema, acute respiratory complications, sleep apnea, spinal or cervical cord compression, back pain, paralysis, urinary incontinence, fecal incontinence'"
19,BEPREVE,adverse reactions,"mild taste following instillation, eye irritation, headache, nasopharyngitis, hypersensitivity reactions, itching, body rash, swelling of lips, tongue and/or throat"
20,BEPREVE,warnings and precautions,contamination
21,PRISTIQ,adverse reactions,"hypersensitivity, suicidal thoughts and behaviors, serotonin syndrome, elevated blood pressure, abnormal bleeding, angle closure glaucoma, activation of mania/hypomania, discontinuation syndrome, seizure, hyponatremia, interstitial lung disease, eosinophilic pneumonia, nausea, dizziness, insomnia, hyperhidrosis, constipation, somnolence, decreased appetite, anxiety, specific male sexual function disorders, blood pressure increased, dry mouth, vomiting, fatigue, chills, feeling jittery, decreased appetite, tremor, disturbance in attention, nervousness, abnormal dreams, urinary hesitation, yawning, vision blurred, mydriasis, vertigo, tinnitus, dysgeusia, hot flush, anorgasmia, libido decreased, orgasm abnormal, ejaculation delayed, erectile dysfunction, ejaculation disorder, ejaculation failure, sexual dysfunction, tachycardia, asthenia, weight increased, liver function test abnormal, blood prolactin increased, musculoskeletal stiffness, syncope, convulsion, dystonia, depersonalization, bruxism, urinary retention, rash, alopecia, photosensitivity reaction, angioedema, myocardial ischemia, myocardial infarction, coronary occlusion requiring revascularization, total cholesterol increase, LDL cholesterol increase, triglycerides increase, proteinuria, supine systolic blood pressure increase, supine diastolic blood pressure increase, pulse rate increase, weight decrease, sustained hypertension, orthostatic hypotension, Stevens-Johnson syndrome"
22,PRISTIQ,boxed warnings,"suicidal thoughts, behaviors"
23,PRISTIQ,warnings and precautions,"clinical worsening, suicide risk, serotonin syndrome, elevated blood pressure, abnormal bleeding, angle closure glaucoma, activation of mania/hypomania, discontinuation syndrome, seizure, hyponatremia, interstitial lung disease, eosinophilic pneumonia"
24,TAFINLAR,adverse reactions,"New Primary Malignancies, Tumor Promotion in BRAF Wild-Type Melanoma, Hemorrhage, Venous Thromboembolism, Cardiomyopathy, Ocular Toxicities, Serious Febrile Reactions, Serious Skin Toxicity, Hyperglycemia, Glucose-6-Phosphate Dehydrogenase Deficiency, hyperkeratosis, headache, pyrexia, arthralgia, papilloma, alopecia, palmar-plantar erythrodysesthesia syndrome, chills, fatigue, rash, nausea, vomiting, diarrhea, abdominal pain, peripheral edema, cough, night sweats, decreased appetite, constipation, myalgia, hyperkeratosis, alopecia, palmar-plantar erythrodysesthesia syndrome, rash, headache, pyrexia, arthralgia, back pain, myalgia, papilloma, cuSCC, cough, constipation, nasopharyngitis, hyperglycemia, hypophosphatemia, increased alkaline phosphatase, hyponatremia, pancreatitis, hypersensitivity manifesting as bullous rash, interstitial nephritis, pyrexia, chills, nausea, rash, night sweats, dry skin, dermatitis acneiform, actinic keratosis, erythema, pruritus, vomiting, diarrhea, abdominal pain, constipation, dry mouth, headache, dizziness, cough, oropharyngeal pain, arthralgia, myalgia, back pain, muscle spasms, pain in extremity, decreased appetite, dehydration, insomnia, hemorrhage, urinary tract infection, renal failure, vision blurred, transient blindness, stomatitis, pancreatitis, asthenia, cellulitis, folliculitis, paronychia, rash pustular, skin papilloma, palmar-plantar erythrodysesthesia syndrome, hyperkeratosis, hyperhidrosis, hypertension, leukopenia, lymphopenia, neutropenia, anemia, thrombocytopenia, increased AST, increased alkaline phosphatase, increased ALT, hyperbilirubinemia, hyperglycemia, increased GGT, hyponatremia, hypoalbuminemia, hypophosphatemia, hypokalemia, increased creatinine, hypomagnesemia, hyperkalemia, hypercalcemia, hypocalcemia, QT Prolongation"
25,TAFINLAR,warnings and precautions,"'retinal vein occlusion, interstitial lung disease, new primary malignancies, cutaneous, non-cutaneous, tumor promotion in BRAF wild-type melanoma, hemorrhage, venous thromboembolism, deep vein thrombosis, pulmonary embolism, cardiomyopathy, ocular toxicities, serious febrile reactions, serious skin toxicity, hyperglycemia, glucose-6-phosphate dehydrogenase deficiency, embryofetal toxicity, cutaneous squamous cell carcinoma, keratoacanthoma, melanoma, basal cell carcinoma, non-cutaneous malignancies, pancreatic adenocarcinoma, colorectal carcinoma, head and neck carcinoma, glioblastoma, major hemorrhagic events, intracranial hemorrhage, gastric hemorrhage, retinal pigment epithelial detachment, uveitis, iritis, fever, hypotension, rigors, chills, dehydration, renal failure, skin toxicity, secondary infections of the skin, hemolytic anemia'"
26,MULTAQ,adverse reactions,"'new or worsening heart failure, liver injury, pulmonary toxicity, hypokalemia, hypomagnesemia, QT prolongation, diarrhea, nausea, abdominal pain, vomiting, asthenia, gastrointestinal disorders, QT prolongation, bradycardia, rashes, pruritus, eczema, dermatitis, dermatitis allergic, photosensitivity reaction, dysgeusia, increases in creatinine, QTc prolonged, worsening heart failure, atrial flutter with 1:1 atrioventricular conduction, liver injury, interstitial lung disease, pneumonitis, pulmonary fibrosis, anaphylactic reactions, angioedema, vasculitis, leukocytoclastic vasculitis'"
27,MULTAQ,boxed warnings,"death, stroke, heart failure"
28,MULTAQ,warnings and precautions,"'atrial fibrillation, liver injury, pulmonary toxicity, hypokalemia, hypomagnesemia, QT interval prolongation, renal impairment, renal failure, increased risk of stroke, new onset or worsening heart failure, hepatocellular liver injury, acute liver failure, interstitial lung disease, pneumonitis, pulmonary fibrosis, dyspnea, non-productive cough, marked increase in serum creatinine, pre-renal azotemia, acute renal failure'"
29,TANZEUM,adverse reactions,"Thyroid C-cell Tumors, Acute Pancreatitis, Hypoglycemia, Hypersensitivity Reactions, Renal Impairment, upper respiratory tract infection, diarrhea, nausea, injection site reaction, cough, back pain, arthralgia, sinusitis, influenza, vomiting, gastroesophageal reflux disease, dyspepsia, constipation, injection site hematoma, injection site erythema, injection site rash, injection site hypersensitivity, injection site hemorrhage, injection site pruritus, pneumonia, atrial fibrillation, atrial flutter, appendicitis, Liver Enzyme Abnormalities, Gamma Glutamyltransferase (GGT) Increase, Heart Rate Increase"
30,TANZEUM,boxed warnings,"thyroid C-cell tumors, medullary thyroid carcinoma"
31,TANZEUM,warnings and precautions,"thyroid C-cell tumors, pancreatitis, hypoglycemia, hypersensitivity reactions, renal impairment, acute renal failure, worsening of chronic renal failure"
32,BELEODAQ,adverse reactions,"'hematologic toxicity, infection, hepatotoxicity, tumor lysis syndrome, gastrointestinal toxicity, nausea, fatigue, pyrexia, anemia, vomiting, constipation, diarrhea, dyspnea, rash, peripheral edema, cough, thrombocytopenia, pruritus, chills, increased blood lactate dehydrogenase, decreased appetite, headache, infusion site pain, hypokalemia, prolonged QT, abdominal pain, hypotension, phlebitis, dizziness, pneumonia, increased creatinine, multi-organ failure, hepatic failure, ventricular fibrillation, febrile neutropenia'"
33,BELEODAQ,warnings and precautions,"thrombocytopenia, leukopenia, neutropenia, lymphopenia, anemia, infections, fatal infections, pneumonia, sepsis, hepatotoxicity, liver function test abnormalities, tumor lysis syndrome, nausea, vomiting, diarrhea, embryo-fetal toxicity, teratogenicity, embryo-fetal lethality"
34,HALAVEN,adverse reactions,"neutropenia, anemia, asthenia/fatigue, alopecia, peripheral neuropathy, nausea, constipation, febrile neutropenia, headache, mucosal inflammation, pyrexia, diarrhea, vomiting, arthralgia/myalgia, back pain, bone pain, pain in extremity, weight decreased, anorexia, cough, dyspnea, urinary tract infection, cytopenias, thrombocytopenia, peripheral motor neuropathy, liver function test abnormalities, increased lacrimation, dyspepsia, abdominal pain, stomatitis, dry mouth, peripheral edema, upper respiratory tract infection, hypokalemia, muscle spasms, muscular weakness, dysgeusia, dizziness, insomnia, depression, rash, lymphopenia, pancreatitis, hepatotoxicity, drug hypersensitivity, pneumonia, sepsis/neutropenic sepsis, hypomagnesemia, dehydration, interstitial lung disease, pruritus"
35,HALAVEN,warnings and precautions,"neutropenia, peripheral neuropathy, embryo-fetal toxicity, QT prolongation, severe neutropenia, Grade 4 neutropenia, febrile neutropenia, Grade 3 peripheral neuropathy, Grade 4 peripheral neuropathy, neuropathy lasting more than one year, new or worsening neuropathy, embryo-fetal toxicity, teratogenicity, QT prolongation, hypokalemia, hypomagnesemia"
36,XIAFLEX,adverse reactions,"tendon ruptures, injury to the injected extremity, corporal rupture (penile fracture), severe penile hematoma, penile ecchymoses, hematoma, sudden penile detumescence, penile ""popping"" sound or sensation, edema peripheral, contusion, injection site hemorrhage, injection site reaction, pain in the injected extremity, pruritus, lymphadenopathy, skin laceration, lymph node pain, erythema, axillary pain, vasovagal syncope, blood blister, injection site hematoma, ecchymosis, penile blister, pruritus genital, painful erection, erectile dysfunction, skin discoloration, procedural pain, injection site vesicles, localized edema, dyspareunia, injection site pruritus, nodule, suprapubic pain"
37,XIAFLEX,boxed warnings,"corporal rupture, penile fracture, serious penile injury, penile ecchymoses, hematoma, sudden penile detumescence, penile ""popping"" sound, severe penile hematoma"
38,XIAFLEX,warnings and precautions,"tendon rupture, serious injury, permanent injury, ligament damage, skin laceration, hypersensitivity reactions, anaphylaxis, abnormal coagulation, corporal rupture (penile fracture), serious injury to the penis, penile ecchymoses, hematoma, sudden penile detumescence, penile ""popping"" sound or sensation, severe penile hematoma, pulley rupture, ligament injury, complex regional pain syndrome (CRPS), sensory abnormality of the hand, skin laceration (tear), skin graft, ecchymosis/contusion, injection site hemorrhage, penile hematoma, penile ecchymosis"
39,CIMZIA,adverse reactions,"upper respiratory tract infection, rash, urinary tract infection, serious infections, malignancies, heart failure, abdominal pain, diarrhea, intestinal obstruction, tuberculosis infections, pyrexia, urticaria, pneumonia, nasopharyngitis, laryngitis, viral infection, bladder infection, bacteriuria, cystitis, arthralgia, anemia, leukopenia, lymphadenopathy, pancytopenia, thrombophilia, angina pectoris, arrhythmias, atrial fibrillation, cardiac failure, hypertensive heart disease, myocardial infarction, myocardial ischemia, pericardial effusion, pericarditis, stroke, transient ischemic attack, optic neuritis, retinal hemorrhage, uveitis, bleeding, injection site reactions, elevated liver enzymes, hepatitis, alopecia totalis, anxiety, bipolar disorder, suicide attempt, nephrotic syndrome, renal failure, menstrual disorder, dermatitis, erythema nodosum, thrombophlebitis, vasculitis, infections, herpes infections, lower respiratory tract infections, serious infection adverse reactions, cellulitis, pyelonephritis, new or worsening heart failure, positive ANA titers, lupus-like syndrome, antibodies to certolizumab pegol, abdominal pain, edema peripheral, erythema nodosum, injection site erythema, injection site pain, pain in extremity, hypersensitivity reactions, angioedema, dermatitis allergic, dizziness (postural), dyspnea, hot flush, hypotension, malaise, serum sickness, (vasovagal) syncope, systemic vasculitis, Stevens-Johnson syndrome, toxic epidermal necrolysis, erythema multiforme, new or worsening psoriasis, sarcoidosis"
40,CIMZIA,boxed warnings,",......, etc."
41,CIMZIA,warnings and precautions,"serious infections, invasive fungal infections, lymphoma, other malignancies, heart failure, anaphylaxis, serious allergic reactions, hepatitis B virus reactivation, demyelinating disease, cytopenias, pancytopenia, lupus-like syndrome, worsening congestive heart failure, new onset CHF, hypersensitivity reactions, angioedema, dyspnea, hypotension, rash, serum sickness, urticaria, hepatitis B virus reactivation, neurologic reactions, seizure disorder, optic neuritis, peripheral neuropathy, hematological reactions, aplastic anemia, leukopenia, thrombocytopenia, autoimmunity, immunosuppression"
42,GRANIX,adverse reactions,"splenic rupture, acute respiratory distress syndrome, serious allergic reactions, capillary leak syndrome, tumor growth stimulatory effects on malignant cells, bone pain, leukocytosis, myalgia, headache, vomiting, Sweet's syndrome, cutaneous vasculitis, thrombocytopenia"
43,GRANIX,warnings and precautions,"'splenic rupture, acute respiratory distress syndrome (ARDS), allergic reactions, angioneurotic edema, dermatitis allergic, drug hypersensitivity, hypersensitivity, rash, pruritic rash, urticaria, sickle cell crisis, capillary leak syndrome'"
44,TUDORZA,adverse reactions,"paradoxical bronchospasm, worsening of narrow-angle glaucoma, worsening of urinary retention, immediate hypersensitivity reactions, headache, nasopharyngitis, cough, diarrhea, sinusitis, rhinitis, toothache, fall, vomiting, diabetes mellitus, dry mouth, 1st degree AV block, osteoarthritis, cardiac failure, cardio-respiratory arrest, anaphylaxis, angioedema, urticaria, rash, bronchospasm, itching"
45,TUDORZA,warnings and precautions,"paradoxical bronchospasm, worsening of narrow-angle glaucoma, worsening of urinary retention, immediate hypersensitivity reactions, anaphylaxis, angioedema, bronchospasm, urticaria, rash, itching"
46,JEVTANA,adverse reactions,"Bone Marrow Suppression, Hypersensitivity Reactions, Gastrointestinal Adverse Reactions, Renal Failure, Embryo-Fetal Toxicity, neutropenia, anemia, leukopenia, thrombocytopenia, diarrhea, fatigue, nausea, vomiting, constipation, asthenia, abdominal pain, hematuria, back pain, anorexia, peripheral neuropathy, pyrexia, dyspnea, dysgeusia, cough, arthralgia, alopecia, infections, renal failure, ventricular fibrillation, cerebral hemorrhage, dyspnea, febrile neutropenia, Neutropenia, Febrile Neutropenia, Anemia, Leukopenia, Thrombocytopenia, Arrhythmia, Diarrhea, Nausea, Vomiting, Constipation, Abdominal Pain, Dyspepsia, Fatigue, Asthenia, Pyrexia, Peripheral Edema, Mucosal Inflammation, Pain, Urinary Tract Infection, Weight Decreased, Dehydration, Back Pain, Arthralgia, Muscle Spasms, Peripheral Neuropathy, Dysgeusia, Dizziness, Headache, Hematuria, Dysuria, Dyspnea, Cough, Alopecia, Hypotension, sepsis, septic shock, Hematuria, increased AST, increased ALT, increased bilirubin, fatigue, neutropenia, asthenia, pyrexia, dizziness, urinary tract infection, dehydration, febrile neutropenia, Gastritis, intestinal obstruction"
47,JEVTANA,boxed warnings,"neutropenic deaths, neutropenia, severe hypersensitivity, generalized rash/erythema, hypotension, bronchospasm"
48,JEVTANA,warnings and precautions,"bone marrow suppression, neutropenia, febrile neutropenia, neutropenic infections, hypersensitivity reactions, nausea, vomiting, diarrhea, gastrointestinal hemorrhage, gastrointestinal perforation, neutropenic enterocolitis, renal failure, fetal harm"
49,ILARIS,adverse reactions,"'infections, serious infections, nasopharyngitis, diarrhea, influenza, headache, nausea, abdominal pain, injection site reactions, vertigo, bronchitis, gastroenteritis, pharyngitis, weight increased, musculoskeletal pain, pneumonia, varicella, measles, sepsis, otitis media, sinusitis, adenovirus, lymph node abscess, hypersensitivity, decreased white blood cells, neutrophils, platelets, high ALT, high AST, elevations of serum bilirubin'"
50,ILARIS,warnings and precautions,"serious infections, infections, recurring infections, opportunistic infections, aspergillosis, atypical mycobacterial infections, cytomegalovirus, herpes zoster, tuberculosis, reactivation of latent tuberculosis, immunosuppression, malignancies, hypersensitivity reactions, anaphylactic reactions, immunizations, macrophage activation syndrome"
51,AMPYRA,adverse reactions,"seizures, anaphylaxis, urinary tract infections, urinary tract infection, insomnia, dizziness, headache, nausea, asthenia, back pain, balance disorder, multiple sclerosis relapse, paresthesia, nasopharyngitis, constipation, dyspepsia, pharyngolaryngeal pain"
52,AMPYRA,warnings and precautions,"seizures, anaphylaxis, severe allergic reactions, respiratory compromise, urticaria, angioedema, urinary tract infections"
53,SIRTURO,adverse reactions,"increased mortality, QT prolongation, hepatotoxicity, nausea, arthralgia, headache, hemoptysis, chest pain, anorexia, transaminases increased, rash, blood amylase increased"
54,SIRTURO,boxed warnings,"increased mortality, QT prolongation, death, ventricular arrhythmia"
55,SIRTURO,warnings and precautions,"QT prolongation, ventricular arrhythmia, QTcF interval > 500 ms, hepatotoxicity, increased mortality, death, ventricular arrhythmias, myocardial infarction, Torsade de Pointes, congenital long QT syndrome, hypothyroidism, bradyarrhythmias, uncompensated heart failure, serum calcium below lower limits of normal, serum magnesium below lower limits of normal, serum potassium below lower limits of normal, clinically significant ventricular arrhythmia, syncope, hepatic-related adverse reactions, fatigue, anorexia, nausea, jaundice, dark urine, liver tenderness, hepatomegaly, aminotransferase elevations, total bilirubin elevation, adverse reactions"
56,ADREVIEW,adverse reactions,"hypersensitivity reactions, dizziness, rash, pruritis, flushing, headache, injection site hemorrhage, hematoma, bruising"
57,ADREVIEW,warnings and precautions,"hypersensitivity reactions, anaphylactic treatment measures, serious reactions, radiation exposure, iodine 123 accumulation, benzyl alcohol toxicity, hypotension, metabolic acidosis, kernicterus, increased long term risk for thyroid neoplasia, hypertension"
58,ARCAPTA,adverse reactions,"asthma-related death, cough, oropharyngeal pain, nasopharyngitis, headache, nausea, COPD, dyspnea, COPD exacerbation, pneumonia, angina pectoris, atrial fibrillation, muscle spasm, musculoskeletal pain, edema peripheral, diabetes mellitus, hyperglycemia, sinusitis, upper respiratory tract infection, hypersensitivity reactions, paradoxical bronchospasm, tachycardia, heart rate increase, palpitations, pruritus, rash, dizziness"
59,ARCAPTA,boxed warnings,asthma-related death
60,ARCAPTA,warnings and precautions,"asthma-related death, cardiovascular effects, fatal, hypersensitivity reactions, paradoxical bronchospasm, cardiovascular disorders, cardiac arrhythmias, hypertension, convulsive disorders, thyrotoxicosis, diabetes mellitus, ketoacidosis, hypokalemia, hyperglycemia"
61,INTELENCE,adverse reactions,"severe skin reactions, hypersensitivity reactions, rash, peripheral neuropathy, diarrhea, myocardial infarction, angina pectoris, atrial fibrillation, vertigo, blurred vision, gastroesophageal reflux disease, flatulence, gastritis, abdominal distension, pancreatitis, constipation, dry mouth, hematemesis, retching, stomatitis, sluggishness, hemolytic anemia, hepatic failure, hepatomegaly, cytolytic hepatitis, hepatic steatosis, hepatitis, drug hypersensitivity, immune reconstitution syndrome, diabetes mellitus, anorexia, dyslipidemia, paraesthesia, somnolence, convulsion, hypoesthesia, amnesia, syncope, disturbance in attention, hypersomnia, tremor, anxiety, sleep disorders, abnormal dreams, confusional state, disorientation, nervousness, nightmares, acute renal failure, gynecomastia, exertional dyspnea, bronchospasm, night sweats, lipohypertrophy, prurigo, hyperhidrosis, dry skin, swelling face, acquired lipodystrophy, angioneurotic edema, erythema multiforme, haemorrhagic stroke, Stevens-Johnson syndrome, erythema multiforme, DRESS, hepatic failure, rhabdomyolysis, toxic epidermal necrolysis"
62,INTELENCE,warnings and precautions,"severe skin reactions, fatal skin reactions, Stevens-Johnson syndrome, hypersensitivity reaction, toxic epidermal necrolysis, erythema multiforme, severe hypersensitivity, severe rash, rash with systemic symptoms, liver transaminase elevations, hypersensitivity reactions, Drug Rash with Eosinophilia and Systemic Symptoms (DRESS), rash, constitutional findings, organ dysfunction, hepatic failure, Grade 3 and 4 rashes, severe rash, rash accompanied by fever, general malaise, fatigue, muscle or joint aches, blisters, oral lesions, conjunctivitis, facial edema, hepatitis, eosinophilia, angioedema, redistribution/accumulation of body fat, central obesity, dorsocervical fat enlargement (buffalo hump), peripheral wasting, facial wasting, breast enlargement, cushingoid appearance, immune reconstitution syndrome, inflammatory response, Mycobacterium avium infection, cytomegalovirus, Pneumocystis jiroveci pneumonia (PCP), tuberculosis, autoimmune disorders, Graves' disease, polymyositis, Guillain-Barre syndrome"
63,PICATO,adverse reactions,"ophthalmic adverse reaction, hypersensitivity reactions, local skin reactions, application site pain, application site pruritus, application site irritation, application site infection, periorbital edema, nasopharyngitis, headache, erythema, flaking/scaling, crusting, swelling, vesiculation/pustulation, erosion/ulceration, eyelid edema, eye pain, conjunctivitis, hypersensitivity, allergic contact dermatitis, herpes zoster, chemical conjunctivitis, corneal burn"
64,PICATO,warnings and precautions,"eye disorders, severe eye pain, chemical conjunctivitis, corneal burn, eyelid edema, eyelid ptosis, periorbital edema, local skin reactions, vesiculation/pustulation, erosion/ulceration, hypersensitivity reactions, anaphylaxis, allergic contact dermatitis, erythema, crusting, swelling"
65,VIZAMYL,adverse reactions,"flushing, headache, increased blood pressure, nausea, dizziness, hypersensitivity reaction, dyspnea, chest pressure"
66,VIZAMYL,warnings and precautions,"hypersensitivity reactions, flushing, dyspnea, image interpretation errors, radiation risk"
67,POTIGA,adverse reactions,"'retinal abnormalities, potential vision loss, urinary retention, skin discoloration, neuropsychiatric symptoms, dizziness, somnolence, QT interval effect, suicidal behavior, ideation, withdrawal seizures, fatigue, confusional state, vertigo, tremor, abnormal coordination, diplopia, disturbance in attention, memory impairment, asthenia, blurred vision, gait disturbance, aphasia, dysarthria, balance disorder, nausea, constipation, dyspepsia, influenza, weight increased, paresthesia, amnesia, dysphasia, anxiety, disorientation, psychotic disorder, dysuria, urinary hesitation, hematuria, chromaturia, increased appetite, hallucinations, myoclonus, peripheral edema, hypokinesia, dry mouth, dysphagia, hyperhydrosis, malaise, increased liver enzymes, rash, nystagmus, dyspnea, leukopenia, muscle spasms, alopecia, nephrolithiasis, syncope, neutropenia, thrombocytopenia, euphoric mood, renal colic, coma, encephalopathy'"
68,POTIGA,boxed warnings,"retinal abnormalities, vision loss, abnormal visual acuity, decreased visual acuity, damage to the photoreceptors, retinal pigmentary abnormalities, vision changes"
69,POTIGA,warnings and precautions,"urinary retention, skin discoloration, confusional state, psychotic symptoms, hallucinations, dizziness, somnolence, QT prolongation, suicidal thoughts or behaviors, retinal abnormalities, potential vision loss, hydronephrosis, renal function impairment, blue skin discoloration, grey-blue skin discoloration, brown skin discoloration, nail discoloration, lip discoloration, mucous membrane discoloration, perivascular pigmentation, retinal pigment epithelium clumping, abnormal visual acuity, retinal dystrophy, electroretinogram abnormalities, electrooculogram abnormalities, fluorescein angiography abnormalities, diminished sensitivity on visual field testing, urinary hesitation, dysuria, psychosis, visual hallucinations, auditory hallucinations, mixed hallucinations, withdrawal seizures"
70,BREO,adverse reactions,"asthma-related death, asthma-related hospitalization, asthma-related deaths, Candida albicans infection, pneumonia, immunosuppression, hypercorticism, adrenal suppression, reduction in bone mineral density, nasopharyngitis, upper respiratory tract infection, headache, oral candidiasis, oropharyngeal candidiasis, oropharyngeal pain, dysphonia, cough, back pain, bronchitis, sinusitis, arthralgia, influenza, pharyngitis, pyrexia, viral respiratory tract infection, extrasystoles, upper abdominal pain, respiratory tract infection, allergic rhinitis, rhinitis, supraventricular extrasystoles, ventricular extrasystoles, acute sinusitis, palpitations, tachycardia, hypersensitivity reactions, anaphylaxis, angioedema, rash, urticaria, muscle spasms, tremor, nervousness"
71,BREO,boxed warnings,"asthma-related death, increase in asthma-related deaths, increased risk of asthma-related hospitalization"
72,BREO,warnings and precautions,"asthma-related death, asthma-related hospitalizations, Candida albicans infection, pneumonia, worsening of infections, tuberculosis, fungal infections, bacterial infections, viral infections, parasitic infections, ocular herpes simplex, chickenpox, measles, impaired adrenal function, hypercorticism, adrenal suppression, paradoxical bronchospasm, anaphylaxis, angioedema, rash, urticaria, cardiovascular effects, cardiac arrhythmias, supraventricular tachycardia, extrasystoles, electrocardiographic changes, QTc interval prolongation, ST segment depression, bone mineral density reduction, glaucoma, cataracts, convulsive disorders, thyrotoxicosis, diabetes mellitus, ketoacidosis, hypokalemia, hyperglycemia, growth velocity reduction"
73,DOTAREM,adverse reactions,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, hepatotoxicity, NSF, hypersensitivity reactions, acute kidney injury, nausea, headache, injection site pain, injection site coldness, burning sensation, feeling cold, rash, somnolence, fatigue, dizziness, vomiting, pruritus, paresthesia, dysgeusia, pain in extremity, anxiety, hypertension, palpitations, oropharyngeal discomfort, serum creatinine increased, injection site reactions, site inflammation, extravasation, warmth, bradycardia, tachycardia, arrhythmia, anaphylactoid reactions, cardiac arrest, respiratory arrest, cyanosis, pharyngeal edema, laryngospasm, bronchospasm, angioedema, conjunctivitis, ocular hyperemia, eyelid edema, lacrimation increased, hyperhidrosis, urticaria, coma, convulsion, syncope, presyncope, parosmia, tremor, muscle contracture, muscle weakness, diarrhea, salivary hypersecretion, malaise, fever, superficial phlebitis"
74,DOTAREM,boxed warnings,"nephrogenic systemic fibrosis, fatal fibrosis, debilitating fibrosis, chronic severe kidney disease, acute kidney injury"
75,DOTAREM,warnings and precautions,"nephrogenic systemic fibrosis, anaphylactoid reactions, anaphylactic reactions, cardiovascular manifestations, respiratory manifestations, cutaneous manifestations, death, acute kidney injury, drug-induced kidney toxicity, NSF, fibrosis affecting the skin, fibrosis affecting the muscle, fibrosis affecting internal organs, circulatory collapse, hypersensitivity reactions, extravasation, tissue irritation"
76,NESINA,adverse reactions,"nasopharyngitis, headache, upper respiratory tract infection, pancreatitis, hypersensitivity reactions, hypoglycemia, anaphylaxis, angioedema, rash, urticaria, severe cutaneous adverse reactions, Stevens-Johnson syndrome, hepatic enzyme elevations, fulminant hepatic failure, severe and disabling arthralgia, acute pancreatitis"
77,NESINA,warnings and precautions,"acute pancreatitis, hypersensitivity reactions, anaphylaxis, angioedema, severe cutaneous adverse reactions, Stevens-Johnson syndrome, hepatic failure, hypoglycemia, arthralgia"
78,EYLEA,adverse reactions,"endophthalmitis, retinal detachments, increased intraocular pressure, thromboembolic events, conjunctival hemorrhage, eye pain, cataract, vitreous floaters, intraocular pressure increased, vitreous detachment, ocular hyperemia, corneal epithelium defect, detachment of the retinal pigment epithelium, injection site pain, foreign body sensation in eyes, lacrimation increased, vision blurred, intraocular inflammation, retinal pigment epithelium tear, injection site hemorrhage, eyelid edema, corneal edema, hypersensitivity, retinal detachment, retinal tear, endophthalmitis, immunogenicity"
79,EYLEA,warnings and precautions,"endophthalmitis, retinal detachments, increases in intraocular pressure, arterial thromboembolic events, nonfatal stroke, nonfatal myocardial infarction, vascular death"
80,TECFIDERA,adverse reactions,"anaphylaxis, angioedema, progressive multifocal leukoencephalopathy, lymphopenia, flushing, abdominal pain, diarrhea, nausea, vomiting, pruritus, rash, albumin urine present, erythema, dyspepsia, aspartate aminotransferase increased, eosinophilia"
81,TECFIDERA,warnings and precautions,"anaphylaxis, angioedema, progressive multifocal leukoencephalopathy (PML), lymphopenia, infections, serious infections, flushing"
82,TREANDA,adverse reactions,"myelosuppression, infections, anaphylaxis, infusion reactions, tumor lysis syndrome, skin reactions, other malignancies, extravasation injury, pyrexia, nausea, vomiting, diarrhea, constipation, anorexia, cough, headache, weight decreased, dyspnea, rash, stomatitis, lymphopenia, anemia, leukopenia, thrombocytopenia, neutropenia, asthenia, fatigue, malaise, weakness, dry mouth, somnolence, mucosal inflammation, hypertension, hypertensive crisis, hypersensitivity, gastrointestinal disorders, general disorders and administration site conditions, immune system disorders, infections and infestations, investigations, metabolism and nutrition disorders, respiratory, thoracic and mediastinal disorders, skin and subcutaneous tissue disorders, bilirubin elevations, increased bilirubin, increased AST, increased ALT, creatinine levels changes, cardiac disorders, tachycardia, abdominal pain, dyspepsia, gastroesophageal reflux disease, edema peripheral, chest pain, infusion site pain, pain, catheter site pain, herpes zoster, upper respiratory tract infection, urinary tract infection, sinusitis, febrile neutropenia, oral candidiasis, nasopharyngitis, dehydration, decreased appetite, hypokalemia, musculoskeletal and connective tissue disorders, back pain, arthralgia, pain in extremity, bone pain, nervous system disorders, dizziness, dysgeusia, psychiatric disorders, insomnia, anxiety, depression, pharyngolaryngeal pain, wheezing, nasal congestion, dry skin, night sweats, hyperhidrosis, vascular disorders, hypotension, hyperglycemia, elevated creatinine, hyponatremia, hypocalcemia, acute renal failure, cardiac failure, pulmonary fibrosis, myelodysplastic syndrome, hemolysis, taste disorder, atypical pneumonia, sepsis, erythema, dermatitis, skin necrosis, anaphylaxis, injection or infusion site reactions, phlebitis, pruritus, irritation, pain, swelling, pneumocystis jiroveci pneumonia, pneumonitis, Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN)"
83,TREANDA,warnings and precautions,"myelosuppression, death, infections, fever, anaphylaxis, infusion reactions, tumor lysis syndrome, acute renal failure, skin reactions, Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), other malignancies, extravasation injury, erythema, swelling, pain, embryo-fetal toxicity, resorptions, skeletal malformations, visceral malformations, decreased fetal body weights"
84,ELIQUIS,adverse reactions,"thrombotic events, bleeding, spinal/epidural anesthesia or puncture, intracranial bleed, intracerebral bleeding, intraventricular bleeding, subdural bleeding, subarachnoid bleeding, hemorrhagic stroke, gastrointestinal bleed, upper GI bleed, lower GI bleed, rectal bleeding, fatal bleeding, non-intracranial bleeding, hypersensitivity reactions, skin rash, anaphylactic reactions, allergic edema, syncope, nausea, anemia, postoperative anemia, hemorrhagic anemia, contusion, hemorrhage, hematoma, vaginal hemorrhage, urethral hemorrhage, postprocedural hemorrhage, postprocedural hematoma, wound hemorrhage, vessel puncture site hematoma, catheter site hemorrhage, transaminases increased, alanine aminotransferase increased, alanine aminotransferase abnormal, aspartate aminotransferase increased, gamma-glutamyltransferase increased, thrombocytopenia, platelet count decreases, hypotension, procedural hypotension, respiratory disorders, thoracic disorders, mediastinal disorders, epistaxis, gastrointestinal hemorrhage, hematemesis, melena, hematochezia, hepatobiliary disorders, liver function test abnormal, blood alkaline phosphatase increased, blood bilirubin increased, renal disorders, urinary disorders, hematuria, injury, poisoning, procedural complications, wound secretion, incision-site hemorrhage, incision-site hematoma, operative hemorrhage, gingival bleeding, hemoptysis, muscle hemorrhage, ocular hemorrhage, conjunctival hemorrhage, rectal hemorrhage, vaginal hemorrhage, metrorrhagia, menometrorrhagia, genital hemorrhage, hemorrhage, ecchymosis, skin hemorrhage, petechiae, eye disorders, conjunctival hemorrhage, retinal hemorrhage, eye hemorrhage, investigations, blood urine present, occult blood positive, occult blood, red blood cells urine positive, general disorders, administration-site conditions, injection-site hematoma, vessel puncture-site hematoma"
85,ELIQUIS,boxed warnings,"thrombotic events, spinal/epidural hematoma, paralysis"
86,ELIQUIS,warnings and precautions,"serious, potentially fatal bleeding, thrombotic events, stroke, bleeding, blood loss, active pathological hemorrhage, epidural or spinal hematoma, long-term or permanent paralysis, neurological impairment"
87,BOSULIF,adverse reactions,"gastrointestinal toxicity, myelosuppression, hepatic toxicity, fluid retention, renal toxicity, diarrhea, nausea, thrombocytopenia, vomiting, abdominal pain, rash, anemia, pyrexia, fatigue, anaphylactic shock, increased alanine aminotransferase, headache, cough, increased aspartate aminotransferase, neutropenia, edema, arthralgia, decreased appetite, respiratory tract infection, nasopharyngitis, back pain, asthenia, pruritus, dizziness, dyspnea, QTcF interval prolongation, platelet count low, absolute neutrophil count low, hemoglobin low, SGPT/ALT increased, SGOT/AST increased, lipase increased, phosphorus low, total bilirubin increased, febrile neutropenia, pericardial effusion, pericarditis, tinnitus, gastritis, acute pancreatitis, gastrointestinal hemorrhage, chest pain, pain, hepatotoxicity, abnormal hepatic function, liver injury, drug hypersensitivity, pneumonia, influenza, bronchitis, electrocardiogram QT prolonged, increased blood creatine phosphokinase, increased blood creatinine, hyperkalemia, dehydration, myalgia, dysgeusia, acute renal failure, renal failure, pleural effusion, acute pulmonary edema, respiratory failure, pulmonary hypertension, urticaria, acne, erythema multiforme, exfoliative rash, drug eruption"
88,BOSULIF,warnings and precautions,"'gastrointestinal toxicity, diarrhea, nausea, vomiting, abdominal pain, myelosuppression, thrombocytopenia, anemia, neutropenia, hepatic toxicity, drug induced liver injury, ALT elevation, AST elevation, fluid retention, pericardial effusion, pleural effusion, pulmonary edema, peripheral edema, renal toxicity, decline in estimated glomerular filtration rate (eGFR), embryofetal toxicity'"
89,GILENYA,adverse reactions,"bradyarrhythmia, atrioventricular blocks, infections, progressive multifocal leukoencephalopathy, macular edema, posterior reversible encephalopathy syndrome, respiratory effects, liver injury, headache, liver transaminase elevation, diarrhea, cough, influenza, sinusitis, back pain, abdominal pain, pain in extremity, serum transaminase elevations, basal cell carcinoma, influenza, sinusitis, bronchitis, herpes zoster, tinea versicolor, bradycardia, headache, migraine, nausea, diarrhea, abdominal pain, asthenia, back pain, pain in extremity, alopecia, actinic keratosis, liver transaminase elevations, blood triglycerides increased, cough, dyspnea, vision blurred, hypertension, lymphopenia, leukopenia, skin papilloma, basal cell carcinoma, dizziness, pneumonia, eczema, pruritus, ischemic strokes, hemorrhagic strokes, peripheral arterial occlusive disease, lymphoma"
90,GILENYA,warnings and precautions,"bradycardia, atrioventricular conduction, infections, progressive multifocal leukoencephalopathy (PML), macular edema, posterior reversible encephalopathy syndrome (PRES), decrease in pulmonary function tests (PFT), liver injury, blood pressure (BP) effects, immune system effects, symptomatic bradycardia, hypotension, dizziness, fatigue, palpitations, chest pain, atrioventricular blocks, third-degree AV block, AV block with junctional escape, transient asystole, unexplained death, syncope, bronchitis, herpes zoster, influenza, sinusitis, pneumonia, herpetic infections, disseminated primary herpes zoster, herpes simplex encephalitis, disseminated varicella zoster, herpes simplex infections, encephalitis, multiorgan failure, cryptococcal infections, cryptococcal meningitis, varicella zoster virus, bradyarrhythmia, atrioventricular blocks, reduction in heart rate, Mobitz Types I, 2:1 AV blocks, second-degree AV blocks, visual disturbances, blurred vision, decreased visual acuity, respiratory effects, dyspnea, elevations of liver enzymes, nausea, vomiting, abdominal pain, fatigue, anorexia, jaundice, dark urine, hypertension, lymphocyte counts decrease"
91,BENLYSTA,adverse reactions,"mortality, serious infections, malignancy, hypersensitivity reactions, anaphylaxis, infusion reactions, depression, nausea, diarrhea, pyrexia, nasopharyngitis, bronchitis, insomnia, pain in extremity, migraine, pharyngitis, cystitis, leukopenia, gastroenteritis viral, fatal anaphylaxis"
92,BENLYSTA,warnings and precautions,"mortality, serious infections, fatal infections, progressive multifocal leukoencephalopathy (PML), hypersensitivity reactions, anaphylaxis, depression, suicidality, malignancies, non-melanoma skin cancers, infusion reactions, bradycardia, myalgia, headache, rash, urticaria, hypotension, nausea, skin reactions, psychiatric events, insomnia, anxiety, serious psychiatric events, serious depression, suicides"
93,XALKORI,adverse reactions,"hepatotoxicity, interstitial lung disease, pneumonitis, QT interval prolongation, bradycardia, severe visual loss, vision disorders, diarrhea, nausea, vomiting, constipation, edema, elevated transaminases, upper respiratory infection, decreased appetite, dysgeusia, dyspnea, pulmonary embolism, septic shock, acute respiratory failure, diabetic ketoacidosis, nausea, elevated transaminases, hepatotoxicity, ILD, neutropenia, lymphopenia, ALT elevation, AST elevation, hypophosphatemia, pneumonia, dyspnea, ILD, respiratory failure, sepsis, alanine aminotransferase elevation, QTc prolongation, neutropenia, ILD, ALT and AST elevation, dyspnea, pulmonary embolism, pulmonary embolism, edema, neuropathy, rash, renal cyst, ILD, syncope, hepatic failure, hypokalemia, hypophosphatemia, visual impairment, photopsia, blurred vision, vitreous floaters, sensory neuropathy"
94,XALKORI,warnings and precautions,"'fatal hepatotoxicity, hepatotoxicity, Interstitial Lung Disease, ILD, Pneumonitis, QT Interval Prolongation, Bradycardia, Severe Visual Loss, Embryofetal Toxicity, elevated transaminases, fatal interstitial lung disease, drug-related ILD/pneumonitis, QTc prolongation, Torsade de pointes, polymorphic ventricular tachycardia, serious arrhythmia, symptomatic bradycardia, Grade 3 syncope, vision loss, optic atrophy, optic nerve disorder, embryotoxicity, fetotoxicity'"
95,CLEVIPREX,adverse reactions,"hypotension, reflex tachycardia, headache, nausea, vomiting, acute renal failure, atrial fibrillation, myocardial infarction, cardiac arrest, syncope, dyspnea, increased blood triglycerides, ileus, hypersensitivity, decreased oxygen saturation (possible pulmonary shunting)"
96,CLEVIPREX,warnings and precautions,"hypotension, reflex tachycardia, negative inotropic effects, exacerbate heart failure, rebound hypertension"
97,LUMIZYME,adverse reactions,"hypersensitivity reactions, anaphylaxis, rash, pyrexia, flushing/feeling hot, urticaria, headache, hyperhidrosis, nausea, cough, decreased oxygen saturation, tachycardia, tachypnea, chest discomfort, dizziness, muscle twitching, agitation, cyanosis, erythema, hypertension/increased blood pressure, pallor, rigors, tremor, vomiting, fatigue, myalgia, acute cardiorespiratory failure, livedo reticularis, irritability, retching, increased lacrimation, ventricular extrasystoles, nodal rhythm, rales, respiratory tract irritation, cold sweat, angioedema, throat tightness, supraventricular tachycardia, local swelling, diarrhea, pruritus, edema, peripheral, rash papular, flu-like illness, arthralgia, pain, anaphylactic shock, respiratory failure, respiratory arrest, cardiac arrest, hypoxia, dyspnea, wheezing, convulsions, peripheral coldness, restlessness, nervousness, back pain, stridor, pharyngeal edema, abdominal pain, apnea, muscle spasm, conjunctivitis, hyperparathyroidism, proteinuria, nephrotic syndrome, membranous glomerulonephritis, necrotizing skin lesions"
98,LUMIZYME,boxed warnings,"anaphylactic reactions, hypersensitivity reactions, respiratory distress, hypoxia, apnea, dyspnea, bradycardia, tachycardia, bronchospasm, throat tightness, hypotension, angioedema, tongue swelling, lip swelling, periorbital edema, face edema, urticaria, proteinuria, nephrotic syndrome, necrotizing skin lesions, fluid overload, exacerbation of cardiac compromise, exacerbation of respiratory compromise"
99,LUMIZYME,warnings and precautions,"'anaphylaxis, hypersensitivity reactions, immune-mediated reactions, acute cardiorespiratory failure, cardiac arrhythmia, sudden cardiac death, antibody development, anaphylactic shock, cardiac arrest, respiratory arrest, respiratory distress, hypoxia, apnea, dyspnea, bradycardia, tachycardia, bronchospasm, throat tightness, hypotension, angioedema, urticaria, chest discomfort/pain, wheezing, tachypnea, cyanosis, decreased oxygen saturation, convulsions, pruritus, rash, hyperhidrosis, nausea, dizziness, hypertension/increased blood pressure, flushing/feeling hot, erythema, pyrexia, pallor, peripheral coldness, restlessness, nervousness, headache, back pain, paresthesia, necrotizing skin lesions, inflammatory arthropathy, pyrexia, elevated erythrocyte sedimentation rate, nephrotic syndrome, membranous glomerulonephritis, immune complex deposition, ventricular arrhythmias, bradycardia, cardiac resuscitation, defibrillation, IgG antibody formation, loss of motor function, ventilator dependence, inhibitory antibody activity, IgE antibodies'"
100,CERDELGA,adverse reactions,"'fatigue, headache, nausea, diarrhea, back pain, pain in extremities, upper abdominal pain, arthralgia, migraine, flatulence, oropharyngeal pain, dizziness, asthenia, cough, dyspepsia, gastroesophageal reflux disease, constipation, palpitations, rash'"
101,CERDELGA,warnings and precautions,"ECG changes, cardiac arrhythmias, prolongation of the PR interval, prolongation of the QTc interval, prolongation of the QRS interval"
102,NEURACEQ,adverse reactions,"erythema, irritation, pain"
103,NEURACEQ,warnings and precautions,"image interpretation errors, false positives, unintentional radiation exposure, errors, motion artifacts, increased risk of cancer"
104,PROLIA,adverse reactions,"hypocalcemia, serious infections, dermatologic adverse reactions, osteonecrosis of the jaw, atypical subtrochanteric and diaphyseal femoral fractures, pancreatitis, new malignancies, back pain, pain in extremity, musculoskeletal pain, hypercholesterolemia, cystitis, arthralgia, nasopharyngitis, anemia, angina pectoris, atrial fibrillation, vertigo, abdominal pain upper, flatulence, gastroesophageal reflux disease, edema peripheral, asthenia, upper respiratory tract infection, pneumonia, pharyngitis, herpes zoster, bone pain, myalgia, spinal osteoarthritis, sciatica, insomnia, rash, pruritus, cataracts, drug-related hypersensitivity reactions, anaphylaxis, rash, urticaria, facial swelling, erythema, severe symptomatic hypocalcemia, severe musculoskeletal pain, marked elevation in serum PTH"
105,PROLIA,warnings and precautions,"hypersensitivity, anaphylactic reactions, hypocalcemia, osteonecrosis of the jaw, atypical femoral fractures, serious infections, skin infections, dermatologic reactions, dermatitis, rashes, eczema, severe bone pain, joint pain, muscle pain, suppression of bone turnover"
106,FANAPT,adverse reactions,"dizziness, dry mouth, fatigue, nasal congestion, orthostatic hypotension, somnolence, tachycardia, weight increased, arthralgia, musculoskeletal stiffness, nausea, diarrhea, abdominal discomfort, nasopharyngitis, upper respiratory tract infection, extrapyramidal disorder, tremor, lethargy, ejaculation failure, dyspnea, rash, hypotension, akathisia, bradykinesia, dyskinesia, dystonia, parkinsonism, anemia, iron deficiency anemia, leukopenia, palpitations, arrhythmia, atrioventricular block first degree, cardiac failure, vertigo, tinnitus, hypothyroidism, conjunctivitis, dry eye, blepharitis, eyelid edema, eye swelling, lenticular opacities, cataract, hyperemia, gastritis, salivary hypersecretion, fecal incontinence, mouth ulceration, aphthous stomatitis, duodenal ulcer, hiatus hernia, hyperchlorhydria, lip ulceration, reflux esophagitis, stomatitis, edema, difficulty in walking, thirst, hyperthermia, cholelithiasis, weight decreased, hemoglobin decreased, neutrophil count increased, hematocrit decreased, increased appetite, dehydration, hypokalemia, fluid retention, myalgia, muscle spasms, torticollis, paresthesia, psychomotor hyperactivity, restlessness, amnesia, nystagmus, restless legs syndrome, aggression, delusion, hostility, libido decreased, paranoia, anorgasmia, confusional state, mania, catatonia, mood swings, panic attack, obsessive-compulsive disorder, bulimia nervosa, delirium, polydipsia psychogenic, impulse-control disorder, major depression, urinary incontinence, dysuria, pollakiuria, enuresis, nephrolithiasis, urinary retention, renal failure acute, erectile dysfunction, testicular pain, amenorrhea, breast pain, menstruation irregular, gynecomastia, menorrhagia, metrorrhagia, postmenopausal hemorrhage, prostatitis, epistaxis, asthma, rhinorrhea, sinus congestion, nasal dryness, dry throat, sleep apnea syndrome, dyspnea exertional, retrograde ejaculation"
107,FANAPT,boxed warnings,"Answer: 'increased mortality, death, cardiovascular reactions (e.g., heart failure, sudden death), infectious reactions (e.g., pneumonia)'"
108,FANAPT,warnings and precautions,"'increased risk of death, cerebrovascular-related adverse events, stroke, QT prolongation, arrhythmia, sudden death, Neuroleptic Malignant Syndrome, Tardive dyskinesia, hyperglycemia, diabetes mellitus, dyslipidemia, weight gain, seizures, orthostatic hypotension, dizziness, tachycardia, syncope, leukopenia, neutropenia, agranulocytosis, suicide, priapism, cognitive impairment, motor impairment, hyperprolactinemia, body temperature regulation disruption, dysphagia, aspiration pneumonia'"
109,FULYZAQ,adverse reactions,"'upper respiratory tract infection, bronchitis, cough, flatulence, increased bilirubin, nausea, back pain, arthralgia, urinary tract infection, nasopharyngitis, musculoskeletal pain, hemorrhoids, giardiasis, anxiety, increased alanine aminotransferase, abdominal distension, abdominal pain, acne, increased aspartate aminotransferase, increased conjugated bilirubin, increased unconjugated blood bilirubin, constipation, depression, dermatitis, dizziness, dry mouth, dyspepsia, gastroenteritis, herpes zoster, nephrolithiasis, pain in extremity, pollakiuria, procedural pain, seasonal allergy, sinusitis, decreased white blood cell count'"
110,FULYZAQ,warnings and precautions,disease may worsen
111,EOVIST,adverse reactions,"nephrogenic systemic fibrosis, hypersensitivity reactions, nausea, headache, feeling hot, dizziness, back pain, vomiting, blood pressure increased, injection site reactions, dysgeusia, paresthesia, flushing, parosmia, pruritus, rash, respiratory disorders, fatigue, chest pain, vertigo, dry mouth, chills, feeling abnormal, tremor, akathisia, bundle branch block, palpitation, oral discomfort, salivary hypersecretion, maculopapular rash, hyperhidrosis, discomfort, malaise, elevation of serum iron values, elevation of serum bilirubin, anaphylactic shock, hypotension, pharyngolaryngeal edema, urticaria, face edema, rhinitis, conjunctivitis, abdominal pain, hypoesthesia, sneezing, cough, pallor, tachycardia, restlessness"
112,EOVIST,boxed warnings,"nephrogenic systemic fibrosis, fatal fibrosis, debilitating fibrosis"
113,EOVIST,warnings and precautions,"nephrogenic systemic fibrosis, hypersensitivity reactions, anaphylactoid reactions, cardiovascular manifestations, respiratory manifestations, cutaneous manifestations, severe reactions, shock, acute kidney injury, dialysis, extravasation, injection site reactions, myocyte necrosis, inflammation, falsely high or low serum iron values, impaired visualization of liver lesions"
114,ONFI,adverse reactions,"somnolence or sedation, potentiation of sedation, withdrawal symptoms, serious dermatological reactions, physical and psychological dependence, suicidal behavior and ideation, constipation, pyrexia, lethargy, drooling, vomiting, dysphagia, irritability, fatigue, upper respiratory tract infection, pneumonia, urinary tract infection, bronchitis, decreased appetite, increased appetite, somnolence, sedation, drooling, ataxia, psychomotor hyperactivity, dysarthria, aggression, insomnia, cough, anemia, eosinophilia, leukopenia, thrombocytopenia, diplopia, vision blurred, abdominal distention, hypothermia, hepatic enzyme increased, muscle spasms, agitation, anxiety, apathy, confusional state, depression, delirium, delusion, hallucination, urinary retention, aspiration, respiratory depression, rash, urticaria, angioedema, facial and lip edema"
115,ONFI,warnings and precautions,"'somnolence, sedation, CNS depression, withdrawal symptoms, serious dermatological reactions, Stevens-Johnson syndrome, toxic epidermal necrolysis, physical dependence, psychological dependence, suicidal behavior, suicidal ideation, convulsions, psychosis, hallucinations, behavioral disorder, tremor, anxiety, dysphoria, insomnia, depression, mood changes, thoughts about self-harm'"
116,COMETRIQ,adverse reactions,"perforations, fistula, hemorrhage, thromboembolic events, wound complications, hypertension, osteonecrosis of the jaw, palmar-plantar erythrodysesthesia syndrome, proteinuria, reversible posterior leukoencephalopathy syndrome, diarrhea, stomatitis, decreased weight, decreased appetite, nausea, fatigue, oral pain, hair color changes, dysgeusia, abdominal pain, constipation, increased AST, increased ALT, lymphopenia, increased alkaline phosphatase, hypocalcemia, neutropenia, thrombocytopenia, hypophosphatemia, hyperbilirubinemia, pneumonia, septicemia, cardiac arrest, respiratory failure, unspecified death, hypocalcemia, increased lipase, pancreatitis, tracheal fistula formation, vomiting, increased levels of thyroid stimulating hormone, dehydration, arthralgia, muscle spasms, musculoskeletal chest pain, headache, dizziness, paresthesia, peripheral sensory neuropathy, peripheral neuropathy, anxiety, dysphonia, rash, dry skin, alopecia, erythema, hyperkeratosis, hypotension, hypomagnesemia, hypokalemia, hyponatremia"
117,COMETRIQ,boxed warnings,"perforations, fistulas, gastrointestinal perforations, fistula formation, hemorrhage, fatal hemorrhage, hemoptysis, gastrointestinal hemorrhage"
118,COMETRIQ,warnings and precautions,"thrombotic events, myocardial infarction, cerebral infarction, arterial thromboembolic events, wound complications, dehiscence, hypertension, hypertensive crisis, osteonecrosis of the jaw, palmar-plantar erythrodysesthesia syndrome, proteinuria, nephrotic syndrome, reversible posterior leukoencephalopathy syndrome, gastrointestinal perforations, fistulas, non-GI fistulas, tracheal/esophageal fistulas, hemorrhage, hemoptysis, thromboembolism, venous thromboembolism, arterial thromboembolism, wound healing complications, treatment-emergent hypertension, jaw pain, osteomyelitis, osteitis, bone erosion, tooth or periodontal infection, toothache, gingival ulceration or erosion, slow healing of the mouth or jaw, seizures, headache, visual disturbances, confusion, altered mental function, embryolethal, skeletal variations, visceral variations, malformations"
119,NULOJIX,adverse reactions,"PTLD, CNS PTLD, malignancies, serious infections, JC virus-associated PML, polyoma virus nephropathy, anemia, diarrhea, urinary tract infection, peripheral edema, constipation, hypertension, pyrexia, graft dysfunction, cough, nausea, vomiting, headache, hypokalemia, hyperkalemia, leukopenia, cytomegalovirus infection, complications of transplanted kidney, post-transplant lymphoproliferative disorder, non-melanoma skin cancer, progressive multifocal leukoencephalopathy, bacterial infections, mycobacterial infections, viral infections, fungal infections, tuberculosis, herpes infections, cryptococcal meningitis, Chagas encephalitis, cerebral aspergillosis, West Nile encephalitis, infusion reactions, hypotension, proteinuria, immunogenicity, new-onset diabetes after transplantation, dyslipidemia, upper respiratory infection, nasopharyngitis, influenza, bronchitis, abdominal pain, hypophosphatemia, dyslipidemia, hyperglycemia, hypocalcemia, hypercholesterolemia, hypomagnesemia, hyperuricemia, graft dysfunction, hematuria, dysuria, renal tubular necrosis, hypotension, dyspnea, blood creatinine increased, arthralgia, back pain, dizziness, tremor, acne, insomnia, anxiety, Guillain-Barre syndrome, stomatitis, aphthous stomatitis, chronic allograft nephropathy, wound dehiscence, arteriovenous fistula thrombosis, neutropenia, renal impairment, acute renal failure, renal artery stenosis, urinary incontinence, hydronephrosis, hematoma, lymphocele, musculoskeletal pain, alopecia, hyperhidrosis, atrial fibrillation"
120,NULOJIX,boxed warnings,"'post-transplant lymphoproliferative disorder, malignancies, serious infections, increased susceptibility to infection, graft loss, death'"
121,NULOJIX,warnings and precautions,"'post-transplant lymphoproliferative disorder, other malignancies, progressive multifocal leukoencephalopathy, serious infections, bacterial infections, viral infections, fungal infections, protozoal infections, opportunistic infections, tuberculosis, polyoma virus-associated nephropathy, graft loss, death, acute rejection, grade III rejection, liver allograft involvement, cytomegalovirus, herpes, pneumocystis jiroveci, JC virus-associated PML, BK virus infection, deteriorating renal function, kidney graft loss, increased rate of graft loss, higher rate of death, fatal outcomes, increased risk of bacterial infections, increased risk of viral infections, increased risk of fungal infections, increased risk of protozoal infections, increased risk of opportunistic infections, increased risk of tuberculosis, cytomegalovirus prophylaxis, pneumocystis prophylaxis, tuberculosis treatment, latent tuberculosis infection treatment, reduction in immunosuppression, increased rate and grade of acute rejection, increased risk of grade III rejection, avoidance of live vaccines, intranasal influenza, measles, mumps, rubella, oral polio, BCG, yellow fever, varicella, TY21a typhoid vaccines'"
122,GILOTRIF,adverse reactions,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, serious infections, opportunistic infections, tumor lysis syndrome, increased toxicity in the presence of severe renal impairment, increased toxicity in the presence of moderate or severe hepatic impairment, hepatotoxicity, diarrhea, bullous skin disorders, exfoliative skin disorders, interstitial lung disease, hepatic toxicity, keratitis, rash/dermatitis acneiform, stomatitis, paronychia, dry skin, decreased appetite, nausea, vomiting, pruritus, serious adverse reactions, pulmonary toxicity/ILD-like adverse reactions, sepsis, pneumonia, ventricular dysfunction, gastrointestinal disorders, skin and subcutaneous tissue disorders, infections and infestations, metabolism and nutrition disorders, respiratory, thoracic and mediastinal disorders, investigations, general disorders and administration site conditions, eye disorders, laboratory abnormalities, pancreatitis"
123,GILOTRIF,warnings and precautions,"diarrhea, dehydration, renal failure, bullous skin disorders, exfoliative skin disorders, interstitial lung disease (ILD), hepatic toxicity, fatal hepatic impairment, keratitis, embryofetal toxicity"
124,DATSCAN,adverse reactions,"hypersensitivity, injection site reactions, headache, nausea, vertigo, dry mouth, dizziness, rash, pruritis, injection site pain"
125,DATSCAN,warnings and precautions,"hypersensitivity reactions, skin erythema, pruritis, anaphylactic, thyroid neoplasia"
126,KALBITOR,adverse reactions,"hypersensitivity reactions, anaphylaxis, headache, nausea, diarrhea, pyrexia, injection site reactions, nasopharyngitis, fatigue, upper respiratory tract infection, vomiting, pruritus, upper abdominal pain, seroconversion, anti-ecallantide antibodies, neutralizing antibodies, anti-ecallantide IgE antibodies, anti-P. pastoris IgE antibodies"
127,KALBITOR,boxed warnings,"Answer: 'anaphylaxis, hypersensitivity reactions'"
128,KALBITOR,warnings and precautions,"hypersensitivity reactions, anaphylaxis, chest discomfort, flushing, pharyngeal edema, pruritus, rhinorrhea, sneezing, nasal congestion, throat irritation, urticaria, wheezing, hypotension, rash"
129,APTIOM,adverse reactions,"suicidal behavior and ideation, serious dermatologic reactions, drug reaction with eosinophilia and systemic symptoms (DRESS)/multiorgan hypersensitivity, anaphylactic reactions, angioedema, hyponatremia, neurological adverse reactions, drug induced liver injury, abnormal thyroid function tests, dizziness, somnolence, nausea, headache, diplopia, vomiting, fatigue, vertigo, ataxia, blurred vision, tremor, ear and labyrinth disorders, vertigo, eye disorders, diplopia, blurred vision, visual impairment, gastrointestinal disorders, nausea, vomiting, diarrhea, constipation, abdominal pain, gastritis, general disorders and administration site conditions, fatigue, asthenia, gait disturbance, peripheral edema, infections and infestations, urinary tract infections, injury, poisoning and procedural complications, fall, metabolism and nutrition disorders, hyponatremia, nervous system disorders, dizziness, somnolence, headache, ataxia, balance disorder, tremor, dysarthria, memory impairment, nystagmus, psychiatric disorders, depression, insomnia, respiratory, thoracic and mediastinal disorders, cough, skin and subcutaneous tissue disorders, rash, vascular disorders, hypertension"
130,APTIOM,warnings and precautions,"'suicidal behavior and ideation, serious dermatologic reactions, drug reaction with eosinophilia and systemic symptoms (DRESS), anaphylactic reactions, angioedema, hyponatremia, dizziness, disturbance in gait and coordination, somnolence, fatigue, cognitive dysfunction, visual changes, drug induced liver injury, abnormal thyroid function tests'"
131,DUAVEE,adverse reactions,"cardiovascular disorders, malignant neoplasms, gallbladder disease, hypertriglyceridemia, muscle spasms, nausea, diarrhea, dyspepsia, abdominal pain upper, oropharyngeal pain, dizziness, neck pain, venous thromboembolism"
132,DUAVEE,boxed warnings,"endometrial cancer, cardiovascular disorders, probable dementia, stroke, deep vein thrombosis (DVT), blood clots, cancer of the uterus, heart disease, heart attacks, dementia, gallbladder problems, loss of vision, high blood pressure, increased fats in your blood, liver problems, thyroid problems, fluid retention, low calcium, swelling of your mouth or tongue, worsening of other medical problems, new breast lumps, changes in vision or speech, sudden new severe headaches, severe pains in your chest or legs with or without shortness of breath, weakness and fatigue, muscle spasms, nausea, diarrhea, upset stomach, abdominal pain, throat pain, dizziness, neck pain"
133,DUAVEE,warnings and precautions,"'cardiovascular disorders, venous thromboembolism, pulmonary embolism, stroke, retinal vascular thrombosis, malignant neoplasms, endometrial cancer, breast cancer, ovarian cancer, gallbladder disease, loss of vision, severe hypertriglyceridemia, cholestatic jaundice, thyroid function, dementia, visual abnormalities, retinal vascular thrombosis, elevated blood pressure, hypertriglyceridemia, hepatic impairment, cholestatic jaundice, hypothyroidism, fluid retention, hypocalcemia, hereditary angioedema, exacerbation of asthma, diabetes mellitus, epilepsy, migraine, porphyria, systemic lupus erythematosus, hepatic hemangiomas, laboratory tests, drug-laboratory test interactions, impaired glucose tolerance'"
134,KALYDECO,adverse reactions,"transaminase elevations, headache, oropharyngeal pain, upper respiratory tract infection, nasal congestion, abdominal pain, nasopharyngitis, diarrhea, rash, nausea, dizziness, increased hepatic enzymes, hypoglycemia, rhinitis, arthralgia, bacteria in sputum, aspartate aminotransferase increased, blood glucose increased, hepatic enzyme increased, musculoskeletal chest pain, myalgia, sinus headache, pharyngeal erythema, pleuritic pain, sinus congestion, wheezing, acne"
135,KALYDECO,warnings and precautions,"'elevated transaminases, increased transaminase levels, lens opacities, cataracts'"
136,AMYVID,adverse reactions,"headache, musculoskeletal pain, blood pressure increased, fatigue, nausea, injection site reaction, anxiety, back pain, claustrophobia, dizziness, feeling cold, insomnia, neck pain, infusion site rash, dysgeusia, pruritis, urticaria, flushing"
137,AMYVID,warnings and precautions,"image interpretation errors, false negatives, radiation risk, cancer"
138,TIVICAY,adverse reactions,"hypersensitivity reactions, effects on serum liver biochemistries, fat redistribution, immune reconstitution syndrome, insomnia, fatigue, headache, abdominal pain, abdominal discomfort, flatulence, upper abdominal pain, vomiting, hepatitis, myositis, suicidal ideation, suicidal attempt, suicidal behavior, suicidal completion, renal impairment, pruritus, rash, insomnia, depression, abnormal dreams, dizziness, headache, nausea, diarrhea, fatigue, vertigo, ALT abnormalities, AST abnormalities, creatine kinase abnormalities, hyperglycemia, lipase abnormalities, total neutrophils abnormalities, cholesterol changes, HDL cholesterol changes, LDL cholesterol changes, triglycerides changes, elevated total bilirubin, elevated lipase"
139,TIVICAY,warnings and precautions,"hypersensitivity reactions, rash, constitutional findings, organ dysfunction, liver injury, transaminase elevations, hepatotoxicity, redistribution/accumulation of body fat, central obesity, dorsocervical fat enlargement, peripheral wasting, facial wasting, breast enlargement, cushingoid appearance, immune reconstitution syndrome, inflammatory response, Mycobacterium avium infection, cytomegalovirus, Pneumocystis jirovecii pneumonia, tuberculosis, autoimmune disorders, Graves' disease, polymyositis, Guillain-Barre syndrome"
140,ULESFIA,adverse reactions,"ocular irritation, application site irritation, application site anesthesia, hypoesthesia, pain, pruritus, erythema, pyoderma, application site dryness, application site excoriation, paraesthesia, application site dermatitis, excoriation, thermal burn, dandruff, rash, skin exfoliation"
141,ULESFIA,warnings and precautions,"gasping syndrome, eye irritation, contact dermatitis"
142,JUBLIA,adverse reactions,"ingrown toenails, application site dermatitis, application site vesicles, application site pain"
143,TRULICITY,adverse reactions,"thyroid C-cell tumors, pancreatitis, hypoglycemia, hypersensitivity reactions, renal impairment, severe gastrointestinal disease, nausea, diarrhea, vomiting, abdominal pain, decreased appetite, dyspepsia, fatigue, gastrointestinal adverse reactions, constipation, flatulence, abdominal distension, gastroesophageal reflux disease, eructation, documented symptomatic hypoglycemia, severe hypoglycemia, heart rate increase, tachycardia, sinus tachycardia, immunogenicity, anti-drug antibodies, dulaglutide-neutralizing antibodies, antibodies against native GLP-1, systemic hypersensitivity, severe urticaria, systemic rash, facial edema, lip swelling, injection-site reactions, injection-site rash, erythema, PR interval prolongation, first degree atrioventricular block, amylase increase, lipase increase"
144,TRULICITY,boxed warnings,"thyroid C-cell tumors, adenomas, carcinomas, medullary thyroid carcinoma"
145,TRULICITY,warnings and precautions,"thyroid C-cell tumors, pancreatitis, hypoglycemia, hypersensitivity reactions, renal impairment, acute renal failure, worsening of chronic renal failure, gastrointestinal adverse reactions, severe gastrointestinal disease"
146,TEFLARO,adverse reactions,"hypersensitivity reactions, Clostridium difficile-associated diarrhea, direct Coombs' test seroconversion, diarrhea, nausea, rash, serious adverse reactions, treatment discontinuation, increased transaminases, hypokalemia, phlebitis, anemia, eosinophilia, neutropenia, thrombocytopenia, bradycardia, palpitations, abdominal pain, pyrexia, hepatitis, anaphylaxis, Clostridium difficile colitis, hyperglycemia, hyperkalemia, dizziness, convulsion, renal failure, urticaria, agranulocytosis"
147,TEFLARO,warnings and precautions,"hypersensitivity reactions, anaphylactic reactions, skin reactions, Clostridium difficile-associated diarrhea, CDAD, fatal colitis, Coombs' test seroconversion, hemolytic anemia, drug-induced hemolytic anemia, development of drug-resistant bacteria"
148,JARDIANCE,adverse reactions,"hypotension, impairment in renal function, hypoglycemia, genital mycotic infections, urinary tract infections, increased LDL-C, urinary tract infection, female genital mycotic infections, upper respiratory tract infection, increased urination, dyslipidemia, arthralgia, male genital mycotic infections, nausea, thirst, volume depletion, blood pressure decreased, blood pressure systolic decreased, dehydration, hypovolemia, orthostatic hypotension, syncope, polyuria, pollakiuria, nocturia, serum creatinine increased, eGFR decreased, phimosis, asymptomatic bacteriuria, cystitis, LDL-C increased, hematocrit increased"
149,JARDIANCE,warnings and precautions,"hypotension, impairment in renal function, hypoglycemia, genital mycotic infections, urinary tract infections, increased LDL-C"
150,ULORIC,adverse reactions,"liver function abnormalities, nausea, arthralgia, rash, dizziness, anemia, idiopathic thrombocytopenic purpura, leukocytosis, leukopenia, neutropenia, pancytopenia, splenomegaly, thrombocytopenia, angina pectoris, atrial fibrillation/flutter, cardiac murmur, ECG abnormal, palpitations, sinus bradycardia, tachycardia, deafness, tinnitus, vertigo, vision blurred, abdominal distention, abdominal pain, constipation, dry mouth, dyspepsia, flatulence, frequent stools, gastritis, gastroesophageal reflux disease, gastrointestinal discomfort, gingival pain, haematemesis, hyperchlorhydria, hematochezia, mouth ulceration, pancreatitis, peptic ulcer, vomiting, asthenia, chest pain/discomfort, edema, fatigue, feeling abnormal, gait disturbance, influenza-like symptoms, mass, pain, thirst, cholelithiasis, cholecystitis, hepatic steatosis, hepatitis, hepatomegaly, hypersensitivity, herpes zoster, contusion, anorexia, appetite decreased/increased, dehydration, diabetes mellitus, hypercholesterolemia, hyperglycemia, hyperlipidemia, hypertriglyceridemia, hypokalemia, weight decreased/increased, arthritis, joint stiffness, joint swelling, muscle spasms, muscle twitching, muscle tightness, muscle weakness, musculoskeletal pain, musculoskeletal stiffness, myalgia, altered taste, balance disorder, cerebrovascular accident, Guillain-Barre syndrome, headache, hemiparesis, hypoesthesia, hyposmia, lacunar infarction, lethargy, mental impairment, migraine, paresthesia, somnolence, transient ischemic attack, tremor, agitation, anxiety, depression, insomnia, irritability, libido decreased, nervousness, panic attack, personality change, hematuria, nephrolithiasis, pollakiuria, proteinuria, renal failure, renal insufficiency, urgency, incontinence, breast pain, erectile dysfunction, gynecomastia, bronchitis, cough, dyspnea, epistaxis, nasal dryness, paranasal sinus hypersecretion, pharyngeal edema, respiratory tract congestion, sneezing, throat irritation, upper respiratory tract infection, alopecia, angio-edema, dermatitis, dermographism, ecchymosis, eczema, hair color changes, hair growth abnormal, hyperhidrosis, peeling skin, petechiae, photosensitivity, pruritus, purpura, skin discoloration, altered pigmentation, skin lesion, skin odor abnormal, urticaria, flushing, hot flush, hypertension, hypotension, activated partial thromboplastin time prolonged, creatine increased, bicarbonate decreased, sodium increased, EEG abnormal, glucose increased, cholesterol increased, triglycerides increased, amylase increased, potassium increased, TSH increased, platelet count decreased, hematocrit decreased, hemoglobin decreased, MCV increased, RBC decreased, creatinine increased, blood urea increased, BUN/creatinine ratio increased, creatine phosphokinase (CPK) increased, alkaline phosphatase increased, LDH increased, PSA increased, urine output increased/decreased, lymphocyte count decreased, neutrophil count decreased, WBC increased/decreased, coagulation test abnormal, low density lipoprotein (LDL) increased, prothrombin time prolonged, urinary casts, urine positive for white blood cells and protein, hepatic failure, jaundice, abnormal liver function test results, liver disorder, anaphylaxis, anaphylactic reaction, rhabdomyolysis, psychotic behavior, aggressive thoughts, tubulointerstitial nephritis, generalized rash, Stevens Johnson Syndrome, hypersensitivity skin reactions"
151,ULORIC,warnings and precautions,"gout flare, cardiovascular thromboembolic events, myocardial infarctions, strokes, hepatic failure, liver injury, transaminase elevations, fatigue, anorexia, right upper abdominal discomfort, dark urine, jaundice, severe drug-induced liver injury"
152,KYPROLIS,adverse reactions,"cardiac toxicities, acute renal failure, tumor lysis syndrome, pulmonary toxicity, pulmonary hypertension, dyspnea, hypertension, venous thrombosis, infusion reactions, thrombocytopenia, hepatic toxicity, hepatic failure, thrombotic thrombocytopenic purpura/hemolytic uremic syndrome, posterior reversible encephalopathy syndrome (PRES), anemia, fatigue, nausea, pyrexia, decreased platelets, diarrhea, decreased lymphocyte, headache, decreased hemoglobin, cough, edema peripheral, decreased lymphocytes, decreased absolute neutrophil count, decreased phosphorus, neutropenia, decreased total white blood cell count, muscle spasm, upper respiratory tract infection, hypokalemia, pneumonia, respiratory tract infection, pulmonary embolism, febrile neutropenia, lymphopenia, cardiac arrest, cardiac failure, cardiac failure congestive, myocardial infarction, myocardial ischemia, cataract, vision blurred, abdominal pain, abdominal pain upper, dyspepsia, toothache, chills, infusion site reaction, multi-organ failure, pain, influenza, sepsis, urinary tract infection, viral infection, dehydration, hyperkalemia, hyperuricemia, hypoalbuminemia, hyponatremia, muscular weakness, myalgia, hypoesthesia, paresthesia, deafness, anxiety, delirium, renal failure, renal failure acute, renal impairment, dysphonia, epistaxis, oropharyngeal pain, pulmonary edema, erythema, hyperhidrosis, pruritus, deep vein thrombosis, hypotension, decreased appetite, hypercalcemia, hypocalcemia, hypomagnesemia, hypophosphatemia, musculoskeletal chest pain, bronchitis, nasopharyngitis, respiratory tract infection, embolic and thrombotic events, venous (including deep vein thrombosis and pulmonary embolism), thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS), posterior reversible encephalopathy syndrome (PRES)"
153,KYPROLIS,warnings and precautions,"cardiac failure, myocardial infarction, myocardial ischemia, acute renal failure, tumor lysis syndrome, acute respiratory distress syndrome, acute respiratory failure, acute diffuse infiltrative pulmonary disease, pulmonary hypertension, dyspnea, hypertension, hypertensive crisis, venous thrombosis, infusion reactions, thrombocytopenia, hepatic toxicity, hepatic failure, thrombotic thrombocytopenic purpura, hemolytic uremic syndrome, posterior reversible encephalopathy syndrome, embryo-fetal toxicity"
154,YERVOY,adverse reactions,"immune-mediated enterocolitis, immune-mediated hepatitis, immune-mediated dermatitis, immune-mediated neuropathies, immune-mediated endocrinopathies, ocular manifestations, fatigue, diarrhea, pruritus, rash, colitis, diarrhea, colitis, pruritus, rash, fatigue, immune-mediated adverse reactions, enterocolitis, hepatotoxicity, dermatitis, neuropathy, endocrinopathy, hypopituitarism, adrenal insufficiency, pneumonitis, meningitis, nephritis, eosinophilia, pericarditis, urticaria, large intestinal ulcer, esophagitis, acute respiratory distress syndrome, renal failure, infusion reaction, Drug reaction with eosinophilia and systemic symptoms (DRESS syndrome)"
155,YERVOY,boxed warnings,"immune-mediated adverse reactions, enterocolitis, hepatitis, dermatitis, toxic epidermal necrolysis, neuropathy, endocrinopathy"
156,YERVOY,warnings and precautions,"immune-mediated reactions, severe reactions, moderate immune-mediated adverse reactions, immune-mediated hepatitis, immune-mediated endocrinopathies, severe immune-mediated enterocolitis, life-threatening immune-mediated enterocolitis, fatal immune-mediated enterocolitis, moderate enterocolitis, intestinal perforation, severe enterocolitis, immune-mediated Hepatitis, severe hepatotoxicity, life-threatening hepatotoxicity, fatal hepatotoxicity, moderate hepatotoxicity, immune-mediated hepatitis, immune-mediated Dermatitis, severe immune-mediated dermatitis, life-threatening immune-mediated dermatitis, fatal immune-mediated dermatitis, moderate dermatitis, Stevens-Johnson syndrome, toxic epidermal necrolysis, severe dermatitis, moderate dermatitis, immune-mediated Neuropathies, fatal Guillain-Barre syndrome, severe peripheral motor neuropathy, Guillain-Barre syndrome, myasthenia gravis, severe neuropathy, moderate neuropathy, severe immune-mediated endocrinopathies, life-threatening immune-mediated endocrinopathies, hypopituitarism, adrenal insufficiency, hypogonadism, hypothyroidism, moderate endocrinopathy, hyperthyroidism, Cushing's syndrome, hypophysitis, Other Immune-mediated Adverse Reactions, nephritis, pneumonitis, meningitis, pericarditis, uveitis, iritis, hemolytic anemia, myocarditis, angiopathy, temporal arteritis, vasculitis, polymyalgia rheumatica, conjunctivitis, blepharitis, episcleritis, scleritis, leukocytoclastic vasculitis, erythema multiforme, psoriasis, pancreatitis, arthritis, autoimmune thyroiditis, sarcoidosis, neurosensory hypoacusis, autoimmune central neuropathy (encephalitis), myositis, polymyositis, ocular myositis, severe immune-mediated adverse reactions, immune-mediated ocular disease"
157,GADAVIST,adverse reactions,"nephrogenic systemic fibrosis, hypersensitivity reactions, headache, nausea, dizziness, dysgeusia, feeling hot, injection site reactions, vomiting, rash, pruritus, erythema, hypersensitivity/anaphylactoid, dyspnea, paresthesia, loss of consciousness, convulsion, parosmia, tachycardia, palpitation, dry mouth, malaise, feeling cold, cardiac arrest, anaphylactic shock, circulatory collapse, respiratory arrest, pulmonary edema, bronchospasm, cyanosis, oropharyngeal swelling, laryngeal edema, blood pressure increased, chest pain, angioedema, conjunctivitis, hyperhidrosis, cough, sneezing, burning sensation, pallor"
158,GADAVIST,boxed warnings,"nephrogenic systemic fibrosis, fatal or debilitating fibrosis affecting the skin, muscle and internal organs, chronic severe kidney disease, acute kidney injury"
159,GADAVIST,warnings and precautions,"nephrogenic systemic fibrosis, anaphylactic reactions, hypersensitivity reactions, cardiovascular manifestations, respiratory manifestations, cutaneous manifestations, death, acute kidney injury, drug-induced kidney toxicity, NSF, fibrosis, hypersensitivity reactions, extravasation, injection site reactions, overestimation of malignant disease"
160,OTEZLA,adverse reactions,"'peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, increased toxicity, hepatotoxicity, diarrhea, nausea, headache, upper respiratory tract infection, tension headache, vomiting, nasopharyngitis, abdominal pain upper, hypersensitivity, weight decrease, frequent bowel movement, gastroesophageal reflux disease, dyspepsia, decreased appetite, migraine, cough, rash, abdominal pain, fatigue, dyspepsia, insomnia, back pain, frequent bowel movements, depression, bronchitis, tooth abscess, folliculitis, sinus headache, severe worsening of psoriasis (rebound)'"
161,OTEZLA,warnings and precautions,"depression, suicidal thoughts, mood changes, weight decrease, drug interactions, depression or depressed mood, suicidal ideation and behavior, suicidal behavior, weight loss"
162,DYSPORT,adverse reactions,"distant spread of toxin effect, lack of interchangeability between botulinum toxin products, spread of effects from toxin, dysphagia, breathing difficulties, facial anatomy in the treatment of glabellar lines, pre-existing neuromuscular disorders, human albumin, intradermal immune reaction, muscular weakness, dry mouth, injection site discomfort, fatigue, headache, neck pain, musculoskeletal pain, dysphonia, injection site pain, eye disorders, nasopharyngitis, upper respiratory tract infection, eyelid edema, eyelid ptosis, sinusitis, nausea, urinary tract infection, dizziness, fall, depression, cervical dystonia, general disorders and administration site conditions, gastrointestinal disorders, nervous system disorders, infections and infestations, respiratory, thoracic and mediastinal disorders, dose-response relationships, facial paresis, breathing difficulty, dyspnea, muscle atrophy, laboratory findings, electrocardiographic findings, blood present in urine, bronchitis, influenza, pharyngolaryngeal pain, cough, contact dermatitis, injection site swelling, injection site bruising, injection site reaction, injection site erythema, injection site haematoma, gait disturbance, hypertonia, sensation of heaviness, vertigo, photophobia, influenza-like illness, amyotrophy, burning sensation, facial paresis, hypoesthesia, erythema, excessive granulation tissue, immunogenicity, antibody formation, binding antibodies, neutralizing antibodies"
163,DYSPORT,boxed warnings,"asthenia, generalized muscle weakness, diplopia, blurred vision, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence, breathing difficulties, death"
164,DYSPORT,warnings and precautions,"asthenia, generalized muscle weakness, diplopia, blurred vision, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence, breathing difficulties, death related to spread of toxin effects, severe dysphagia, aspiration, respiratory failure, eyelid ptosis, severe dysphagia, respiratory compromise"
165,FIRAZYR,adverse reactions,"'injection site reactions, pyrexia, transaminase increase, dizziness, rash, nausea, headache, anti-icatibant antibodies'"
166,FIRAZYR,warnings and precautions,laryngeal attacks
167,INVOKANA,adverse reactions,"'hypotension, impairment in renal function, hyperkalemia, hypoglycemia, genital mycotic infections, hypersensitivity reactions, bone fracture, increased low-density lipoprotein, female genital mycotic infections, urinary tract infection, increased urination, male genital mycotic infections, vulvovaginal pruritus, thirst, constipation, nausea, abdominal pain, fatigue, loss of strength or energy, asthenia, pancreatitis, erythema, rash, pruritus, urticaria, angioedema, photosensitivity reaction, polymorphic light eruption, sunburn, volume depletion-related adverse reactions, hypotension, postural dizziness, orthostatic hypotension, syncope, dehydration, falls, increased blood creatinine, decreased glomerular filtration rate, renal impairment, acute renal failure, candidal balanitis, balanoposthitis, phimosis, severe hypoglycemia, increases in serum potassium, increases in serum magnesium, increases in serum phosphate, increases in low-density lipoprotein cholesterol, increases in non-high-density lipoprotein cholesterol, increases in hemoglobin, decreases in bone mineral density'"
168,INVOKANA,warnings and precautions,"hypotension, impairment in renal function, hyperkalemia, hypoglycemia, genital mycotic infections, hypersensitivity reactions, bone fracture, increased LDL-C"
169,XTANDI,adverse reactions,"seizure, asthenia/fatigue, back pain, decreased appetite, constipation, arthralgia, diarrhea, hot flush, upper respiratory tract infection, peripheral edema, dyspnea, musculoskeletal pain, weight decreased, headache, hypertension, dizziness/vertigo, muscular weakness, musculoskeletal stiffness, spinal cord compression and cauda equina syndrome, paresthesia, mental impairment disorders, hypoesthesia, lower respiratory tract and lung infection, insomnia, anxiety, hematuria, pollakiuria, fall, non-pathologic fractures, pruritus, dry skin, epistaxis, dysgeusia, restless legs syndrome, gynecomastia, neutropenia, thrombocytopenia, elevations in ALT, elevations in bilirubin, infections, falls and fall-related injuries, hypertensive crisis"
170,XTANDI,warnings and precautions,seizure
171,AFINITOR,adverse reactions,"non-infectious pneumonitis, infections, angioedema, oral ulceration, renal failure, impaired wound healing, stomatitis, rash, fatigue, diarrhea, edema, abdominal pain, nausea, fever, asthenia, cough, headache, decreased appetite, hyperglycemia, dyspnea, pneumonitis, hypercholesterolemia, leukopenia, thrombocytopenia, lymphopenia, anemia, increased aspartate transaminase (AST), increased alanine transaminase (ALT), hypertriglyceridemia, arthralgia, back pain, pain in extremity, dysgeusia, insomnia, pruritus, alopecia, hot flush, hemoglobin decreased, WBC decreased, platelets decreased, glucose increased, cholesterol increased, creatinine increased, potassium decreased, abdominal pain, vomiting, constipation, dry mouth, peripheral edema, pyrexia, weight decreased, muscle spasms, dizziness, cough/productive cough, epistaxis, dyspnea/dyspnea exertional, pneumonitis, oropharyngeal pain, nail disorders, pruritus/pruritus generalized, dry skin/xeroderma, hypertension, diabetes mellitus, urinary tract infection, nasopharyngitis/rhinitis/URI, alkaline phosphatase increased, bicarbonate decreased, phosphate decreased, calcium decreased, sodium decreased, bilirubin increased, potassium increased, acute renal failure, acute respiratory distress, cardiac arrest, hepatic failure, pneumonia, sepsis, pulmonary embolism, hypoglycemia, myocardial infarction, congestive heart failure, sudden death, renal failure, thrombotic events, pulmonary embolus, thrombosis, amenorrhea, menorrhagia, menstrual irregularities, vaginal hemorrhage, epistaxis, decreased appetite, otitis media, depression, abnormal taste, increased blood luteinizing hormone (LH) levels, increased blood follicle stimulating hormone (FSH) levels, hypersensitivity, ovarian cyst, angioedema, respiratory tract infection, gastroenteritis, aggression, agitation, elevated partial thromboplastin time, neutropenia, elevated aspartate transaminase (AST), hypertriglyceridemia, elevated alanine transaminase (ALT), hypophosphatemia, cellulitis, hyperglycemia, elevated creatinine, acute pancreatitis, cholecystitis, cholelithiasis, arterial thrombotic events, reflex sympathetic dystrophy"
172,AFINITOR,warnings and precautions,"'non-infectious pneumonitis, fatal cases, infections, fatal infections, angioedema, oral ulceration, mouth ulcers, stomatitis, oral mucositis, renal failure, acute renal failure, fatal outcome, impaired wound healing, wound-related complications, wound dehiscence, wound infection, incisional hernia, lymphocele, seroma, surgical intervention, elevations of serum creatinine, urinary protein, blood glucose, lipids, decreases in hemoglobin, neutrophils, platelets, hyperglycemia, hyperlipidemia, hypertriglyceridemia, decreased hemoglobin, lymphocytes, neutrophils, platelets, embryo-fetal toxicity, fetal harm'"
173,ENTEREG,adverse reactions,dyspepsia
174,ENTEREG,boxed warnings,myocardial infarction
175,ENTEREG,warnings and precautions,"myocardial infarctions, abdominal pain, nausea and vomiting, diarrhea, serious adverse reactions, dose-related serious adverse reactions"
176,COARTEM,adverse reactions,"headache, anorexia, dizziness, asthenia, arthralgia, myalgia, pyrexia, cough, vomiting, hypersensitivity reactions, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, hepatotoxicity, chills, fatigue, malaise, nausea, abdominal pain, diarrhea, sleep disorder, insomnia, palpitations, hepatomegaly, splenomegaly, anemia, pruritus, rash, vertigo, nasopharyngitis, Plasmodium falciparum infection, rhinitis, aspartate aminotransferase increased, eosinophilia, tinnitus, conjunctivitis, constipation, dyspepsia, dysphagia, peptic ulcer, gait disturbance, abscess, acrodermatitis, bronchitis, ear infection, gastroenteritis, helminthic infection, hookworm infection, impetigo, influenza, lower respiratory tract infection, malaria, oral herpes, pneumonia, respiratory tract infection, subcutaneous abscess, upper respiratory tract infection, urinary tract infection, alanine aminotransferase increased, hematocrit decreased, lymphocyte morphology abnormal, platelet count decreased, platelet count increased, white blood cell count decreased, white blood cell count increased, hypokalemia, back pain, ataxia, clonus, fine motor delay, hyperreflexia, hypoesthesia, nystagmus, tremor, agitation, mood swings, hematuria, proteinuria, asthma, pharyngo-laryngeal pain, urticaria, angioedema, serious skin reactions (bullous eruption)"
177,COARTEM,warnings and precautions,"QT prolongation, hypokalemia, hypomagnesemia, symptomatic cardiac arrhythmias, clinically relevant bradycardia, severe cardiac disease, sudden death, electrolyte balance disturbances, decreased exposure to lumefantrine, decreased efficacy, decreased concentrations of substrate, potential loss of substrate efficacy, increased concentrations of artemether and/or lumefantrine, potentiate QT prolongation, decreased concentrations of artemether and/or lumefantrine, loss of antimalarial efficacy, reduced effectiveness of hormonal contraceptives, increased plasma concentrations of coadministered drug, increased risk of adverse effects, risk of recrudescence, severe hepatic impairment, severe renal impairment, relapsing malaria"
178,DALVANCE,adverse reactions,"nausea, headache, diarrhea, vomiting, rash, pruritus, anemia, hemorrhagic anemia, leucopenia, neutropenia, thrombocytopenia, petechiae, eosinophilia, thrombocytosis, gastrointestinal hemorrhage, melena, hematochezia, abdominal pain, infusion-related reactions, hepatotoxicity, anaphylactoid reaction, Clostridium difficile colitis, oral candidiasis, vulvovaginal mycotic infection, hepatic transaminases increased, blood alkaline phosphatase increased, international normalized ratio increased, hypoglycemia, dizziness, bronchospasm, urticaria, flushing, phlebitis, wound hemorrhage, spontaneous hematoma, ALT elevations"
179,DALVANCE,warnings and precautions,"hypersensitivity reactions, anaphylactic reactions, skin reactions, infusion reactions, ALT elevations, Clostridium difficile-associated diarrhea, flushing of the upper body, urticaria, pruritus, rash, liver test abnormalities, morbidity, mortality, fluid and electrolyte management, protein supplementation, surgical evaluation"
180,FERRIPROX,adverse reactions,"chromaturia, nausea, vomiting, abdominal pain, alanine aminotransferase increased, arthralgia, neutropenia, agranulocytosis, elevated ALT, decreased plasma zinc concentrations, abdominal pain/discomfort, diarrhea, dyspepsia, neutrophil count decreased, weight increased, aspartate aminotransferase increased, increased appetite, decreased appetite, back pain, pain in extremity, arthropathy, headache, thrombocytosis, pancytopenia, atrial fibrillation, cardiac failure, hypospadias, diplopia, papilledema, retinal toxicity, enterocolitis, rectal hemorrhage, gastric ulcer, pancreatitis, parotid gland enlargement, chills, pyrexia, edema peripheral, multi-organ failure, jaundice, hepatomegaly, anaphylactic shock, hypersensitivity, cryptococcal cutaneous infection, enteroviral encephalitis, pharyngitis, pneumonia, sepsis, furuncle, infectious hepatitis, rash pustular, subcutaneous abscess, blood bilirubin increased, blood creatinine phosphokinase increased, metabolic acidosis, dehydration, myositis, chondropathy, trismus, cerebellar syndrome, cerebral hemorrhage, convulsion, gait disturbance, intracranial pressure increased, psychomotor skills impaired, pyramidal tract syndrome, somnolence, bruxism, depression, obsessive-compulsive disorder, glycosuria, hemoglobinuria, acute respiratory distress syndrome, epistaxis, hemoptysis, pulmonary embolism, hyperhidrosis, periorbital edema, photosensitivity reaction, pruritis, urticaria, rash, Henoch-Schonlein purpura, hypotension, hypertension"
181,FERRIPROX,boxed warnings,"agranulocytosis, neutropenia, serious infections, death, infection"
182,FERRIPROX,warnings and precautions,"infection, fetal harm, agranulocytosis, neutropenia, death, embryofetal death, malformations, increased ALT values, increased AST values, decreased plasma zinc concentrations"
183,PRADAXA,adverse reactions,"bleeding, gastritis-like symptoms, gastrointestinal hemorrhage, diarrhea, dyspepsia, nausea, upper abdominal pain, gastrointestinal hemorrhage, major bleeding, intracranial hemorrhage, hemorrhagic stroke, gastrointestinal bleeding, fatal bleeding, ICH, non-intracranial fatal bleed, hypersensitivity reactions, urticaria, rash, pruritus, allergic edema, anaphylactic reaction, anaphylactic shock, myocardial infarction, abdominal pain upper, abdominal discomfort, epigastric discomfort, gastritis, GERD, esophagitis, erosive gastritis, gastric hemorrhage, angioedema, thrombocytopenia, esophageal ulcer"
184,PRADAXA,boxed warnings,"thrombotic events, spinal/epidural hematoma, paralysis"
185,PRADAXA,warnings and precautions,"bleeding, fatal bleeding, thrombotic events, blood loss, hypotension, pathological bleeding, spinal hematoma, paralysis, neurological impairment, back pain, sensory deficits, motor deficits, numbness, tingling, weakness in lower limbs, bowel dysfunction, bladder dysfunction, thromboembolic events, valve thrombosis, stroke, transient ischemic attack, myocardial infarction, major bleeding, post-operative pericardial effusions"
186,VORAXAZE,adverse reactions,"serious allergic reactions, anaphylactic reactions, paraesthesias, flushing, nausea and/or vomiting, hypotension, headache, myelosuppression, mucositis, acute hepatitis, renal dysfunction, renal failure, paresthesia, blurred vision, diarrhea, hypersensitivity, hypertension, rash, throat irritation, throat tightness, tremor"
187,VORAXAZE,warnings and precautions,"Answer: 'serious allergic reactions, anaphylactic reactions'"
188,HORIZANT,adverse reactions,"somnolence/sedation, dizziness, headache, nausea, dry mouth, flatulence, fatigue, irritability, feeling drunk, feeling abnormal, peripheral edema, weight increased, increased appetite, vertigo, depression, libido decreased, balance disorder, blurred vision, disorientation, lethargy, asthenia, insomnia, confusional state, breast enlargement, gynecomastia, elevated creatine kinase"
189,HORIZANT,warnings and precautions,"driving impairment, somnolence/sedation, dizziness, suicidal thoughts or behaviors, depression, mood or behavior changes, Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS), multiorgan hypersensitivity, fever, rash, lymphadenopathy, hepatitis, nephritis, hematological abnormalities, myocarditis, myositis, eosinophilia, withdrawal seizure, pancreatic acinar cell adenoma, pancreatic acinar cell carcinoma, fatigue/asthenia"
190,STENDRA,adverse reactions,"'headache, flushing, nasal congestion, nasopharyngitis, back pain, upper respiratory infection, bronchitis, influenza, sinusitis, sinus congestion, hypertension, dyspepsia, nausea, constipation, rash, dizziness, arthralgia, diarrhea, edema peripheral, fatigue, angina, unstable angina, deep vein thrombosis, palpitations, gastritis, gastroesophageal reflux disease, hypoglycemia, blood glucose increased, alanine aminotransferase increased, oropharyngeal pain, stomach discomfort, vomiting, muscle spasms, musculoskeletal pain, myalgia, pain in extremity, depression, insomnia, somnolence, vertigo, cough, dyspnea exertional, epistaxis, wheezing, pruritus, balanitis, erection increased, hematuria, nephrolithiasis, pollakiuria, urinary tract infection, upper respiratory infection, electrocardiogram abnormal, gastroenteritis viral, color vision change, non-arteritic anterior ischemic optic neuropathy (NAION)'"
191,STENDRA,warnings and precautions,"hypotension, erection lasts greater than 4 hours, sudden loss of vision, sudden decrease or loss of hearing, symptomatic hypotension (e.g., dizziness, lightheadedness, fainting), orthostatic signs and symptoms (including increase in heart rate, decrease in standing blood pressure, dizziness, headache), bleeding disorders, active peptic ulceration"
192,ADCETRIS,adverse reactions,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, serious infections, opportunistic infections, tumor lysis syndrome, increased toxicity, hepatotoxicity, progressive multifocal leukoencephalopathy, pulmonary toxicity, serious dermatologic reactions, neutropenia, peripheral sensory neuropathy, fatigue, nausea, anemia, upper respiratory tract infection, diarrhea, pyrexia, rash, thrombocytopenia, cough, vomiting, peripheral motor neuropathy, lymphadenopathy, headache, dizziness, chills, pain, edema peripheral, abdominal pain, constipation, pruritus, alopecia, night sweats, dry skin, dyspnea, oropharyngeal pain, arthralgia, myalgia, back pain, pain in extremity, muscle spasms, insomnia, anxiety, decreased appetite, weight decreased, febrile neutropenia, hyperglycemia, pancreatitis, noninfectious pulmonary toxicity, pneumonitis, interstitial lung disease, ARDS, toxic epidermal necrolysis, infusion related reactions, pulmonary embolism, pneumothorax, pyelonephritis, septic shock, supraventricular arrhythmia, urinary tract infection, pneumonia, acute respiratory distress syndrome, paraesthesia"
193,ADCETRIS,boxed warnings,"Progressive multifocal leukoencephalopathy (PML), JC virus infection"
194,ADCETRIS,warnings and precautions,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, hepatotoxicity, pulmonary toxicity, serious dermatologic reactions, embryo-fetal toxicity, severe neutropenia, Grade 3 or Grade 4 thrombocytopenia, anemia, febrile neutropenia, pneumonia, bacteremia, sepsis, septic shock, progressive multifocal leukoencephalopathy, pneumonitis, interstitial lung disease, acute respiratory distress syndrome, Stevens-Johnson syndrome, toxic epidermal necrolysis, fetal harm, embryo-fetal toxicities, decreased embryo viability, fetal malformations"
195,ZERBAXA,adverse reactions,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, increased toxicity, hepatotoxicity, hypersensitivity reactions, Clostridium difficile-associated diarrhea, nausea, diarrhea, headache, pyrexia, constipation, insomnia, vomiting, hypokalemia, ALT increased, AST increased, anemia, thrombocytosis, abdominal pain, anxiety, dizziness, hypotension, atrial fibrillation, rash, renal impairment, renal failure, cardiac disorders, gastrointestinal disorders, general disorders and administration site conditions, infections and infestations, investigations, metabolism and nutrition disorders, nervous system disorders, renal and urinary system, respiratory, thoracic and mediastinal disorders, skin and subcutaneous tissue disorders, vascular disorders"
196,ZERBAXA,warnings and precautions,"decreased efficacy, hypersensitivity reactions, anaphylactic reactions, Clostridium difficile-associated diarrhea (CDAD), fatal colitis"
197,ZYDELIG,adverse reactions,"hepatotoxicity, severe diarrhea, colitis, pneumonitis, intestinal perforation, severe cutaneous reactions, anaphylaxis, neutropenia, diarrhea, pyrexia, fatigue, nausea, cough, pneumonia, abdominal pain, chills, rash, hypertriglyceridemia, hyperglycemia, ALT elevations, AST elevations, pneumonia, sepsis, febrile neutropenia, elevated transaminases, gastroesophageal reflux disease, stomatitis, headache, pain, nasal congestion, bronchitis, sinusitis, urinary tract infection, arthralgia, neutrophil count decreased, lymphocyte count decreased, lymphocyte count increased, GGT increased, triglycerides increased, hypoglycemia, hyponatremia, vomiting, asthenia, peripheral edema, upper respiratory tract infection, dyspnea, night sweats, decreased appetite, insomnia, hemoglobin decreased, platelets decreased"
198,ZYDELIG,boxed warnings,"hepatotoxicity, severe diarrhea, colitis, pneumonitis, intestinal perforation"
199,ZYDELIG,warnings and precautions,"severe cutaneous reactions, anaphylaxis, neutropenia, embryo-fetal toxicity, hepatotoxicity, severe diarrhea, colitis, pneumonitis, intestinal perforation, toxic epidermal necrolysis (TEN), dermatitis exfoliative, rash, rash erythematous, rash generalized, rash macular, rash maculo-papular, rash papular, rash pruritic, exfoliative rash, skin disorder, serious allergic reactions, treatment-emergent Grade 3 or 4 neutropenia"
200,SIMPONI,adverse reactions,"serious infections, malignancies, upper respiratory tract infection, viral infection, bronchitis, hypertension, rash, sepsis, pneumonia, cellulitis, abscess, opportunistic infections, tuberculosis, invasive fungal infections, liver enzyme elevations, autoimmune disorders, autoantibodies, infusion reactions, immunogenicity, infections and infestations, vascular disorders, skin and subcutaneous disorders, general disorders and administration site conditions, blood and lymphatic disorders, superficial fungal infection, sinusitis, lower respiratory tract infection, pyelonephritis, alanine aminotransferase increased, aspartate aminotransferase increased, neutrophil count decreased, nervous system disorders, dizziness, paresthesia, gastrointestinal disorders, constipation, neoplasm benign and malignant, melanoma, immune system disorders, serious systemic hypersensitivity reactions, anaphylactic reaction, sarcoidosis, respiratory, thoracic and mediastinal disorders, interstitial lung disease, skin and subcutaneous tissue disorders, skin exfoliation, bullous skin reactions"
201,SIMPONI,boxed warnings,"serious infections, hospitalization, death, tuberculosis (TB), bacterial sepsis, invasive fungal infections, histoplasmosis, opportunistic infections, sepsis, lymphoma, malignancies, active tuberculosis, reactivation of latent tuberculosis, disseminated disease, extrapulmonary disease, invasive fungal infections, coccidioidomycosis, candidiasis, aspergillosis, blastomycosis, pneumocystosis, bacterial infections, viral infections, Legionella, Listeria"
202,SIMPONI,warnings and precautions,"serious infections, invasive fungal infections, hepatitis B reactivation, malignancies, lymphoma, heart failure, demyelinating disease, hypersensitivity reactions, anaphylaxis, infections, opportunistic infections, tuberculosis, aspergillosis, blastomycosis, candidiasis, coccidioidomycosis, histoplasmosis, legionellosis, listeriosis, pneumocystosis, chronic or recurrent infection, worsening congestive heart failure, new onset congestive heart failure, new onset or exacerbation of central nervous system demyelinating disorders, multiple sclerosis, peripheral demyelinating disorders, Guillain-Barre syndrome, central demyelination, optic neuritis, peripheral demyelinating polyneuropathy, pancytopenia, leukopenia, neutropenia, aplastic anemia, thrombocytopenia, serious systemic hypersensitivity reactions, anaphylactic reaction"
203,BLINCYTO,adverse reactions,"cytokine release syndrome, neurological toxicities, infections, tumor lysis syndrome, neutropenia, febrile neutropenia, effects on ability to drive and use machines, elevated liver enzymes, leukoencephalopathy, preparation and administration errors, pyrexia, headache, peripheral edema, nausea, hypokalemia, tremor, rash, constipation, pneumonia, sepsis, device-related infection, encephalopathy, overdose, confusion, Staphylococcal bacteremia, anemia, thrombocytopenia, leukopenia, diarrhea, abdominal pain, vomiting, fatigue, chills, chest pain, cytokine release syndrome, bacterial infections, fungal infections, viral infections, increased alanine aminotransferase, increased aspartate aminotransferase, hypomagnesemia, hyperglycemia, decreased appetite, hypophosphatemia, back pain, pain in extremity, bone pain, arthralgia, dizziness, insomnia, cough, dyspnea, hypotension, hypertension, leukocytosis, lymphopenia, tachycardia, edema, cytokine storm, decreased immunoglobulins, increased blood bilirubin, increased gamma-glutamyl-transferase, increased liver enzymes, tumor lysis syndrome, hypoalbuminemia, encephalopathy, paresthesia, aphasia, convulsion, memory impairment, cognitive disorder, speech disorder, confusion, disorientation, capillary leak syndrome, hypersensitivity, bronchospasm"
204,BLINCYTO,boxed warnings,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, hepatotoxicity, cytokine release syndrome, neurological toxicities"
205,BLINCYTO,warnings and precautions,"infections, effects on ability to drive and use machines, preparation and administration errors, cytokine release syndrome (CRS), infusion reactions, pyrexia, headache, nausea, asthenia, hypotension, increased alanine aminotransferase, increased aspartate aminotransferase, increased total bilirubin, disseminated intravascular coagulation (DIC), capillary leak syndrome (CLS), hemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS), neurological toxicities, encephalopathy, convulsions, speech disorders, disturbances in consciousness, confusion and disorientation, coordination and balance disorders, sepsis, pneumonia, bacteremia, opportunistic infections, catheter-site infections, tumor lysis syndrome (TLS), neutropenia, febrile neutropenia, elevated liver enzymes, leukoencephalopathy"
206,NATAZIA,adverse reactions,"serious cardiovascular events, stroke, vascular events, liver disease, irregular uterine bleeding, nausea, breast tenderness, headache, headaches, headache (including migraines), breast tenderness, pain, menstrual disorders, nausea/ or vomiting, acne, mood changes, increased weight, menstrual disorder (metrorrhagia, menorrhagia, menstruation irregular, genital hemorrhage, vaginal hemorrhage, dysfunctional uterine bleeding), mood changes (depression, mood swings, mood altered, depressed mood, dysthymic disorder, crying), headache (including migraines), weight increased, headache (including migraines), breast pain, discomfort or tenderness, menstrual disorders (metrorrhagia, menstruation irregular, menorrhagia, vaginal hemorrhage, dysfunctional uterine bleeding, genital hemorrhage, abnormal withdrawal bleeding, uterine hemorrhage), nausea or vomiting, acne, mood changes (depression, mood swings, depressed mood, mood altered, affect lability, dysthymic disorder, crying), increased weight, myocardial infarction, ruptured ovarian cyst, deep vein thrombosis, focal nodular hyperplasia of the liver, uterine leiomyoma, acute cholecystitis, chronic acalculous cholecystitis, venous and arterial thromboembolic events (including pulmonary emboli, deep vein thrombosis, cerebral thrombosis, myocardial infarction and stroke), hypertension, gallbladder disease, hepatitis, hypersensitivity, fluid retention, hypertriglyceridemia, dizziness, chloasma, angioedema, erythema nodosum, erythema multiforme, gastrointestinal symptoms (for example, abdominal pain), vulvovaginal candidiasis"
207,NATAZIA,boxed warnings,serious cardiovascular events
208,NATAZIA,warnings and precautions,"thrombotic event, venous thromboembolism, arterial thromboses, strokes, myocardial infarctions, loss of vision, proptosis, diplopia, papilledema, retinal vascular lesions, retinal vein thrombosis, cervical cancer, intraepithelial neoplasia, jaundice, hepatic adenomas, intra-abdominal hemorrhage, hepatocellular carcinoma, cholestasis, high blood pressure, gallbladder disease, decreased glucose tolerance, dyslipidemia, hypertriglyceridemia, pancreatitis, headaches, migraine, breakthrough bleeding, spotting, amenorrhea, oligomenorrhea, intracyclic bleeding, depression, chloasma"
209,DIFICID,adverse reactions,"nausea, vomiting, abdominal pain, gastrointestinal hemorrhage, anemia, neutropenia, abdominal distension, abdominal tenderness, dyspepsia, dysphagia, flatulence, intestinal obstruction, megacolon, increased blood alkaline phosphatase, decreased blood bicarbonate, increased hepatic enzymes, decreased platelet count, hyperglycemia, metabolic acidosis, drug eruption, pruritus, rash, hypersensitivity reactions, dyspnea, angioedema"
210,DIFICID,warnings and precautions,"acute hypersensitivity reactions, angioedema, dyspnea, pruritus, rash, hypersensitivity reactions, drug-resistant bacteria"
211,EDARBI,adverse reactions,"diarrhea, hypotension, orthostatic hypotension, nausea, asthenia, fatigue, muscle spasm, dizziness, dizziness postural, cough, serum creatinine increases, low hemoglobin, low hematocrit, low RBC counts, abnormal platelet counts, abnormal WBC counts, rash, pruritus, angioedema"
212,EDARBI,boxed warnings,"fetal toxicity, injury, death"
213,EDARBI,warnings and precautions,"fetal toxicity, fetal lung hypoplasia, skeletal deformations, skull hypoplasia, anuria, hypotension, renal failure, death, symptomatic hypotension, oliguria, progressive azotemia, acute renal failure, increases in serum creatinine, increases in blood urea nitrogen"
214,IMBRUVICA,adverse reactions,"hemorrhage, infections, cytopenias, atrial fibrillation, second primary malignancies, tumor lysis syndrome, thrombocytopenia, neutropenia, diarrhea, anemia, fatigue, musculoskeletal pain, bruising, nausea, upper respiratory tract infection, rash, peripheral edema, dyspnea, constipation, abdominal pain, vomiting, decreased appetite, pneumonia, stomatitis, dyspepsia, urinary tract infection, skin infections, sinusitis, pyrexia, asthenia, muscle spasms, arthralgia, cough, epistaxis, dehydration, dizziness, headache, renal failure, lymphocytosis, intracranial hemorrhage, lethargy, gait instability, hyperuricemia, pyrexia, chills, peripheral neuropathy, second malignancies, laceration, anxiety, insomnia, hypertension, vision blurred, contusion, pruritus, arthropathy, skin cancer, hypersensitivity reactions, anaphylactic shock, urticaria, angioedema"
215,IMBRUVICA,warnings and precautions,"hemorrhage, bleeding, subdural hematoma, gastrointestinal bleeding, hematuria, post procedural hemorrhage, bruising, petechiae, infections, progressive multifocal leukoencephalopathy (PML), cytopenias, neutropenia, thrombocytopenia, anemia, atrial fibrillation, atrial flutter, second primary malignancies, non-skin carcinomas, non-melanoma skin cancer, tumor lysis syndrome, embryo-fetal toxicity, malformations, reduced fetal weights"
216,DUREZOL,adverse reactions,"elevated intraocular pressure, optic nerve damage, visual acuity and field defects, posterior subcapsular cataract formation, secondary ocular infection, perforation of the globe, corneal edema, ciliary and conjunctival hyperemia, eye pain, photophobia, posterior capsule opacification, anterior chamber cells, anterior chamber flare, conjunctival edema, blepharitis, reduced visual acuity, punctate keratitis, eye inflammation, iritis, application site discomfort or irritation, corneal pigmentation and striae, episcleritis, eye pruritis, eyelid irritation and crusting, foreign body sensation, increased lacrimation, macular edema, sclera hyperemia, uveitis, blurred vision, headache, increased IOP, limbal and conjunctival hyperemia, anterior chamber flare, dry eye, iridocyclitis"
217,DUREZOL,warnings and precautions,"IOP increase, glaucoma, damage to the optic nerve, defects in visual acuity and fields of vision, cataracts, posterior subcapsular cataract formation, delayed healing, bleb formation, corneal or scleral thinning, perforations, bacterial infections, secondary ocular infections, mask infection, enhance existing infection, viral infections, exacerbate the severity of viral infections, fungal infections, corneal ulceration, fungus invasion"
218,ZYKADIA,adverse reactions,"Severe or Persistent Gastrointestinal Toxicity, Hepatotoxicity, Interstitial Lung Disease/Pneumonitis, QT Interval Prolongation, Hyperglycemia, Bradycardia, Pancreatitis, diarrhea, nausea, elevated transaminases, vomiting, abdominal pain, fatigue, decreased appetite, constipation, increased ALT, increased AST, convulsion, pneumonia, ILD/pneumonitis, dyspnea, dehydration, respiratory failure, pneumothorax, gastric hemorrhage, general physical health deterioration, pulmonary tuberculosis, cardiac tamponade, sepsis, neuropathy, vision disorder, prolonged QT interval, Hemoglobin decreased, Alanine transaminase (ALT) increased, Aspartate transaminase (AST) increased, Creatinine increased, Glucose increased, Phosphate decreased, Lipase increased, Bilirubin (total) increased"
219,ZYKADIA,warnings and precautions,"gastrointestinal toxicity, diarrhea, nausea, vomiting, abdominal pain, hepatotoxicity, interstitial lung disease (ILD), pneumonitis, QT interval prolongation, hyperglycemia, bradycardia, pancreatitis, embryofetal toxicity"
220,CHOLINE,adverse reactions,injection site reaction
221,CHOLINE,warnings and precautions,"'imaging errors, allergic reactions, anaphylaxis, radiation risk, false positive results, false negative results, tissue inflammation, prostatic hyperplasia, increased risk for cancer'"
222,ERWINAZE,adverse reactions,"hypersensitivity reactions, pancreatitis, glucose intolerance, thrombosis, hemorrhage, systemic hypersensitivity, hyperglycemia, transaminases abnormal, fever, local reactions, vomiting, nausea, hyperbilirubinemia, abdominal pain/discomfort, diarrhea, allergy, coagulopathy, hyperlipidemia, ketoacidosis, CNS events"
223,ERWINAZE,warnings and precautions,"hypersensitivity reactions, anaphylaxis, severe or hemorrhagic pancreatitis, glucose intolerance, hyperglycemia, thrombosis, hemorrhage, sagittal sinus thrombosis, pulmonary embolism, decreased fibrinogen, decreased protein C activity, decreased protein S activity, decreased anti-thrombin III"
224,SAPHRIS,adverse reactions,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, hepatotoxicity, dementia-related psychosis, neuroleptic malignant syndrome, tardive dyskinesia, metabolic changes, hypersensitivity reactions, oral ulcers, blisters, peeling/sloughing, inflammation, orthostatic hypotension, syncope, hemodynamic effects, leukopenia, neutropenia, agranulocytosis, QT interval prolongation, hyperprolactinemia, seizures, cognitive impairment, motor impairment, body temperature regulation, suicide, dysphagia, akathisia, oral hypoesthesia, somnolence, dizziness, extrapyramidal symptoms, increased weight, dysgeusia, oral paresthesia, nausea, increased appetite, fatigue, constipation, dry mouth, salivary hypersecretion, stomach discomfort, vomiting, irritability, insomnia, hypertension, anxiety, dyspepsia, toothache, arthralgia, pain in extremity, headache, depression, tachycardia, heart rate increased, glossodynia, muscle strain, hyperinsulinemia, ALT increased, AST increased, dehydration, myalgia, parkinsonism, suicidal ideation, anger, dysmenorrhea, oropharyngeal pain, nasal congestion, dyspnea, rash, diplopia, vision blurred, gastroesophageal reflux disease, fall, photosensitivity reaction, enuresis, choking, oropharyngeal muscular dysfunction"
225,SAPHRIS,boxed warnings,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, hepatotoxicity, increased mortality"
226,SAPHRIS,warnings and precautions,"cerebrovascular adverse events, stroke, transient ischemic attack, neuroleptic malignant syndrome, tardive dyskinesia, metabolic changes, hyperglycemia, dyslipidemia, weight gain, hypersensitivity reactions, anaphylaxis, angioedema, orthostatic hypotension, syncope, hemodynamic effects, leukopenia, neutropenia, agranulocytosis, QT prolongation, seizures, cognitive and motor impairment, suicide, dysphagia, aspiration, body temperature regulation, hyperprolactinemia, galactorrhea, amenorrhea, gynecomastia, impotence, decreased bone density, somnolence, pyrexia, feeling hot"
227,CARBAGLU,adverse reactions,"'infections, vomiting, abdominal pain, pyrexia, tonsilitis, anemia, ear infection, diarrhea, nasopharyngitis, headache, dysgeusia, asthenia, hyperhidrosis, influenza, pneumonia, hemoglobin decreased, weight decreased, anorexia, somnolence, rash'"
228,CARBAGLU,warnings and precautions,"Hyperammonemia, brain injury, death, brain damage"
229,PROMACTA,adverse reactions,"hepatic decompensation, hepatotoxicity, thrombotic/thromboembolic complications, cataracts, nausea, diarrhea, upper respiratory tract infection, vomiting, increased ALT, myalgia, urinary tract infection, nasopharyngitis, rhinitis, anemia, pyrexia, fatigue, headache, decreased appetite, influenza-like illness, asthenia, insomnia, cough, pruritus, chills, alopecia, peripheral edema, hemorrhage, oropharyngeal pain, increased AST, pharyngitis, back pain, influenza, paresthesia, rash, alopecia, musculoskeletal pain, blood alkaline phosphatase increased, dry mouth, hyperbilirubinemia, cataract, serum liver test abnormalities, portal vein thromboses, abdominal pain, toothache, vitamin D deficiency, thrombotic microangiopathy with acute renal failure, pain in extremity, dyspnea, dizziness, febrile neutropenia, ecchymosis, muscle spasms, transaminases increased, arthralgia, rhinorrhea"
230,PROMACTA,boxed warnings,hepatic decompensation
231,PROMACTA,warnings and precautions,"hepatic decompensation, ascites, encephalopathy, liver enzyme elevations, indirect hyperbilirubinemia, clinical symptoms of liver injury, hepatic decompensation, thrombotic event, portal venous system events, venous events, arterial events, thromboembolism, Factor V Leiden, ATIII deficiency, antiphospholipid syndrome, chronic liver disease, thrombotic complications, portal vein thrombosis, abdominal pain, nausea, vomiting, diarrhea, cataracts"
232,BESIVANCE,adverse reactions,"conjunctival redness, blurred vision, eye pain, eye irritation, eye pruritus, headache"
233,BESIVANCE,warnings and precautions,"growth of resistant organisms, overgrowth of non-susceptible organisms, super-infection"
234,INLYTA,adverse reactions,"diarrhea, hypertension, fatigue, decreased appetite, nausea, dysphonia, palmar-plantar erythrodysesthesia syndrome, weight decreased, vomiting, asthenia, constipation, hypothyroidism, cough, mucosal inflammation, arthralgia, stomatitis, dyspnea, abdominal pain, headache, pain in extremity, rash, proteinuria, dysgeusia, dry skin, dyspepsia, pruritus, alopecia, erythema, dizziness, upper abdominal pain, myalgia, dehydration, epistaxis, anemia, hemorrhoids, hematuria, tinnitus, lipase increased, glossodynia, pulmonary embolism, rectal hemorrhage, hemoptysis, deep vein thrombosis, retinal-vein occlusion/thrombosis, polycythemia, transient ischemic attack, hemoglobin decreased, lymphocytes decreased, platelets decreased, white blood cells decreased, creatinine increased, bicarbonate decreased, hypocalcemia, ALP increased, hyperglycemia, lipase increased, amylase increased, ALT increased, AST increased, hypernatremia, hypoalbuminemia, hyperkalemia, hypoglycemia, hyponatremia, hypophosphatemia, hemoglobin increased, hypercalcemia"
235,INLYTA,warnings and precautions,"hypertension, hypertensive crisis, arterial thrombotic events, venous thrombotic events, hemorrhagic events, cardiac failure, gastrointestinal perforation, fistula, hypothyroidism, reversible posterior leukoencephalopathy syndrome (RPLS), proteinuria, liver enzyme elevation, fetal harm"
236,NORTHERA,adverse reactions,"supine hypertension, hyperpyrexia, confusion, ischemic heart disease, arrhythmias, congestive heart failure, headache, dizziness, nausea, hypertension, fatigue, falls, urinary tract infections, syncope"
237,NORTHERA,boxed warnings,supine hypertension
238,NORTHERA,warnings and precautions,"supine hypertension, hyperpyrexia, confusion, exacerbation of ischemic heart disease, arrhythmias, congestive heart failure, allergic reactions, bronchial asthma"
239,ADCETRIS,all-concat,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, hepatotoxicity, progressive multifocal leukoencephalopathy, pulmonary toxicity, serious dermatologic reactions, neutropenia, peripheral sensory neuropathy, fatigue, nausea, anemia, upper respiratory tract infection, diarrhea, pyrexia, rash, thrombocytopenia, cough, vomiting, peripheral motor neuropathy, lymphadenopathy, headache, dizziness, chills, pain, edema peripheral, abdominal pain, constipation, pruritus, alopecia, night sweats, dry skin, dyspnea, oropharyngeal pain, arthralgia, myalgia, back pain, pain in extremity, muscle spasms, insomnia, anxiety, decreased appetite, weight decreased, febrile neutropenia, hyperglycemia, pancreatitis, noninfectious pulmonary toxicity, pneumonitis, interstitial lung disease, ARDS, toxic epidermal necrolysis, Stevens-Johnson syndrome, embryo-fetal toxicity, pneumonia, bacteremia, sepsis, septic shock, pulmonary embolism, pneumothorax, pyelonephritis, septic shock, supraventricular arrhythmia, urinary tract infection, PML, hepatocellular injury, hepatotoxicity, acute respiratory distress syndrome, paraesthesia"
240,ADREVIEW,all-concat,"hypersensitivity reactions, dizziness, rash, pruritis, flushing, headache, injection site hemorrhage, hematoma, bruising, benzyl alcohol toxicity, hypotension, metabolic acidosis, kernicterus, increased radiation exposure, thyroid neoplasia, hypertension"
241,AFINITOR,all-concat,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, hepatotoxicity, non-infectious pneumonitis, angioedema, oral ulceration, renal failure, impaired wound healing, stomatitis, rash, fatigue, diarrhea, edema, abdominal pain, nausea, fever, asthenia, cough, headache, decreased appetite, hyperglycemia, dyspnea, pneumonitis, hypercholesterolemia, anemia, leukopenia, thrombocytopenia, lymphopenia, increased aspartate transaminase (AST), increased alanine transaminase (ALT), hypertriglyceridemia, vomiting, constipation, dry mouth, pyrexia, weight decreased, arthralgia, back pain, pain in extremity, dysgeusia, insomnia, epistaxis, pruritus, alopecia, hot flush, hemoglobin decreased, WBC decreased, platelets decreased, glucose increased, cholesterol increased, triglycerides increased, albumin decreased, potassium decreased, creatinine increased, abdominal pain, diabetes mellitus, muscle spasms, headache/migraine, dizziness, cough/productive cough, dyspnea/dyspnea exertional, oropharyngeal pain, hypertension, alkaline phosphatase increased, glucose (fasting) increased, bicarbonate decreased, phosphate decreased, calcium decreased, sodium decreased, bilirubin increased, potassium increased, asthenia, mucosal inflammation, anorexia, pain in extremity, abdominal pain, dehydration, pleural effusion, pharyngolaryngeal pain, rhinorrhea, hand-foot syndrome, nail disorder, erythema, onychoclasis, skin lesion, acneiform dermatitis, angioedema, exacerbation of pre-existing diabetes mellitus, new onset of diabetes mellitus, tachycardia, congestive cardiac failure, jaw pain, hemorrhage, amenorrhea, menorrhagia, menstrual irregularities, vaginal hemorrhage, hypersensitivity/angioedema/bronchospasm, convulsion, upper respiratory tract infection, acne, otitis media, depression, abnormal taste, increased blood luteinizing hormone (LH) levels, increased blood follicle stimulating hormone (FSH) levels, ovarian cyst, pneumonitis, elevated partial thromboplastin time, neutropenia, elevated aspartate transaminase (AST), hypertriglyceridemia, elevated alanine transaminase (ALT), hypophosphatemia, cellulitis, hyperglycemia, elevated creatinine, acute pancreatitis, cholecystitis, cholelithiasis, arterial thrombotic events, reflex sympathetic dystrophy, non-infectious pneumonitis, pneumonia, mycobacterial infections, invasive fungal infections, aspergillosis, candidiasis, pneumocystis jiroveci pneumonia (PJP), viral infections, hepatitis B virus, sepsis, respiratory failure, hepatic failure, renal failure, acute renal failure, wound dehiscence, wound infection, incisional hernia, lymphocele, seroma, serum creatinine, urinary protein, blood glucose, lipids, hemoglobin, neutrophils, platelets, live vaccines, embryo-fetal toxicity"
242,AMPYRA,all-concat,"seizures, anaphylaxis, urinary tract infections, insomnia, dizziness, headache, nausea, asthenia, back pain, balance disorder, multiple sclerosis relapse, paresthesia, nasopharyngitis, constipation, dyspepsia, pharyngolaryngeal pain, confusional state, renal impairment, allergic reactions, respiratory compromise, urticaria, angioedema"
243,AMYVID,all-concat,"headache, musculoskeletal pain, blood pressure increased, fatigue, nausea, injection site reaction, anxiety, back pain, claustrophobia, dizziness, feeling cold, insomnia, neck pain, infusion site rash, dysgeusia, pruritis, urticaria, flushing"
244,APTIOM,all-concat,"suicidal behavior and ideation, serious dermatologic reactions, drug reaction with eosinophilia and systemic symptoms (DRESS), anaphylactic reactions, angioedema, hyponatremia, neurological adverse reactions, drug induced liver injury, abnormal thyroid function tests, dizziness, somnolence, nausea, headache, diplopia, vomiting, fatigue, vertigo, ataxia, blurred vision, tremor, ear and labyrinth disorders, eye disorders, gastrointestinal disorders, general disorders and administration site conditions, infections and infestations, injury, poisoning and procedural complications, metabolism and nutrition disorders, nervous system disorders, psychiatric disorders, respiratory, thoracic and mediastinal disorders, skin and subcutaneous tissue disorders, vascular disorders, decreases in hemoglobin and hematocrit, increases in total cholesterol, triglycerides, LDL, increases in creatine phosphokinase, serious dermatologic reactions including Stevens-Johnson Syndrome (SJS), toxic epidermal necrolysis (TEN), hepatitis, nephritis, hematological abnormalities, myocarditis, myositis, fever, rash, lymphadenopathy, laryngeal edema, seizures, severe nausea/vomiting, dehydration, severe gait instability, injury, hypochloremia, dizziness and disturbance in gait and coordination, ataxia, balance disorder, gait disturbance, nystagmus, abnormal coordination, somnolence and fatigue-related adverse reactions, fatigue, asthenia, malaise, hypersomnia, sedation, lethargy, cognitive dysfunction, memory impairment, disturbance in attention, amnesia, confusional state, aphasia, speech disorder, slowness of thought, disorientation, psychomotor retardation, visual changes, diplopia, blurred vision, impaired vision, mild to moderate elevations in transaminases, elevations of total bilirubin, decreases in serum T3 and T4 (free and total)."
245,ARCAPTA,all-concat,"asthma-related death, cough, oropharyngeal pain, nasopharyngitis, headache, nausea, COPD exacerbation, pneumonia, angina pectoris, atrial fibrillation, muscle spasm, musculoskeletal pain, edema peripheral, diabetes mellitus, hyperglycemia, sinusitis, upper respiratory tract infection, hypersensitivity reactions, paradoxical bronchospasm, tachycardia, heart rate increase, palpitations, pruritus, rash, dizziness, cardiovascular effects, fatalities, immediate hypersensitivity reactions, life-threatening paradoxical bronchospasm, increases in pulse rate, systolic blood pressure, diastolic blood pressure, ECG changes, flattening of the T wave, prolongation of the QTc interval, ST segment depression, coronary insufficiency, cardiac arrhythmias, hypertension, convulsive disorders, thyrotoxicosis, hypokalemia, hyperglycemia"
246,BELEODAQ,all-concat,"hematologic toxicity, infection, hepatotoxicity, tumor lysis syndrome, gastrointestinal toxicity, nausea, fatigue, pyrexia, anemia, vomiting, constipation, diarrhea, dyspnea, rash, peripheral edema, cough, thrombocytopenia, pruritus, chills, increased blood lactate dehydrogenase, decreased appetite, headache, infusion site pain, hypokalemia, prolonged QT, abdominal pain, hypotension, phlebitis, dizziness, pneumonia, increased creatinine, multi-organ failure, hepatic failure, ventricular fibrillation, febrile neutropenia, leukopenia (neutropenia and lymphopenia), sepsis, embryo-fetal toxicity"
247,BENLYSTA,all-concat,"mortality, serious infections, malignancy, hypersensitivity reactions, anaphylaxis, infusion reactions, depression, suicidality, immunization, Progressive Multifocal Leukoencephalopathy (PML), nausea, diarrhea, pyrexia, nasopharyngitis, bronchitis, insomnia, pain in extremity, migraine, pharyngitis, cystitis, leukopenia, gastroenteritis viral, fatal anaphylaxis, infection, cardiovascular disease, suicide, upper respiratory tract infection, urinary tract infection, sinusitis, influenza, pneumonia, cellulitis, JC virus-associated PML, neurological deficits, non-melanoma skin cancers, rash, fatigue, myalgia, headache, facial edema, hypotension, angioedema, urticaria, pruritus, dyspnea, bradycardia, anxiety, live vaccines, biologic therapies, intravenous cyclophosphamide"
248,BEPREVE,all-concat,"mild taste following instillation, eye irritation, headache, nasopharyngitis, hypersensitivity reactions, itching, body rash, swelling of lips, tongue and/or throat"
249,BESIVANCE,all-concat,"conjunctival redness, blurred vision, eye pain, eye irritation, eye pruritus, headache, overgrowth of non-susceptible organisms, super-infection"
250,BLINCYTO,all-concat,"'cytokine release syndrome, neurological toxicities, infections, tumor lysis syndrome, neutropenia, febrile neutropenia, elevated liver enzymes, leukoencephalopathy, preparation and administration errors, pyrexia, headache, peripheral edema, nausea, hypokalemia, tremor, rash, constipation, febrile neutropenia, pneumonia, sepsis, neutropenia, device-related infection, encephalopathy, infection, overdose, confusion, Staphylococcal bacteremia, anemia, thrombocytopenia, leukopenia, diarrhea, abdominal pain, vomiting, fatigue, chills, chest pain, cytokine release syndrome, other pathogen infections, bacterial infections, fungal infections, viral infections, pneumonia, sepsis, increased alanine aminotransferase, increased aspartate aminotransferase, increased weight, hypomagnesemia, hyperglycemia, decreased appetite, hypophosphatemia, back pain, pain in extremity, bone pain, arthralgia, dizziness, insomnia, cough, dyspnea, hypotension, hypertension, leukocytosis, lymphopenia, tachycardia, edema, cytokine storm, decreased immunoglobulins, increased blood bilirubin, increased gamma-glutamyl-transferase, increased liver enzymes, tumor lysis syndrome, hypoalbuminemia, encephalopathy, paresthesia, aphasia, convulsion, memory impairment, cognitive disorder, speech disorder, confusion, disorientation, capillary leak syndrome, hypersensitivity, bronchospasm, asthenia, disseminated intravascular coagulation, capillary leak syndrome, hemophagocytic lymphohistiocytosis/macrophage activation syndrome, disturbances in consciousness, coordination and balance disorders, loss of consciousness'"
251,BOSULIF,all-concat,"'gastrointestinal toxicity, myelosuppression, hepatic toxicity, fluid retention, renal toxicity, diarrhea, nausea, thrombocytopenia, vomiting, abdominal pain, rash, anemia, pyrexia, fatigue, anaphylactic shock, increased alanine aminotransferase, headache, cough, increased aspartate aminotransferase, neutropenia, edema, arthralgia, decreased appetite, respiratory tract infection, nasopharyngitis, back pain, asthenia, pruritus, dizziness, dyspnea, QTcF interval prolongation, platelet count low, absolute neutrophil count low, hemoglobin low, SGPT/ALT elevation, SGOT/AST elevation, lipase increase, phosphorus low, total bilirubin increase, febrile neutropenia, pericardial effusion, pericarditis, tinnitus, gastritis, acute pancreatitis, gastrointestinal hemorrhage, chest pain, pain, hepatotoxicity, liver disorder, liver injury, drug hypersensitivity, pneumonia, influenza, bronchitis, electrocardiogram QT prolonged, increased blood creatine phosphokinase, increased blood creatinine, hyperkalemia, dehydration, myalgia, dysgeusia, acute renal failure, renal failure, pleural effusion, acute pulmonary edema, respiratory failure, pulmonary hypertension, urticaria, acne, erythema multiforme, exfoliative rash, drug eruption, embryofetal toxicity'"
252,BREO,all-concat,"'asthma-related death, asthma-related hospitalization, nasopharyngitis, upper respiratory tract infection, headache, oral candidiasis, oropharyngeal candidiasis, candidiasis, fungal oropharyngitis, bronchitis, sinusitis, oropharyngeal pain, dysphonia, cough, back pain, pneumonia, bronchitis, sinusitis, cough, oropharyngeal pain, arthralgia, influenza, pharyngitis, pyrexia, viral respiratory tract infection, pharyngitis, pyrexia, arthralgia, extrasystoles, upper abdominal pain, respiratory tract infection, allergic rhinitis, pharyngitis, rhinitis, arthralgia, supraventricular extrasystoles, ventricular extrasystoles, acute sinusitis, pneumonia, palpitations, tachycardia, hypersensitivity reactions, anaphylaxis, angioedema, rash, urticaria, muscle spasms, tremor, nervousness, paradoxical bronchospasm, adrenal insufficiency, hypercorticism, adrenal suppression, adrenal crisis, hypokalemia, hyperglycemia, growth velocity reduction in children and adolescents'"
253,CARBAGLU,all-concat,"'infections, vomiting, abdominal pain, pyrexia, tonsilitis, anemia, ear infection, diarrhea, nasopharyngitis, headache, dysgeusia, asthenia, hyperhidrosis, influenza, pneumonia, hemoglobin decreased, weight decreased, anorexia, somnolence, rash, hyperammonemia'"
254,CERDELGA,all-concat,"fatigue, headache, nausea, diarrhea, back pain, pain in extremities, upper abdominal pain, arthralgia, migraine, flatulence, oropharyngeal pain, dizziness, asthenia, cough, dyspepsia, gastroesophageal reflux disease, constipation, palpitations, rash, ECG changes, cardiac arrhythmias"
255,CHOLINE,all-concat,"injection site reaction, imaging errors, allergic reactions, anaphylaxis, radiation risk"
256,CIMZIA,all-concat,"upper respiratory tract infection, rash, urinary tract infection, serious infections, malignancies, heart failure, abdominal pain, diarrhea, intestinal obstruction, tuberculosis infections, pyrexia, urticaria, pneumonia, upper respiratory infections, nasopharyngitis, laryngitis, viral infection, bladder infection, bacteriuria, cystitis, arthralgia, anemia, leukopenia, lymphadenopathy, pancytopenia, thrombophilia, angina pectoris, arrhythmias, atrial fibrillation, cardiac failure, hypertensive heart disease, myocardial infarction, myocardial ischemia, pericardial effusion, pericarditis, stroke, transient ischemic attack, optic neuritis, retinal hemorrhage, uveitis, bleeding, injection site reactions, elevated liver enzymes, hepatitis, alopecia totalis, anxiety, bipolar disorder, suicide attempt, nephrotic syndrome, renal failure, menstrual disorder, dermatitis, erythema nodosum, thrombophlebitis, vasculitis, infections, bacterial infections, viral infections, pneumonia, pyelonephritis, tuberculosis, cellulitis, systemic vasculitis, Stevens-Johnson syndrome, toxic epidermal necrolysis, erythema multiforme, psoriasis, sarcoidosis, active tuberculosis, invasive fungal infections, histoplasmosis, coccidioidomycosis, candidiasis, aspergillosis, blastomycosis, pneumocystosis, Legionella, Listeria, lymphoma, Hodgkin's lymphoma, non-Hodgkin's lymphoma, hepatosplenic T-cell lymphoma, leukemia, worsening congestive heart failure, new onset congestive heart failure, angioedema, dyspnea, hypotension, serum sickness, hepatitis B virus reactivation, central nervous system demyelinating disease, multiple sclerosis, peripheral demyelinating disease, Guillain-Barre syndrome, seizure disorder, peripheral neuropathy, aplastic anemia, leukopenia, thrombocytopenia, lupus-like syndrome"
257,CLEVIPREX,all-concat,"hypotension, reflex tachycardia, headache, nausea, vomiting, acute renal failure, atrial fibrillation, myocardial infarction, cardiac arrest, syncope, dyspnea, increased blood triglycerides, ileus, hypersensitivity, decreased oxygen saturation, negative inotropic effects, exacerbate heart failure, rebound hypertension"
258,COARTEM,all-concat,"headache, anorexia, dizziness, asthenia, arthralgia, myalgia, pyrexia, cough, vomiting, hypersensitivity reactions, anaphylaxis, urticaria, angioedema, serious skin reactions, bullous eruption, QT prolongation, eosinophilia, tinnitus, conjunctivitis, constipation, dyspepsia, dysphagia, peptic ulcer, gait disturbance, abscess, acrodermatitis, bronchitis, ear infection, gastroenteritis, helminthic infection, hookworm infection, impetigo, influenza, lower respiratory tract infection, malaria, nasopharyngitis, oral herpes, pneumonia, respiratory tract infection, subcutaneous abscess, upper respiratory tract infection, urinary tract infection, alanine aminotransferase increased, aspartate aminotransferase increased, hematocrit decreased, lymphocyte morphology abnormal, platelet count decreased, platelet count increased, white blood cell count decreased, white blood cell count increased, hypokalemia, back pain, ataxia, clonus, fine motor delay, hyperreflexia, hypoesthesia, nystagmus, tremor, agitation, mood swings, hematuria, proteinuria, asthma, pharyngo-laryngeal pain, chills, fatigue, malaise, nausea, abdominal pain, diarrhea, sleep disorder, insomnia, palpitations, hepatomegaly, splenomegaly, anemia, pruritus, rash, vertigo, malaria, nasopharyngitis, Plasmodium falciparum infection, rhinitis, aspartate aminotransferase increased, arthralgia, myalgia, rash"
259,COMETRIQ,all-concat,"perforations, fistula, hemorrhage, thromboembolic events, wound complications, hypertension, osteonecrosis of the jaw, palmar-plantar erythrodysesthesia syndrome, proteinuria, reversible posterior leukoencephalopathy syndrome, diarrhea, stomatitis, decreased weight, decreased appetite, nausea, fatigue, oral pain, hair color changes, dysgeusia, abdominal pain, constipation, increased AST, increased ALT, lymphopenia, increased alkaline phosphatase, hypocalcemia, neutropenia, thrombocytopenia, hypophosphatemia, hyperbilirubinemia, pneumonia, septicemia, cardiac arrest, respiratory failure, unspecified death, hypocalcemia, increased lipase, pancreatitis, tracheal fistula formation, vomiting, increased levels of thyroid stimulating hormone, gastrointestinal perforations, fistula formation, hemoptysis, gastrointestinal hemorrhage, myocardial infarction, cerebral infarction, arterial thromboembolism, dehiscence, nephrotic syndrome, jaw pain, osteomyelitis, osteitis, bone erosion, tooth or periodontal infection, toothache, gingival ulceration or erosion, slow healing of the mouth or jaw, seizures, headache, visual disturbances, confusion, altered mental function, embryolethal, skeletal variations, visceral variations, malformations"
260,DALVANCE,all-concat,"nausea, headache, diarrhea, vomiting, rash, pruritus, anemia, hemorrhagic anemia, leucopenia, neutropenia, thrombocytopenia, petechiae, eosinophilia, thrombocytosis, gastrointestinal hemorrhage, melena, hematochezia, abdominal pain, infusion-related reactions, hepatotoxicity, anaphylactoid reaction, Clostridium difficile colitis, oral candidiasis, vulvovaginal mycotic infection, hepatic transaminases increased, blood alkaline phosphatase increased, international normalized ratio increased, hypoglycemia, dizziness, bronchospasm, urticaria, flushing, phlebitis, wound hemorrhage, spontaneous hematoma, serious hypersensitivity (anaphylactic) reactions, skin reactions, ""Red-Man Syndrome"", Clostridium difficile-associated diarrhea (CDAD)"
261,DATSCAN,all-concat,"hypersensitivity reactions, injection site reactions, headache, nausea, vertigo, dry mouth, dizziness, rash, pruritis, injection site pain, skin erythema"
262,DIFICID,all-concat,"nausea, vomiting, abdominal pain, gastrointestinal hemorrhage, anemia, neutropenia, abdominal distension, abdominal tenderness, dyspepsia, dysphagia, flatulence, intestinal obstruction, megacolon, increased blood alkaline phosphatase, decreased blood bicarbonate, increased hepatic enzymes, decreased platelet count, hyperglycemia, metabolic acidosis, drug eruption, pruritus, rash, hypersensitivity reactions, dyspnea, angioedema"
263,DOTAREM,all-concat,"'NSF, hypersensitivity reactions, acute kidney injury, nausea, headache, injection site pain, injection site coldness, burning sensation, feeling cold, rash, somnolence, fatigue, dizziness, vomiting, pruritus, paresthesia, dysgeusia, pain in extremity, anxiety, hypertension, palpitations, oropharyngeal discomfort, serum creatinine increased, injection site reactions, site inflammation, extravasation, warmth, bradycardia, tachycardia, arrhythmia, cardiac arrest, respiratory arrest, cyanosis, pharyngeal edema, laryngospasm, bronchospasm, angioedema, conjunctivitis, ocular hyperemia, eyelid edema, lacrimation increased, hyperhidrosis, urticaria, coma, convulsion, syncope, presyncope, parosmia, tremor, muscle contracture, muscle weakness, diarrhea, salivary hypersecretion, malaise, fever, superficial phlebitis'"
264,DUAVEE,all-concat,"'peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, hepatotoxicity, cardiovascular disorders, malignant neoplasms, gallbladder disease, hypertriglyceridemia, muscle spasms, nausea, diarrhea, dyspepsia, abdominal pain upper, oropharyngeal pain, dizziness, neck pain, venous thromboembolism, deep venous thrombosis, pulmonary embolism, retinal vein thrombosis, endometrial cancer, stroke, deep vein thrombosis, probable dementia, hot flush, abdominal pain, breast cancer, ovarian cancer, gallbladder problems, loss of vision, high blood pressure, increased fats in blood, liver problems, thyroid problems, fluid retention, low calcium, swelling of mouth or tongue, worsening of asthma, diabetes, epilepsy, migraines, porphyria, lupus, liver problems, blood clots, heart attack, cancer of the lining of the uterus, dementia, gallbladder disease, visual abnormalities, retinal vascular thrombosis, elevated blood pressure, pancreatitis, cholestatic jaundice, hypothyroidism, hypocalcemia, hereditary angioedema, exacerbation of asthma, diabetes mellitus, epilepsy, migraine, porphyria, systemic lupus erythematosus, hepatic hemangiomas, impaired glucose tolerance'"
265,DUREZOL,all-concat,"elevated intraocular pressure, optic nerve damage, visual acuity and field defects, posterior subcapsular cataract formation, secondary ocular infection, perforation of the globe, corneal edema, ciliary and conjunctival hyperemia, eye pain, photophobia, posterior capsule opacification, anterior chamber cells, anterior chamber flare, conjunctival edema, blepharitis, reduced visual acuity, punctate keratitis, eye inflammation, iritis, application site discomfort or irritation, corneal pigmentation and striae, episcleritis, eye pruritis, eyelid irritation and crusting, foreign body sensation, increased lacrimation, macular edema, sclera hyperemia, uveitis, blurred vision, eye irritation, headache, increased IOP, limbal and conjunctival hyperemia, dry eye, iridocyclitis, glaucoma, defects in visual acuity and fields of vision, posterior subcapsular cataract formation, delayed healing, bleb formation, bacterial infections, viral infections, fungal infections"
266,DYSPORT,all-concat,"distant spread of toxin effect, lack of interchangeability between botulinum toxin products, spread of effects from toxin, dysphagia, breathing difficulties, facial anatomy in the treatment of glabellar lines, pre-existing neuromuscular disorders, human albumin, intradermal immune reaction, muscular weakness, dry mouth, injection site discomfort, fatigue, headache, neck pain, musculoskeletal pain, dysphonia, injection site pain, eye disorders, blurred vision, diplopia, reduced visual acuity and accommodation, disturbance in attention, eyelid disorder, feeling abnormal, nasopharyngitis, upper respiratory tract infection, eyelid edema, eyelid ptosis, sinusitis, nausea, urinary tract infection, dizziness, fall, depression, breathing difficulty, dyspnea, muscle atrophy, blood glucose increase, heart rate reduction, blood present in urine, bronchitis, influenza, pharyngolaryngeal pain, cough, contact dermatitis, injection site swelling, injection site bruising, injection site reaction, numbness, discomfort, erythema, tenderness, tingling, itching, stinging, warmth, irritation, tightness, swelling, eyelid ptosis, pain in extremity, back pain, convulsion, syncope, hypoaesthesia, partial seizures, asthenia, injury, contusion, diarrhea, constipation, blood triglycerides increased, hypertension, vertigo, photophobia, influenza-like illness, amyotrophy, burning sensation, facial paresis, hypoesthesia, excessive granulation tissue, dysphagia, gait disturbance, hypertonia, sensation of heaviness"
267,EDARBI,all-concat,"diarrhea, hypotension, orthostatic hypotension, nausea, asthenia, fatigue, muscle spasm, dizziness, dizziness postural, cough, serum creatinine increases, low hemoglobin, low hematocrit, low RBC counts, abnormal platelet counts, abnormal WBC counts, rash, pruritus, angioedema, fetal toxicity, oligohydramnios, fetal lung hypoplasia, skeletal deformations, skull hypoplasia, anuria, neonatal hypotension, renal failure, neonatal death, symptomatic hypotension, oliguria, progressive azotemia, acute renal failure"
268,ELIQUIS,all-concat,"thrombotic events, bleeding, spinal/epidural anesthesia or puncture, increased risk of thrombotic events after premature discontinuation, hemorrhagic stroke, gastrointestinal bleed, fatal bleeding, intracranial bleed, non-intracranial bleed, hypersensitivity reactions, skin rash, anaphylactic reactions, allergic edema, syncope, nausea, anemia, contusion, hemorrhage, postprocedural hemorrhage, transaminases increased, aspartate aminotransferase increased, gamma-glutamyltransferase increased, thrombocytopenia, hypotension, epistaxis, gastrointestinal hemorrhage, hematochezia, liver function test abnormal, blood alkaline phosphatase increased, blood bilirubin increased, hematuria, wound secretion, incision-site hemorrhage, operative hemorrhage, gingival bleeding, hemoptysis, hypersensitivity, muscle hemorrhage, ocular hemorrhage, rectal hemorrhage, hemorrhagic anemia, hemorrhoidal hemorrhage, hematemesis, melena, anal hemorrhage, wound hemorrhage, postprocedural hemorrhage, traumatic hematoma, periorbital hematoma, muscle hemorrhage, vaginal hemorrhage, metrorrhagia, menometrorrhagia, genital hemorrhage, hemorrhage, ecchymosis, skin hemorrhage, petechiae, conjunctival hemorrhage, retinal hemorrhage, eye hemorrhage, blood urine present, occult blood positive, occult blood, red blood cells urine positive, injection-site hematoma, vessel puncture-site hematoma"
269,ENTEREG,all-concat,"dyspepsia, myocardial infarction, abdominal pain, nausea, vomiting, diarrhea"
270,EOVIST,all-concat,"nephrogenic systemic fibrosis, hypersensitivity reactions, nausea, headache, feeling hot, dizziness, back pain, vomiting, blood pressure increased, injection site reactions, dysgeusia, paresthesia, flushing, parosmia, pruritus, rash, respiratory disorders, fatigue, chest pain, vertigo, dry mouth, chills, feeling abnormal, tremor, akathisia, bundle branch block, palpitation, oral discomfort, salivary hypersecretion, maculopapular rash, hyperhidrosis, discomfort, malaise, elevation of serum iron values, elevation of serum bilirubin, anaphylactic shock, hypotension, pharyngolaryngeal edema, urticaria, face edema, rhinitis, conjunctivitis, abdominal pain, hypoesthesia, sneezing, cough, pallor, tachycardia, restlessness, acute kidney injury, dialysis, local tissue reactions, myocyte necrosis, inflammation, falsely high or low serum iron values, impaired EOVIST imaging performance, reduced hepatic contrast"
271,ERWINAZE,all-concat,"hypersensitivity reactions, pancreatitis, glucose intolerance, thrombosis, hemorrhage, systemic hypersensitivity, hyperglycemia, transaminases abnormal, fever, local reactions, vomiting, nausea, hyperbilirubinemia, abdominal pain/discomfort, diarrhea, allergy, coagulopathy, hyperbilirubinemia, hyperlipidemia, ketoacidosis, CNS events, hemorrhagic events, hepatobiliary disorders, pancreatic disorders, hyperglycemia, anaphylaxis, severe pancreatitis, hemorrhagic pancreatitis, sagittal sinus thrombosis, pulmonary embolism, fibrinogen decreased, protein C activity decreased, protein S activity decreased, anti-thrombin III decreased"
272,EYLEA,all-concat,"endophthalmitis, retinal detachments, increased intraocular pressure, thromboembolic events, conjunctival hemorrhage, eye pain, cataract, vitreous floaters, vitreous detachment, ocular hyperemia, corneal epithelium defect, detachment of the retinal pigment epithelium, injection site pain, foreign body sensation in eyes, lacrimation increased, vision blurred, intraocular inflammation, retinal pigment epithelium tear, injection site hemorrhage, eyelid edema, corneal edema, hypersensitivity, retinal tear, immunogenicity"
273,FANAPT,all-concat,"'peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, hepatotoxicity, dizziness, dry mouth, fatigue, nasal congestion, orthostatic hypotension, somnolence, tachycardia, weight increased, arthralgia, musculoskeletal stiffness, vision blurred, nausea, diarrhea, abdominal discomfort, nasopharyngitis, upper respiratory tract infection, extrapyramidal disorder, tremor, lethargy, ejaculation failure, dyspnea, rash, hypotension, palpitations, arrhythmia, atrioventricular block first degree, cardiac failure, vertigo, tinnitus, hypothyroidism, conjunctivitis, dry eye, blepharitis, eyelid edema, eye swelling, lenticular opacities, cataract, hyperemia, gastritis, salivary hypersecretion, fecal incontinence, mouth ulceration, aphthous stomatitis, duodenal ulcer, hiatus hernia, hyperchlorhydria, lip ulceration, reflux esophagitis, stomatitis, edema, difficulty in walking, thirst, hyperthermia, cholelithiasis, weight decreased, hemoglobin decreased, neutrophil count increased, hematocrit decreased, increased appetite, dehydration, hypokalemia, fluid retention, myalgia, muscle spasms, torticollis, paresthesia, psychomotor hyperactivity, restlessness, amnesia, nystagmus, restless legs syndrome, restlessness, aggression, delusion, hostility, libido decreased, paranoia, anorgasmia, confusional state, mania, catatonia, mood swings, panic attack, obsessive-compulsive disorder, bulimia nervosa, delirium, polydipsia psychogenic, impulse-control disorder, major depression, urinary incontinence, dysuria, pollakiuria, enuresis, nephrolithiasis, urinary retention, renal failure acute, erectile dysfunction, testicular pain, amenorrhea, breast pain, menstruation irregular, gynecomastia, menorrhagia, metrorrhagia, postmenopausal hemorrhage, prostatitis, epistaxis, asthma, rhinorrhea, sinus congestion, nasal dryness, dry throat, sleep apnea syndrome, dyspnea exertional, retrograde ejaculation, increased mortality, cerebrovascular adverse events, stroke, QT prolongation, arrhythmia, sudden death, Neuroleptic Malignant Syndrome, Tardive dyskinesia, hyperglycemia, diabetes mellitus, dyslipidemia, seizures, leukopenia, neutropenia, agranulocytosis, hyperprolactinemia, body temperature regulation, dysphagia, suicide, priapism, cognitive and motor impairment'"
274,FARXIGA,all-concat,"hypotension, impairment in renal function, hypoglycemia, genital mycotic infections, increases in low-density lipoprotein cholesterol (LDL-C), bladder cancer, female genital mycotic infections, nasopharyngitis, urinary tract infections, back pain, increased urination, male genital mycotic infections, nausea, influenza, dyslipidemia, constipation, discomfort with urination, pain in extremity, volume depletion, dehydration, hypovolemia, orthostatic hypotension, renal failure, blood creatinine increase, bone fractures, hypersensitivity reactions, angioedema, urticaria, anaphylactic reactions, severe cutaneous adverse reactions, increase in hematocrit, increase in serum inorganic phosphorus, hyperphosphatemia"
275,FERRIPROX,all-concat,"chromaturia, nausea, vomiting, abdominal pain, alanine aminotransferase increased, arthralgia, neutropenia, agranulocytosis, elevated ALT, decreased plasma zinc concentrations, neutropenia, abdominal pain/discomfort, diarrhea, dyspepsia, neutrophil count decreased, weight increased, aspartate aminotransferase increased, increased appetite, decreased appetite, back pain, pain in extremity, arthropathy, headache, thrombocytosis, pancytopenia, atrial fibrillation, cardiac failure, hypospadias, diplopia, papilledema, retinal toxicity, enterocolitis, rectal hemorrhage, gastric ulcer, pancreatitis, parotid gland enlargement, chills, pyrexia, edema peripheral, multi-organ failure, jaundice, hepatomegaly, anaphylactic shock, hypersensitivity, cryptococcal cutaneous infection, enteroviral encephalitis, pharyngitis, pneumonia, sepsis, furuncle, infectious hepatitis, rash pustular, subcutaneous abscess, blood bilirubin increased, blood creatinine phosphokinase increased, metabolic acidosis, dehydration, myositis, chondropathy, trismus, cerebellar syndrome, cerebral hemorrhage, convulsion, gait disturbance, intracranial pressure increased, psychomotor skills impaired, pyramidal tract syndrome, somnolence, bruxism, depression, obsessive-compulsive disorder, glycosuria, hemoglobinuria, acute respiratory distress syndrome, epistaxis, hemoptysis, pulmonary embolism, hyperhidrosis, periorbital edema, photosensitivity reaction, pruritis, urticaria, rash, Henoch-Schonlein purpura, hypotension, hypertension"
276,FIRAZYR,all-concat,"'injection site reactions, pyrexia, transaminase increase, dizziness, rash, nausea, headache, anti-icatibant antibodies, hypersensitivity, anaphylactic reactions'"
277,FULYZAQ,all-concat,"upper respiratory tract infection, bronchitis, cough, flatulence, increased bilirubin, nausea, back pain, arthralgia, urinary tract infection, nasopharyngitis, musculoskeletal pain, hemorrhoids, giardiasis, anxiety, increased alanine aminotransferase, abdominal distension, abdominal pain, acne, increased aspartate aminotransferase, increased conjugated bilirubin, increased unconjugated blood bilirubin, constipation, depression, dermatitis, dizziness, dry mouth, dyspepsia, gastroenteritis, herpes zoster, nephrolithiasis, pain in extremity, pollakiuria, procedural pain, seasonal allergy, sinusitis, decreased white blood cell count"
278,GADAVIST,all-concat,"nephrogenic systemic fibrosis (NSF), hypersensitivity reactions, headache, nausea, dizziness, dysgeusia, feeling hot, injection site reactions, vomiting, rash, pruritus, erythema, hypersensitivity/anaphylactoid, dyspnea, paresthesia, loss of consciousness, convulsion, parosmia, tachycardia, palpitation, dry mouth, malaise, feeling cold, cardiac arrest, anaphylactic shock, circulatory collapse, respiratory arrest, pulmonary edema, bronchospasm, cyanosis, oropharyngeal swelling, laryngeal edema, blood pressure increased, chest pain, angioedema, conjunctivitis, hyperhidrosis, cough, sneezing, burning sensation, pallor, acute kidney injury, extravasation, moderate irritation"
279,GILENYA,all-concat,"'bradyarrhythmia, atrioventricular blocks, infections, progressive multifocal leukoencephalopathy, macular edema, posterior reversible encephalopathy syndrome, respiratory effects, liver injury, headache, liver transaminase elevation, diarrhea, cough, influenza, sinusitis, back pain, abdominal pain, pain in extremity, bradycardia, hypotension, dizziness, fatigue, palpitations, chest pain, atrioventricular conduction delays, symptomatic bradycardia, second-degree AV blocks, Mobitz Types I, 2:1 AV blocks, third-degree AV block, AV block with junctional escape, syncope, bronchitis, herpes zoster, pneumonia, herpetic infections, disseminated primary herpes zoster, herpes simplex encephalitis, disseminated varicella zoster, herpes simplex infections, encephalitis, multiorgan failure, cryptococcal infections, cryptococcal meningitis, varicella zoster virus, blurred vision, decreased visual acuity, vision blurred, hypertension, lymphopenia, leukopenia, skin papilloma, basal cell carcinoma, dizziness, pneumonia, eczema, pruritus, ischemic strokes, hemorrhagic strokes, peripheral arterial occlusive disease, lymphomas, bradyarrhythmia, atrioventricular conduction, heart rate decrease, atrioventricular blocks, transient AV conduction delays, first-degree AV block, second-degree AV blocks, Mobitz Types I, 2:1 AV blocks, third-degree AV block, AV block with junctional escape, syncope, unexplained death, infections, serious infections, herpetic infections, disseminated primary herpes zoster, herpes simplex encephalopathy, disseminated varicella zoster, herpes simplex infections, encephalitis, multiorgan failure, cryptococcal infections, cryptococcal meningitis, antineoplastic, immunosuppressive, immune-modulating therapies, corticosteroids, varicella zoster virus antibody testing, vaccination, progressive multifocal leukoencephalopathy, PML, JC virus, JCV, macular edema, visual disturbances, blurred vision, decreased visual acuity, posterior reversible encephalopathy syndrome, PRES, severe headache, altered mental status, visual disturbances, seizure, ischemic stroke, cerebral hemorrhage, respiratory effects, forced expiratory volume, FEV1, diffusion lung capacity for carbon monoxide, DLCO, dyspnea, liver injury, liver enzymes, liver transaminase elevations, serum transaminase levels, hepatic dysfunction, nausea, vomiting, abdominal pain, fatigue, anorexia, jaundice, dark urine, severe hepatic impairment, fetal risk, blood pressure effects, hypertension, immune system effects, lymphocyte counts, additive immunosuppressant effects'"
280,GILOTRIF,all-concat,"diarrhea, bullous and exfoliative skin disorders, interstitial lung disease, hepatic toxicity, keratitis, pancreatitis, dehydration, renal failure, rash/dermatitis acneiform, stomatitis, paronychia, dry skin, decreased appetite, nausea, vomiting, pruritus, pulmonary toxicity/ILD-like adverse reactions, sepsis, pneumonia, dyspnea, fatigue, hypokalemia, ventricular dysfunction, diastolic dysfunction, left ventricular dysfunction, ventricular dilation, cheilitis, cystitis, epistaxis, rhinorrhea, weight decreased, pyrexia, conjunctivitis, alanine aminotransferase increased, aspartate aminotransferase increased, embryofetal toxicity"
281,GRANIX,all-concat,"'splenic rupture, acute respiratory distress syndrome, serious allergic reactions, sickle cell crisis, capillary leak syndrome, tumor growth stimulatory effects, bone pain, leukocytosis, myalgia, headache, vomiting, Sweet's syndrome, cutaneous vasculitis, thrombocytopenia, allergic reactions, anaphylaxis, angioneurotic edema, dermatitis allergic, drug hypersensitivity, hypersensitivity, rash, pruritic rash, urticaria'"
282,HALAVEN,all-concat,"'neutropenia, anemia, asthenia/fatigue, alopecia, peripheral neuropathy, nausea, constipation, febrile neutropenia, headache, mucosal inflammation, pyrexia, diarrhea, vomiting, arthralgia/myalgia, back pain, bone pain, pain in extremity, weight decreased, anorexia, cough, dyspnea, urinary tract infection, peripheral motor neuropathy, liver function test abnormalities, increased lacrimation, dyspepsia, abdominal pain, stomatitis, dry mouth, peripheral edema, upper respiratory tract infection, hypokalemia, muscle spasms, muscular weakness, dysgeusia, dizziness, insomnia, depression, rash, lymphopenia, pancreatitis, hepatotoxicity, drug hypersensitivity, pneumonia, sepsis/neutropenic sepsis, hypomagnesemia, dehydration, interstitial lung disease, pruritus, embryo-fetal toxicity, QT prolongation'"
283,HORIZANT,all-concat,"'somnolence/sedation, dizziness, headache, nausea, dry mouth, flatulence, fatigue, irritability, feeling drunk, feeling abnormal, peripheral edema, weight increased, increased appetite, vertigo, depression, libido decreased, balance disorder, blurred vision, disorientation, lethargy, breast enlargement, gynecomastia, elevated creatine kinase, driving impairment, suicidal thoughts or behaviors, insomnia, asthenia, confusional state, Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS)/Multiorgan Hypersensitivity, withdrawal seizure, pancreatic acinar cell adenoma, pancreatic acinar cell carcinoma, tumors'"
284,ILARIS,all-concat,"'upper respiratory tract infections, serious infections, nasopharyngitis, diarrhea, influenza, headache, nausea, infections, abdominal pain, injection site reactions, vertigo, bronchitis, gastroenteritis, pharyngitis, weight increased, musculoskeletal pain, pneumonia, varicella, gastroenteritis, measles, sepsis, otitis media, sinusitis, adenovirus, lymph node abscess, pharyngitis, abdominal pain, nasopharyngitis, upper respiratory tract infection, pneumonia, rhinitis, pharyngitis, tonsillitis, sinusitis, urinary tract infection, gastroenteritis, viral infection, abdominal pain, injection site reaction, hypersensitivity, decreased white blood cells, neutrophils, platelets, elevated transaminases, asymptomatic elevations of serum bilirubin, opportunistic infections, tuberculosis, malignancies, macrophage activation syndrome'"
285,IMBRUVICA,all-concat,"hemorrhage, infections, cytopenias, atrial fibrillation, second primary malignancies, tumor lysis syndrome, embryo-fetal toxicity, thrombocytopenia, neutropenia, diarrhea, anemia, fatigue, musculoskeletal pain, bruising, nausea, upper respiratory tract infection, rash, peripheral edema, dyspnea, constipation, abdominal pain, vomiting, decreased appetite, pneumonia, stomatitis, dyspepsia, pyrexia, asthenia, muscle spasms, arthralgia, cough, epistaxis, dehydration, dizziness, headache, renal failure, subdural hematoma, lymphocytosis, intracranial hemorrhage, lethargy, gait instability, hyperuricemia, sinusitis, urinary tract infection, skin infections, petechiae, chills, anxiety, insomnia, hypertension, gastroesophageal reflux disease, pruritus, arthropathy, oropharyngeal pain, vision blurred, contusion, laceration, hypersensitivity reactions, anaphylactic shock, urticaria, angioedema, progressive multifocal leukoencephalopathy (PML), skin cancer"
286,INLYTA,all-concat,"'hypertension, arterial thromboembolic events, venous thromboembolic events, hemorrhage, cardiac failure, gastrointestinal perforation, fistula formation, thyroid dysfunction, wound healing complications, RPLS, proteinuria, elevation of liver enzymes, hepatic impairment, fetal development, diarrhea, fatigue, decreased appetite, nausea, dysphonia, palmar-plantar erythrodysesthesia syndrome, weight decreased, vomiting, asthenia, constipation, hypothyroidism, cough, mucosal inflammation, arthralgia, stomatitis, dyspnea, abdominal pain, headache, pain in extremity, rash, proteinuria, dysgeusia, dry skin, dyspepsia, pruritus, alopecia, erythema, dizziness, upper abdominal pain, myalgia, dehydration, epistaxis, anemia, hemorrhoids, hematuria, tinnitus, lipase increased, glossodynia, pulmonary embolism, rectal hemorrhage, hemoptysis, deep vein thrombosis, retinal-vein occlusion/thrombosis, polycythemia, transient ischemic attack, hypertensive crisis, cerebrovascular accident, myocardial infarction, retinal artery occlusion, cerebral hemorrhage, lower gastrointestinal hemorrhage, melena, gastric hemorrhage, reversible posterior leukoencephalopathy syndrome, alanine aminotransferase elevations, aspartate aminotransferase elevations, bilirubin elevations, hypercalcemia, hemoglobin increased'"
287,INTELENCE,all-concat,"severe skin and hypersensitivity reactions, rash, peripheral neuropathy, diarrhea, myocardial infarction, angina pectoris, atrial fibrillation, vertigo, blurred vision, gastroesophageal reflux disease, flatulence, gastritis, abdominal distension, pancreatitis, constipation, dry mouth, hematemesis, retching, stomatitis, sluggishness, hemolytic anemia, hepatic failure, hepatomegaly, cytolytic hepatitis, hepatic steatosis, hepatitis, drug hypersensitivity, immune reconstitution syndrome, diabetes mellitus, anorexia, dyslipidemia, paraesthesia, somnolence, convulsion, hypoesthesia, amnesia, syncope, disturbance in attention, hypersomnia, tremor, anxiety, sleep disorders, abnormal dreams, confusional state, disorientation, nervousness, nightmares, acute renal failure, gynecomastia, exertional dyspnea, bronchospasm, night sweats, lipohypertrophy, prurigo, hyperhidrosis, dry skin, swelling face, acquired lipodystrophy, angioneurotic edema, erythema multiforme, haemorrhagic stroke, Stevens-Johnson syndrome, toxic epidermal necrolysis, DRESS, hepatic failure, rhabdomyolysis, fatal cases of toxic epidermal necrolysis, severe hypersensitivity, severe rash, rash with systemic symptoms, liver transaminase elevations, Drug Rash with Eosinophilia and Systemic Symptoms (DRESS), central obesity, dorsocervical fat enlargement (buffalo hump), peripheral wasting, facial wasting, breast enlargement, ""cushingoid appearance"", Mycobacterium avium infection, cytomegalovirus, Pneumocystis jiroveci pneumonia (PCP), tuberculosis, Graves' disease, polymyositis, Guillain-Barre syndrome"
288,INVOKANA,all-concat,"hypotension, impairment in renal function, hyperkalemia, hypoglycemia, genital mycotic infections, hypersensitivity reactions, bone fracture, increased LDL-C, increased urination, male genital mycotic infections, vulvovaginal pruritus, thirst, constipation, nausea, abdominal pain, fatigue, loss of strength or energy, asthenia, pancreatitis, erythema, rash, pruritus, urticaria, angioedema, photosensitivity reaction, polymorphic light eruption, sunburn, volume depletion-related adverse reactions, hypotension, postural dizziness, orthostatic hypotension, syncope, dehydration, falls, increased blood creatinine, decreased glomerular filtration rate, renal impairment, acute renal failure, phimosis, increased serum potassium, increased serum magnesium, increased serum phosphate, increased hemoglobin, decreases in bone mineral density"
289,JARDIANCE,all-concat,"hypotension, impairment in renal function, hypoglycemia, genital mycotic infections, urinary tract infections, increased LDL-C, increased urination, dyslipidemia, arthralgia, nausea, thirst, volume depletion, dehydration, orthostatic hypotension, syncope, increased hematocrit, phimosis"
290,JEVTANA,all-concat,"'bone marrow suppression, hypersensitivity reactions, gastrointestinal adverse reactions, renal failure, embryo-fetal toxicity, neutropenia, anemia, leukopenia, thrombocytopenia, diarrhea, fatigue, nausea, vomiting, constipation, asthenia, abdominal pain, hematuria, back pain, anorexia, peripheral neuropathy, pyrexia, dyspnea, dysgeusia, cough, arthralgia, alopecia, infections, ventricular fibrillation, cerebral hemorrhage, febrile neutropenia, arrhythmia, peripheral edema, mucosal inflammation, pain, urinary tract infection, weight decreased, dehydration, muscle spasms, dizziness, headache, dysuria, hypotension, gastritis, intestinal obstruction, neutropenic deaths, generalized rash/erythema, bronchospasm, neutropenic infections, neutropenic enterocolitis, gastrointestinal hemorrhage, gastrointestinal perforation, ileus, enterocolitis, sepsis, septic shock, increased AST, increased ALT, increased bilirubin, febrile neutropenia, sepsis, septic shock, neutropenia without a documented infection, neutropenia complications, hypersensitivity reactions, generalized rash/erythema, hypotension, bronchospasm, severe diarrhea, electrolyte imbalance, gastrointestinal (GI) hemorrhage, perforation, ileus, enterocolitis, neutropenic enterocolitis, abdominal pain, tenderness, fever, persistent constipation, diarrhea, obstructive uropathy, embryotoxic, fetotoxic, abortifacient'"
291,JUBLIA,all-concat,"ingrown toenails, application site dermatitis, application site vesicles, application site pain"
292,KALBITOR,all-concat,"hypersensitivity reactions, anaphylaxis, headache, nausea, diarrhea, pyrexia, injection site reactions, nasopharyngitis, fatigue, upper respiratory tract infection, vomiting, pruritus, upper abdominal pain, chest discomfort, flushing, pharyngeal edema, rhinorrhea, sneezing, nasal congestion, throat irritation, wheezing, hypotension, rash"
293,KALYDECO,all-concat,"transaminase elevations, headache, oropharyngeal pain, upper respiratory tract infection, nasal congestion, abdominal pain, nasopharyngitis, diarrhea, rash, nausea, dizziness, increased hepatic enzymes, hypoglycemia, rhinitis, bacteria in sputum, arthralgia, musculoskeletal chest pain, myalgia, sinus headache, pharyngeal erythema, pleuritic pain, sinus congestion, wheezing, acne, cataracts"
294,KYPROLIS,all-concat,"cardiac toxicities, acute renal failure, tumor lysis syndrome, pulmonary toxicity, pulmonary hypertension, dyspnea, hypertension, venous thrombosis, infusion reactions, thrombocytopenia, hepatic toxicity, hepatic failure, thrombotic thrombocytopenic purpura/hemolytic uremic syndrome, posterior reversible encephalopathy syndrome, embryo-fetal toxicity, anemia, fatigue, nausea, pyrexia, decreased platelets, diarrhea, decreased lymphocyte, headache, decreased hemoglobin, cough, edema peripheral, decreased lymphocytes, decreased absolute neutrophil count, decreased phosphorus, neutropenia, decreased total white blood cell count, muscle spasm, upper respiratory tract infection, hypokalemia, pneumonia, constipation, infections, nasopharyngitis, bronchitis, hypokalemia, hypocalcemia, hyperglycemia, muscle spasms, peripheral neuropathies NEC, insomnia, dyspnea, rash, embolic and thrombotic events, venous, hypertension, febrile neutropenia, lymphopenia, cardiac arrest, cardiac failure, cardiac failure congestive, myocardial infarction, myocardial ischemia, cataract, vision blurred, abdominal pain, abdominal pain upper, dyspepsia, toothache, chills, infusion site reaction, multi-organ failure, pain, influenza, sepsis, urinary tract infection, viral infection, dehydration, hyperkalemia, hyperuricemia, hypoalbuminemia, hyponatremia, tumor lysis syndrome, muscular weakness, myalgia, hypoesthesia, paresthesia, deafness, anxiety, delirium, renal failure, renal failure acute, renal impairment, dysphonia, epistaxis, oropharyngeal pain, pulmonary embolism, pulmonary edema, erythema, hyperhidrosis, pruritus, deep vein thrombosis, hypotension, decreased appetite, hypercalcemia, back pain, arthralgia, pain in extremity, musculoskeletal pain, dizziness, insomnia, dyspnea, epistaxis, renal failure, hypotension, febrile neutropenia, hepatic failure, bronchitis, nasopharyngitis, respiratory tract infection, hyperglycemia, hyperkalemia, hyperuricemia, hypocalcemia, hypomagnesemia, hypophosphatemia, musculoskeletal chest pain, erythema, rash, embolic and thrombotic events, venous"
295,LUMIZYME,all-concat,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, hepatotoxicity, hypersensitivity reactions, rash, pyrexia, flushing/feeling hot, urticaria, headache, hyperhidrosis, nausea, cough, decreased oxygen saturation, tachycardia, tachypnea, chest discomfort, dizziness, muscle twitching, agitation, cyanosis, erythema, hypertension/increased blood pressure, pallor, rigors, tremor, vomiting, fatigue, myalgia, acute cardiorespiratory failure, serious adverse reactions, anaphylactic shock, respiratory failure, respiratory arrest, cardiac arrest, hypoxia, dyspnea, wheezing, convulsions, peripheral coldness, restlessness, nervousness, back pain, stridor, pharyngeal edema, abdominal pain, apnea, muscle spasm, conjunctivitis, hyperparathyroidism, proteinuria, nephrotic syndrome, membranous glomerulonephritis, necrotizing skin lesions, respiratory distress, bradycardia, bronchospasm, hypotension, angioedema, chest pain/discomfort, supraventricular tachycardia, local swelling, diarrhea, pruritus, throat tightness, edema, peripheral, rash papular, flu-like illness, chills, arthralgia, pain, anaphylactic reactions, immune-mediated reactions, cardiorespiratory failure, acute exacerbation of cardiac or respiratory compromise, fluid overload, cardiac arrhythmia, sudden cardiac death, general anesthesia complications, antibody development, reduced clinical efficacy, loss of motor function, ventilator dependence, death, inhibitory antibody activity, IgE antibodies, mediators of anaphylaxis"
296,MULTAQ,all-concat,"'new or worsening heart failure, liver injury, pulmonary toxicity, hypokalemia, hypomagnesemia, QT prolongation, diarrhea, nausea, abdominal pain, vomiting, asthenia, gastrointestinal disorders, bradycardia, rashes, pruritus, eczema, dermatitis, dermatitis allergic, photosensitivity reaction, dysgeusia, increases in creatinine, QTc prolonged, atrial flutter with 1:1 atrioventricular conduction, interstitial lung disease, pneumonitis, pulmonary fibrosis, anaphylactic reactions, angioedema, vasculitis, leukocytoclastic vasculitis, cardiovascular death, stroke, heart failure, hepatocellular liver injury, acute liver failure, hepatotoxicity, renal impairment, renal failure, pre-renal azotemia, acute renal failure, marked increase in serum creatinine, fetal harm'"
297,NATAZIA,all-concat,"'serious cardiovascular events, stroke, vascular events, liver disease, irregular uterine bleeding, nausea, breast tenderness, headache, headaches, irregular uterine bleeding, headache, breast tenderness, pain, menstrual disorders, nausea, vomiting, acne, mood changes, increased weight, myocardial infarction, ruptured ovarian cyst, deep vein thrombosis, focal nodular hyperplasia of the liver, uterine leiomyoma, acute cholecystitis, chronic acalculous cholecystitis, venous thromboembolic events, pulmonary emboli, deep vein thrombosis, cerebral thrombosis, myocardial infarction, stroke, hypertension, gallbladder disease, hepatitis, hypersensitivity, fluid retention, hypertriglyceridemia, dizziness, chloasma, angioedema, erythema nodosum, erythema multiforme, gastrointestinal symptoms, abdominal pain, vulvovaginal candidiasis, thrombotic event, venous thromboembolism, arterial thromboses, strokes, myocardial infarctions, retinal vein thrombosis, carcinoma of the breasts, cervical cancer, intraepithelial neoplasia, liver disease, jaundice, hepatic adenomas, hepatocellular carcinoma, high blood pressure, gallbladder disease, carbohydrate and lipid metabolic effects, pancreatitis, headache, bleeding irregularities, breakthrough bleeding, spotting, amenorrhea, oligomenorrhea, intracyclic bleeding, depression, hereditary angioedema, symptoms of angioedema, chloasma'"
298,NESINA,all-concat,"nasopharyngitis, headache, upper respiratory tract infection, pancreatitis, hypersensitivity reactions, serum sickness, hypoglycemia, anaphylaxis, angioedema, rash, urticaria, severe cutaneous adverse reactions, Stevens-Johnson syndrome, hepatic enzyme elevations, fulminant hepatic failure, severe and disabling arthralgia, acute pancreatitis"
299,NEURACEQ,all-concat,"'injection site reaction, erythema, irritation, pain, image interpretation errors, radiation risk'"
300,NORTHERA,all-concat,"supine hypertension, hyperpyrexia, confusion, ischemic heart disease, arrhythmias, congestive heart failure, headache, dizziness, nausea, hypertension, falls, urinary tract infections, syncope, allergic reactions"
301,NULOJIX,all-concat,"PTLD, CNS PTLD, malignancies, serious infections, JC virus-associated PML, polyoma virus nephropathy, anemia, diarrhea, urinary tract infection, peripheral edema, constipation, hypertension, pyrexia, graft dysfunction, cough, nausea, vomiting, headache, hypokalemia, hyperkalemia, leukopenia, CNS infections, cryptococcal meningitis, Chagas encephalitis, cerebral aspergillosis, West Nile encephalitis, infusion reactions, hypotension, hypertension, proteinuria, immunogenicity, new-onset diabetes after transplantation (NODAT), dyslipidemia, infections and infestations, upper respiratory infection, nasopharyngitis, cytomegalovirus infection, influenza, bronchitis, gastrointestinal disorders, abdominal pain, abdominal pain upper, metabolism and nutrition disorders, hyperkalemia, hypokalemia, hypophosphatemia, dyslipidemia, hyperglycemia, hypocalcemia, hypercholesterolemia, hypomagnesemia, hyperuricemia, procedural complications, graft dysfunction, general disorders, peripheral edema, pyrexia, blood and lymphatic system disorders, anemia, leukopenia, renal and urinary disorders, hematuria, proteinuria, dysuria, renal tubular necrosis, vascular disorders, hypertension, hypotension, respiratory, thoracic, and mediastinal disorders, cough, dyspnea, investigations, blood creatinine increased, musculoskeletal and connective tissue disorders, arthralgia, back pain, nervous system disorders, headache, dizziness, tremor, skin and subcutaneous tissue disorders, acne, psychiatric disorders, insomnia, anxiety, Guillain-Barre syndrome, stomatitis, including aphthous stomatitis, chronic allograft nephropathy, complications of transplanted kidney, including wound dehiscence, arteriovenous fistula thrombosis, neutropenia, renal impairment, including acute renal failure, renal artery stenosis, urinary incontinence, hydronephrosis, hematoma, lymphocele, musculoskeletal pain, alopecia, hyperhidrosis, atrial fibrillation"
302,ONFI,all-concat,"'somnolence or sedation, potentiation of sedation, withdrawal symptoms, serious dermatological reactions, physical and psychological dependence, suicidal behavior and ideation, constipation, pyrexia, lethargy, drooling, vomiting, dysphagia, irritability, fatigue, upper respiratory tract infection, pneumonia, urinary tract infection, bronchitis, decreased appetite, increased appetite, somnolence, sedation, ataxia, psychomotor hyperactivity, dysarthria, aggression, insomnia, cough, anemia, eosinophilia, leukopenia, thrombocytopenia, diplopia, vision blurred, abdominal distention, hypothermia, hepatic enzyme increased, muscle spasms, agitation, anxiety, apathy, confusional state, depression, delirium, delusion, hallucination, urinary retention, aspiration, respiratory depression, rash, urticaria, angioedema, facial and lip edema, Stevens-Johnson syndrome, toxic epidermal necrolysis'"
303,OTEZLA,all-concat,"diarrhea, nausea, headache, upper respiratory tract infection, tension headache, vomiting, nasopharyngitis, abdominal pain upper, hypersensitivity, weight decrease, gastroesophageal reflux disease, dyspepsia, decreased appetite, migraine, cough, rash, abdominal pain, fatigue, dyspepsia, insomnia, back pain, frequent bowel movements, depression, bronchitis, tooth abscess, folliculitis, sinus headache, severe worsening of psoriasis (rebound), suicidal thoughts, suicidal behavior, suicidal ideation"
304,PICATO,all-concat,"ophthalmic adverse reaction, hypersensitivity reactions, local skin reactions, application site pain, application site pruritus, application site irritation, application site infection, periorbital edema, nasopharyngitis, headache, erythema, flaking/scaling, crusting, swelling, vesiculation/pustulation, erosion/ulceration, eyelid edema, eye pain, conjunctivitis, hypersensitivity, allergic contact dermatitis, herpes zoster, chemical conjunctivitis, corneal burn, eyelid ptosis, severe eye pain, anaphylaxis"
305,POTIGA,all-concat,"retinal abnormalities, potential vision loss, urinary retention, skin discoloration, neuropsychiatric symptoms, dizziness, somnolence, QT interval effect, suicidal behavior and ideation, withdrawal seizures, diplopia, blurred vision, nausea, constipation, dyspepsia, fatigue, asthenia, influenza, weight increased, memory impairment, tremor, vertigo, abnormal coordination, disturbance in attention, gait disturbance, aphasia, dysarthria, balance disorder, paresthesia, amnesia, dysphasia, anxiety, disorientation, psychotic disorder, dysuria, urinary hesitation, hematuria, chromaturia, increased appetite, hallucinations, myoclonus, peripheral edema, hypokinesia, dry mouth, dysphagia, hyperhydrosis, malaise, increased liver enzymes, rash, nystagmus, dyspnea, leukopenia, muscle spasms, alopecia, nephrolithiasis, syncope, neutropenia, thrombocytopenia, euphoric mood, renal colic, coma, encephalopathy"
306,PRADAXA,all-concat,"bleeding, gastritis-like symptoms, gastrointestinal hemorrhage, diarrhea, major bleeding, intracranial hemorrhage, hemorrhagic stroke, gastrointestinal bleeds, fatal bleeding, non-intracranial fatal bleed, gastrointestinal adverse reactions, dyspepsia, abdominal pain upper, abdominal pain, abdominal discomfort, epigastric discomfort, GERD, esophagitis, erosive gastritis, gastric hemorrhage, hemorrhagic gastritis, hemorrhagic erosive gastritis, gastrointestinal ulcer, hypersensitivity reactions, urticaria, rash, pruritus, allergic edema, anaphylactic reaction, anaphylactic shock, myocardial infarction, thrombocytopenia, esophageal ulcer, thrombotic events, spinal/epidural hematoma, paralysis, thromboembolic events, valve thrombosis, stroke, transient ischemic attack, myocardial infarction, major bleeding, post-operative pericardial effusions"
307,PRISTIQ,all-concat,"hypersensitivity, suicidal thoughts and behaviors, serotonin syndrome, elevated blood pressure, abnormal bleeding, angle closure glaucoma, activation of mania/hypomania, discontinuation syndrome, seizure, hyponatremia, interstitial lung disease, eosinophilic pneumonia, nausea, dizziness, insomnia, hyperhidrosis, constipation, somnolence, decreased appetite, anxiety, specific male sexual function disorders, blood pressure increased, dry mouth, vomiting, fatigue, chills, feeling jittery, decreased appetite, tremor, disturbance in attention, insomnia, nervousness, abnormal dreams, urinary hesitation, yawning, hyperhidrosis, vision blurred, mydriasis, vertigo, tinnitus, dysgeusia, hot flush, anorgasmia, libido decreased, orgasm abnormal, ejaculation delayed, erectile dysfunction, ejaculation disorder, ejaculation failure, sexual dysfunction, tachycardia, asthenia, weight increased, liver function test abnormal, blood prolactin increased, musculoskeletal stiffness, syncope, convulsion, dystonia, depersonalization, bruxism, urinary retention, rash, alopecia, photosensitivity reaction, angioedema, myocardial ischemia, myocardial infarction, coronary occlusion requiring revascularization, fasting serum total cholesterol increase, LDL cholesterol increase, triglycerides increase, proteinuria, supine systolic blood pressure increase, supine diastolic blood pressure increase, pulse rate increase, weight decrease, sustained hypertension, orthostatic hypotension, Stevens-Johnson syndrome"
308,PROLIA,all-concat,"hypocalcemia, serious infections, dermatologic adverse reactions, osteonecrosis of the jaw, atypical subtrochanteric and diaphyseal femoral fractures, pancreatitis, new malignancies, anemia, angina pectoris, atrial fibrillation, vertigo, abdominal pain upper, flatulence, gastroesophageal reflux disease, edema peripheral, asthenia, cystitis, upper respiratory tract infection, pneumonia, pharyngitis, herpes zoster, hypercholesterolemia, back pain, pain in extremity, musculoskeletal pain, bone pain, myalgia, spinal osteoarthritis, sciatica, insomnia, rash, pruritus, hypersensitivity reactions, anaphylaxis, urticaria, facial swelling, erythema, severe symptomatic hypocalcemia, musculoskeletal pain, marked elevation in serum PTH, severe bone, joint, muscle pain, suppression of bone turnover, cataracts, drug-related hypersensitivity reactions, opportunistic infections, epidermal and dermal adverse events, dermatitis, eczema, rashes, severe symptoms, bone remodeling, bone histomorphometry, adverse outcomes, osteonecrosis of the jaw, atypical fractures, delayed fracture healing"
309,PROMACTA,all-concat,"hepatic decompensation, hepatotoxicity, thrombotic/thromboembolic complications, cataracts, nausea, diarrhea, upper respiratory tract infection, vomiting, increased ALT, myalgia, urinary tract infection, nasopharyngitis, rhinitis, anemia, pyrexia, fatigue, headache, decreased appetite, influenza-like illness, asthenia, insomnia, cough, pruritus, chills, alopecia, peripheral edema, hemorrhage, oropharyngeal pain, increased AST, pharyngitis, back pain, influenza, paresthesia, rash, alopecia, musculoskeletal pain, blood alkaline phosphatase increased, dry mouth, hyperbilirubinemia, abdominal pain, toothache, vitamin D deficiency, thrombotic microangiopathy with acute renal failure, portal vein thrombosis, pain in extremity, dyspnea, dizziness, febrile neutropenia, ecchymosis, muscle spasms, transaminases increased, arthralgia, rhinorrhea"
310,QUTENZA,all-concat,"'application-associated pain, increase in blood pressure, application site erythema, application site pain, application site pruritus, application site papules, application site edema, application site swelling, application site dryness, nasopharyngitis, bronchitis, sinusitis, nausea, vomiting, pruritus, hypertension, application site urticaria, application site paresthesia, application site dermatitis, application site hyperesthesia, application site excoriation, application site warmth, application site anesthesia, application site bruising, application site inflammation, application site exfoliation, peripheral edema, headache, burning sensation, peripheral sensory neuropathy, dizziness, dysgeusia, hyperesthesia, hypoesthesia, cough, throat irritation, abnormal skin odor, eye and mucous membrane exposure, aerosolization of capsaicin, unintended skin exposure, application associated pain, increase in blood pressure'"
311,SAPHRIS,all-concat,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, hepatotoxicity, dementia-related psychosis, neuroleptic malignant syndrome, tardive dyskinesia, metabolic changes, hypersensitivity reactions, oral ulcers, blisters, peeling/sloughing, inflammation, orthostatic hypotension, syncope, hemodynamic effects, leukopenia, neutropenia, agranulocytosis, QT interval prolongation, hyperprolactinemia, seizures, cognitive and motor impairment, body temperature regulation, suicide, dysphagia, cerebrovascular adverse events, stroke, transient ischemic attack, hyperpyrexia, muscle rigidity, altered mental status, autonomic instability, irregular pulse, blood pressure, tachycardia, diaphoresis, cardiac dysrhythmia, myoglobinuria, rhabdomyolysis, acute renal failure, hyperglycemia, dyslipidemia, weight gain, hypotension, tachycardia, swollen tongue, dyspnea, wheezing, rash, edema peripheral, hypertension, dystonia, parkinsonism, oculogyration, tremor, galactorrhea, amenorrhea, gynecomastia, impotence, decreased bone density, hypogonadism, aspiration pneumonia, myocardial infarction, unstable heart disease"
312,SIMPONI,all-concat,"serious infections, malignancies, upper respiratory tract infection, viral infection, bronchitis, hypertension, rash, sepsis, pneumonia, cellulitis, abscess, opportunistic infections, tuberculosis, invasive fungal infections, liver enzyme elevations, autoimmune disorders, autoantibodies, infusion reactions, immunogenicity, leukopenia, superficial fungal infection, sinusitis, lower respiratory tract infection, pyelonephritis, alanine aminotransferase increased, aspartate aminotransferase increased, neutrophil count decreased, dizziness, paresthesia, constipation, melanoma, serious systemic hypersensitivity reactions, anaphylactic reaction, sarcoidosis, interstitial lung disease, skin exfoliation, bullous skin reactions, hepatitis B reactivation, congestive heart failure, demyelinating disorders, hematologic cytopenias, pancytopenia, aplastic anemia, thrombocytopenia"
313,SIRTURO,all-concat,"increased mortality, QT prolongation, hepatotoxicity, nausea, arthralgia, headache, hemoptysis, chest pain, anorexia, transaminases increased, rash, blood amylase increased, aminotransferase elevations, ventricular arrhythmia, Torsade de Pointes, congenital long QT syndrome, hypothyroidism, bradyarrhythmias, uncompensated heart failure, clinically significant ventricular arrhythmia, syncope"
314,STENDRA,all-concat,"headache, flushing, nasal congestion, nasopharyngitis, back pain, upper respiratory infection, bronchitis, influenza, sinusitis, sinus congestion, hypertension, dyspepsia, nausea, constipation, rash, dizziness, arthralgia, diarrhea, edema peripheral, fatigue, angina, unstable angina, deep vein thrombosis, palpitations, gastritis, gastroesophageal reflux disease, hypoglycemia, blood glucose increased, alanine aminotransferase increased, oropharyngeal pain, stomach discomfort, vomiting, muscle spasms, musculoskeletal pain, myalgia, pain in extremity, depression, insomnia, somnolence, vertigo, cough, dyspnea exertional, epistaxis, wheezing, pruritus, balanitis, erection increased, hematuria, nephrolithiasis, pollakiuria, urinary tract infection, electrocardiogram abnormal, gastroenteritis viral, Non-arteritic anterior ischemic optic neuropathy (NAION), sudden loss of vision, prolonged erection, priapism, penile tissue damage, permanent loss of potency, anatomical deformation of the penis, angulation, cavernosal fibrosis, Peyronie's disease, sickle cell anemia, multiple myeloma, leukemia, sudden decrease or loss of hearing, tinnitus, symptomatic hypotension, lightheadedness, fainting, orthostatic signs and symptoms, increase in heart rate, decrease in standing blood pressure, bleeding disorders, active peptic ulceration, anti-aggregatory effect, sexually transmitted diseases, Human Immunodeficiency Virus (HIV)."
315,STRIBILD,all-concat,"Lactic Acidosis/Severe Hepatomegaly with Steatosis, Severe Acute Exacerbations of Hepatitis B, New Onset or Worsening Renal Impairment, Bone Effects of Tenofovir DF, Immune Reconstitution Syndrome, nausea, diarrhea, ocular icterus, flatulence, fatigue, jaundice, somnolence, headache, dizziness, insomnia, abnormal dreams, rash, suicidal ideation, suicide attempt, depression, abdominal pain, dyspepsia, vomiting, fever, pain, nasopharyngitis, pneumonia, sinusitis, upper respiratory tract infection, arthralgia, back pain, myalgia, paresthesia, peripheral neuropathy, anxiety, increased cough, rhinitis, skin discoloration, hyperpigmentation, AST elevation, ALT elevation, amylase elevation, creatine kinase elevation, hematuria, bone mineral density decrease, bone fractures, proteinuria, serum creatinine increase, estimated creatinine clearance decrease, allergic reaction, angioedema, hypokalemia, hypophosphatemia, dyspnea, pancreatitis, hepatic steatosis, hepatitis, increased liver enzymes, rhabdomyolysis, osteomalacia, muscular weakness, myopathy, acute renal failure, renal failure, acute tubular necrosis, Fanconi syndrome, proximal renal tubulopathy, interstitial nephritis, nephrogenic diabetes insipidus, renal insufficiency, polyuria, asthenia, immune reconstitution syndrome, redistribution/accumulation of body fat, central obesity, dorsocervical fat enlargement, peripheral wasting, facial wasting, breast enlargement, ""cushingoid appearance"", autoimmune disorders, Graves' disease, polymyositis, Guillain-Barre syndrome"
316,TAFINLAR,all-concat,"'peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, serious infections, opportunistic infections, tumor lysis syndrome, increased toxicity, hepatotoxicity, new primary malignancies, tumor promotion in BRAF wild-type melanoma, hemorrhage, venous thromboembolism, cardiomyopathy, ocular toxicities, serious febrile reactions, serious skin toxicity, hyperglycemia, glucose-6-phosphate dehydrogenase deficiency, hyperkeratosis, headache, pyrexia, arthralgia, papilloma, alopecia, palmar-plantar erythrodysesthesia syndrome, chills, fatigue, rash, nausea, vomiting, diarrhea, abdominal pain, peripheral edema, cough, night sweats, decreased appetite, constipation, myalgia, pancreatitis, hypersensitivity manifesting as bullous rash, interstitial nephritis, vision blurred, transient blindness, stomatitis, asthenia, cellulitis, folliculitis, paronychia, rash pustular, skin papilloma, hyperhidrosis, hypertension, leukopenia, lymphopenia, neutropenia, anemia, thrombocytopenia, increased AST, increased alkaline phosphatase, increased ALT, hyperbilirubinemia, hypophosphatemia, hyponatremia, hypoalbuminemia, hypokalemia, increased creatinine, hypomagnesemia, hyperkalemia, hypercalcemia, hypocalcemia, QT prolongation, retinal vein occlusion, interstitial lung disease, cutaneous squamous cell carcinoma, keratoacanthoma, melanoma, basal cell carcinoma, non-cutaneous malignancies, deep vein thrombosis, pulmonary embolism, decreased LVEF, retinal pigment epithelial detachment, uveitis, iritis, renal failure, oropharyngeal pain, muscle spasms, pain in extremity, dehydration, insomnia, hemorrhage, urinary tract infection'"
317,TANZEUM,all-concat,"'thyroid C-cell tumors, acute pancreatitis, hypoglycemia, hypersensitivity reactions, renal impairment, upper respiratory tract infection, diarrhea, nausea, injection site reaction, cough, back pain, arthralgia, sinusitis, influenza, vomiting, gastroesophageal reflux disease, dyspepsia, constipation, injection site hematoma, injection site erythema, injection site rash, injection site hypersensitivity, injection site hemorrhage, injection site pruritus, pneumonia, atrial fibrillation, atrial flutter, appendicitis, liver enzyme abnormalities, gamma glutamyltransferase (GGT) increase, heart rate increase'"
318,TECFIDERA,all-concat,"anaphylaxis, angioedema, progressive multifocal leukoencephalopathy, lymphopenia, flushing, abdominal pain, diarrhea, nausea, vomiting, pruritus, rash, albumin urine present, erythema, dyspepsia, aspartate aminotransferase increased, eosinophilia, PML, weakness, clumsiness of limbs, disturbance of vision, changes in thinking, memory, and orientation, confusion, personality changes"
319,TEFLARO,all-concat,"hypersensitivity reactions, Clostridium difficile-associated diarrhea, Direct Coombs' Test Seroconversion, diarrhea, nausea, rash, constipation, vomiting, increased transaminases, hypokalemia, phlebitis, anemia, eosinophilia, neutropenia, thrombocytopenia, bradycardia, palpitations, abdominal pain, pyrexia, hepatitis, anaphylaxis, Clostridium difficile colitis, hyperglycemia, hyperkalemia, dizziness, convulsion, renal failure, urticaria, agranulocytosis"
320,TIVICAY,all-concat,"hypersensitivity reactions, effects on serum liver biochemistries, fat redistribution, immune reconstitution syndrome, insomnia, fatigue, headache, abdominal pain, abdominal discomfort, flatulence, upper abdominal pain, vomiting, hepatitis, myositis, suicidal ideation, attempt, behavior, or completion, renal impairment, pruritus, rash, depression, abnormal dreams, dizziness, nausea, diarrhea, vertigo, elevated ALT, elevated AST, elevated cholesterol, elevated creatine kinase, hyperglycemia, elevated lipase, elevated total neutrophils, worsening or development of transaminase elevations, central obesity, dorsocervical fat enlargement (buffalo hump), peripheral wasting, facial wasting, breast enlargement, ""cushingoid appearance"", inflammatory response to infections, autoimmune disorders (such as Graves' disease, polymyositis, and Guillain-Barre syndrome)"
321,TOVIAZ,all-concat,"'dry mouth, constipation, dyspepsia, nausea, abdominal pain upper, urinary tract infection, upper respiratory tract infection, dry eyes, dysuria, urinary retention, cough, dry throat, edema peripheral, back pain, insomnia, ALT increased, GGT increased, rash, angina, chest pain, gastroenteritis, QT prolongation on ECG, blurred vision, palpitations, hypersensitivity reactions, angioedema with airway obstruction, face edema, dizziness, headache, somnolence, urticaria, pruritus, urinary retention, diverticulitis, irritable bowel syndrome, electrocardiogram QT corrected interval prolongation'"
322,TREANDA,all-concat,"myelosuppression, infections, anaphylaxis, infusion reactions, tumor lysis syndrome, skin reactions, other malignancies, extravasation injury, pyrexia, nausea, vomiting, diarrhea, constipation, anorexia, cough, headache, weight decreased, dyspnea, rash, stomatitis, lymphopenia, anemia, leukopenia, thrombocytopenia, neutropenia, asthenia, fatigue, malaise, weakness, dry mouth, somnolence, mucosal inflammation, hypertension, hypersensitivity, gastrointestinal disorders, immune system disorders, nasopharyngitis, herpes simplex, hyperuricemia, respiratory disorders, hepatotoxicity, bilirubin elevations, creatinine levels changes, tachycardia, abdominal pain, dyspepsia, gastroesophageal reflux disease, edema peripheral, chest pain, infusion site pain, pain, catheter site pain, herpes zoster, upper respiratory tract infection, urinary tract infection, sinusitis, febrile neutropenia, oral candidiasis, weight decreased, dehydration, decreased appetite, hypokalemia, back pain, arthralgia, pain in extremity, bone pain, headache, dizziness, dysgeusia, insomnia, anxiety, depression, cough, dyspnea, pharyngolaryngeal pain, wheezing, nasal congestion, pruritus, dry skin, night sweats, hyperhidrosis, hypotension, acute renal failure, cardiac failure, pulmonary fibrosis, myelodysplastic syndrome, hemolysis, taste disorder, atypical pneumonia, sepsis, erythema, dermatitis, skin necrosis, anaphylaxis, injection or infusion site reactions, phlebitis, irritation, pain, swelling, pneumocystis jiroveci pneumonia, pneumonitis, Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), embryo-fetal toxicity"
323,TRULICITY,all-concat,"thyroid C-cell tumors, pancreatitis, hypoglycemia, hypersensitivity reactions, renal impairment, severe gastrointestinal disease, nausea, diarrhea, vomiting, abdominal pain, decreased appetite, dyspepsia, fatigue, gastrointestinal adverse reactions, constipation, flatulence, abdominal distension, gastroesophageal reflux disease, eructation, documented symptomatic hypoglycemia, severe hypoglycemia, heart rate increase, tachycardia, sinus tachycardia, immunogenicity, systemic hypersensitivity, injection-site reactions, PR interval prolongation, first degree AV block, amylase increase, lipase increase"
324,TUDORZA,all-concat,"paradoxical bronchospasm, worsening of narrow-angle glaucoma, worsening of urinary retention, immediate hypersensitivity reactions, headache, nasopharyngitis, cough, diarrhea, sinusitis, rhinitis, toothache, fall, vomiting, diabetes mellitus, dry mouth, 1st degree AV block, osteoarthritis, cardiac failure, cardio-respiratory arrest, anaphylaxis, angioedema, urticaria, rash, bronchospasm, itching"
325,ULESFIA,all-concat,"ocular irritation, application site irritation, application site anesthesia, hypoesthesia, pain, pruritus, erythema, pyoderma, ocular irritation, application site dryness, application site excoriation, paraesthesia, application site dermatitis, excoriation, thermal burn, dandruff, rash, skin exfoliation, gasping syndrome, eye irritation, contact dermatitis"
326,ULORIC,all-concat,"'liver function abnormalities, nausea, arthralgia, rash, dizziness, anemia, idiopathic thrombocytopenic purpura, leukocytosis/leukopenia, neutropenia, pancytopenia, splenomegaly, thrombocytopenia, angina pectoris, atrial fibrillation/flutter, cardiac murmur, ECG abnormal, palpitations, sinus bradycardia, tachycardia, deafness, tinnitus, vertigo, vision blurred, abdominal distention, abdominal pain, constipation, dry mouth, dyspepsia, flatulence, frequent stools, gastritis, gastroesophageal reflux disease, gastrointestinal discomfort, gingival pain, haematemesis, hyperchlorhydria, hematochezia, mouth ulceration, pancreatitis, peptic ulcer, vomiting, asthenia, chest pain/discomfort, edema, fatigue, feeling abnormal, gait disturbance, influenza-like symptoms, mass, pain, thirst, cholelithiasis/cholecystitis, hepatic steatosis, hepatitis, hepatomegaly, hypersensitivity, herpes zoster, contusion, anorexia, appetite decreased/increased, dehydration, diabetes mellitus, hypercholesterolemia, hyperglycemia, hyperlipidemia, hypertriglyceridemia, hypokalemia, weight decreased/increased, arthritis, joint stiffness, joint swelling, muscle spasms/twitching/tightness/weakness, musculoskeletal pain/stiffness, myalgia, altered taste, balance disorder, cerebrovascular accident, Guillain-Barre syndrome, headache, hemiparesis, hypoesthesia, hyposmia, lacunar infarction, lethargy, mental impairment, migraine, paresthesia, somnolence, transient ischemic attack, tremor, agitation, anxiety, depression, insomnia, irritability, libido decreased, nervousness, panic attack, personality change, hematuria, nephrolithiasis, pollakiuria, proteinuria, renal failure, renal insufficiency, urgency, incontinence, breast pain, erectile dysfunction, gynecomastia, bronchitis, cough, dyspnea, epistaxis, nasal dryness, paranasal sinus hypersecretion, pharyngeal edema, respiratory tract congestion, sneezing, throat irritation, upper respiratory tract infection, alopecia, angio-edema, dermatitis, dermographism, ecchymosis, eczema, hair color changes, hair growth abnormal, hyperhidrosis, peeling skin, petechiae, photosensitivity, pruritus, purpura, skin discoloration/altered pigmentation, skin lesion, skin odor abnormal, urticaria, flushing, hot flush, hypertension, hypotension, activated partial thromboplastin time prolonged, creatine increased, bicarbonate decreased, sodium increased, EEG abnormal, glucose increased, cholesterol increased, triglycerides increased, amylase increased, potassium increased, TSH increased, platelet count decreased, hematocrit decreased, hemoglobin decreased, MCV increased, RBC decreased, creatinine increased, blood urea increased, BUN/creatinine ratio increased, creatine phosphokinase (CPK) increased, alkaline phosphatase increased, LDH increased, PSA increased, urine output increased/decreased, lymphocyte count decreased, neutrophil count decreased, WBC increased/decreased, coagulation test abnormal, low density lipoprotein (LDL) increased, prothrombin time prolonged, urinary casts, urine positive for white blood cells and protein, hepatic failure, jaundice, abnormal liver function test results, liver disorder, anaphylaxis, anaphylactic reaction, rhabdomyolysis, psychotic behavior including aggressive thoughts, tubulointerstitial nephritis, generalized rash, Stevens Johnson Syndrome, hypersensitivity skin reactions, gout flare, cardiovascular thromboembolic events, myocardial infarction, stroke, hepatic failure, transaminase elevations, serum alanine aminotransferase (ALT) increased, aspartate aminotransferase (AST) increased, alkaline phosphatase increased, total bilirubin increased'"
327,VICTRELIS,all-concat,"'anemia, neutropenia, pancytopenia, hypersensitivity, fatigue, nausea, headache, dysgeusia, agranulocytosis, thrombocytopenia, mouth ulceration, stomatitis, pneumonia, sepsis, angioedema, urticaria, drug rash with eosinophilia and systemic symptoms (DRESS) syndrome, exfoliative rash, exfoliative dermatitis, Stevens-Johnson syndrome, toxic skin eruption, toxicoderma, embryofetal toxicity, decreased hemoglobin, decreased neutrophils, decreased platelets, dyspnea, exertional dyspnea, dizziness, syncope, thromboembolic events, pulmonary embolism, acute myocardial infarction, cerebrovascular accident, deep vein thrombosis, serious infections, life-threatening neutropenia'"
328,VIMIZIM,all-concat,"'anaphylaxis, hypersensitivity reactions, pyrexia, vomiting, headache, nausea, abdominal pain, chills, fatigue, cough, erythema, throat tightness, urticaria, flushing, cyanosis, hypotension, rash, dyspnea, chest discomfort, gastrointestinal symptoms, retching, peripheral edema, acute respiratory complications, spinal or cervical cord compression'"
329,VIZAMYL,all-concat,"flushing, headache, increased blood pressure, nausea, dizziness, serious hypersensitivity reaction, flushing, dyspnea, chest pressure"
330,VORAXAZE,all-concat,"serious allergic reactions, anaphylactic reactions, paraesthesias, flushing, nausea and/or vomiting, hypotension, headache, myelosuppression, mucositis, acute hepatitis, renal dysfunction, renal failure, paresthesia, blurred vision, diarrhea, hypersensitivity, hypertension, rash, throat irritation, throat tightness, tremor"
331,XALKORI,all-concat,"hepatotoxicity, interstitial lung disease/pneumonitis, QT interval prolongation, bradycardia, severe visual loss, vision disorders, diarrhea, nausea, vomiting, constipation, edema, elevated transaminases, upper respiratory infection, decreased appetite, dysgeusia, dyspnea, pulmonary embolism, septic shock, acute respiratory failure, diabetic ketoacidosis, nausea, elevated transaminases, hepatotoxicity, ILD, cardiac disorders, eye disorders, gastrointestinal disorders, general disorders and administration site conditions, infections and infestations, investigations, musculoskeletal and connective tissue disorders, nervous system disorder, neuropathy, rash, renal cyst, ILD, syncope, hematology, chemistry, neutropenia, lymphopenia, ALT elevation, AST elevation, hypophosphatemia, pneumonia, pulmonary embolism, ILD, respiratory failure, sepsis, QTc prolongation, neutropenia, hypokalemia, hypophosphatemia, vision disorders, visual impairment, photopsia, blurred vision, vitreous floaters, neuropathy, sensory in nature, renal cysts, hepatic failure, embryofetal toxicity"
332,XEOMIN,all-concat,"hypersensitivity, dysphagia, breathing difficulties, spread of effects from toxin, cervical dystonia, neck pain, muscle weakness, injection site pain, musculoskeletal pain, blepharospasm, eyelid ptosis, dry eye, dry mouth, diarrhea, headache, visual impairment, dyspnea, nasopharyngitis, respiratory tract infection, glabellar lines, facial paresis, injection site hematoma, eyelid edema, eye swelling, nausea, flu-like symptoms, injection site reaction, allergic dermatitis, localized allergic reactions, swelling, edema, erythema, pruritus, rash, herpes zoster, muscular weakness, muscle spasm, dysarthria, myalgia, asthenia, generalized muscle weakness, diplopia, blurred vision, ptosis, dysphonia, urinary incontinence, corneal exposure, ulceration, ectropion, ecchymosis"
333,XIAFLEX,all-concat,"tendon ruptures, serious injury to the injected extremity, corporal rupture (penile fracture), severe penile hematoma, penile ecchymoses, sudden penile detumescence, penile ""popping"" sound or sensation, edema peripheral, contusion, injection site hemorrhage, injection site reaction, pain in the injected extremity, tenderness, injection site swelling, pruritus, lymphadenopathy, skin laceration, lymph node pain, erythema, axillary pain, vasovagal syncope, blood blister, injection site hematoma, ecchymosis, severe penile hematoma, penile swelling, penile pain, penile blister, pruritus genital, painful erection, erectile dysfunction, skin discoloration, procedural pain, injection site vesicles, localized edema, dyspareunia, injection site pruritus, nodule, suprapubic pain, hypersensitivity reactions, anaphylaxis, allergic reactions, IgE-anti-drug antibodies, risk of bleeding, ecchymosis/contusion, injection site hemorrhage, penile hematoma, penile ecchymosis"
334,XTANDI,all-concat,"seizure, asthenia/fatigue, back pain, decreased appetite, constipation, arthralgia, diarrhea, hot flush, upper respiratory tract infection, peripheral edema, dyspnea, musculoskeletal pain, weight decreased, headache, hypertension, dizziness/vertigo, muscular weakness, musculoskeletal stiffness, spinal cord compression and cauda equina syndrome, paresthesia, mental impairment disorders, hypoesthesia, lower respiratory tract and lung infection, insomnia, anxiety, hematuria, pollakiuria, fall, non-pathologic fractures, pruritus, dry skin, epistaxis, dysgeusia, restless legs syndrome, gynecomastia, neutropenia, thrombocytopenia, elevations in ALT, elevations in bilirubin, infections, sepsis, fall-related injuries, hypertensive crisis"
335,YERVOY,all-concat,"immune-mediated enterocolitis, immune-mediated hepatitis, immune-mediated dermatitis, immune-mediated neuropathies, immune-mediated endocrinopathies, ocular manifestations, fatigue, diarrhea, pruritus, rash, colitis, severe to fatal immune-mediated adverse reactions, enterocolitis, hepatotoxicity, dermatitis, neuropathy, endocrinopathy, hypopituitarism, adrenal insufficiency, pneumonitis, meningitis, nephritis, eosinophilia, pericarditis, urticaria, large intestinal ulcer, esophagitis, acute respiratory distress syndrome, renal failure, infusion reaction, Drug reaction with eosinophilia and systemic symptoms (DRESS syndrome), Stevens-Johnson syndrome, toxic epidermal necrolysis, Guillain-Barre syndrome, peripheral motor neuropathy, myasthenia gravis, hypophysitis, hyperthyroidism, Cushing's syndrome, nephritis, pneumonitis, meningitis, pericarditis, uveitis, iritis, hemolytic anemia, myocarditis, angiopathy, temporal arteritis, vasculitis, polymyalgia rheumatica, conjunctivitis, blepharitis, episcleritis, scleritis, leukocytoclastic vasculitis, erythema multiforme, psoriasis, pancreatitis, arthritis, autoimmune thyroiditis, sarcoidosis, neurosensory hypoacusis, autoimmune central neuropathy (encephalitis), myositis, polymyositis, ocular myositis"
336,ZERBAXA,all-concat,"hypersensitivity reactions, Clostridium difficile-associated diarrhea, nausea, diarrhea, headache, pyrexia, constipation, insomnia, vomiting, hypokalemia, ALT increased, AST increased, anemia, thrombocytosis, abdominal pain, anxiety, dizziness, hypotension, atrial fibrillation, rash, renal impairment, renal failure, cardiac disorders, tachycardia, angina pectoris, gastrointestinal disorders, ileus, gastritis, abdominal distension, dyspepsia, flatulence, ileus paralytic, general disorders and administration site conditions, infusion site reactions, infections and infestations, candidiasis, oropharyngeal, fungal urinary tract infection, investigations, increased serum gamma-glutamyl transpeptidase (GGT), increased serum alkaline phosphatase, positive Coombs test, metabolism and nutrition disorders, hyperglycemia, hypomagnesemia, hypophosphatemia, nervous system disorders, ischemic stroke, respiratory, thoracic and mediastinal disorders, dyspnea, skin and subcutaneous tissue disorders, urticaria, vascular disorders, venous thrombosis"
337,ZYDELIG,all-concat,"hepatotoxicity, severe diarrhea, colitis, pneumonitis, intestinal perforation, severe cutaneous reactions, anaphylaxis, neutropenia, diarrhea, pyrexia, fatigue, nausea, cough, pneumonia, abdominal pain, chills, rash, neutropenia, hypertriglyceridemia, hyperglycemia, ALT elevations, AST elevations, pneumonia, sepsis, febrile neutropenia, elevated transaminases, gastroesophageal reflux disease, stomatitis, headache, pain, nasal congestion, bronchitis, sinusitis, urinary tract infection, arthralgia, lymphocyte count decreased, lymphocyte count increased, GGT increased, hypoglycemia, hyponatremia, asthenia, peripheral edema, upper respiratory tract infection, dyspnea, night sweats, decreased appetite, insomnia, hemoglobin decreased, platelets decreased"
338,ZYKADIA,all-concat,"Severe or Persistent Gastrointestinal Toxicity, Hepatotoxicity, Interstitial Lung Disease/Pneumonitis, QT Interval Prolongation, Hyperglycemia, Bradycardia, Pancreatitis, Embryofetal Toxicity, diarrhea, nausea, elevated transaminases, vomiting, abdominal pain, fatigue, decreased appetite, constipation, convulsion, pneumonia, ILD/pneumonitis, dyspnea, dehydration, respiratory failure, pneumothorax, gastric hemorrhage, general physical health deterioration, pulmonary tuberculosis, cardiac tamponade, sepsis, neuropathy, vision disorder, prolonged QT interval, Hemoglobin decreased, Alanine transaminase (ALT) increased, Aspartate transaminase (AST) increased, Creatinine increased, Glucose increased, Phosphate decreased, Lipase increased, Bilirubin (total) increased"
339,ZYTIGA,all-concat,"hypertension, hypokalemia, fluid retention, adrenocortical insufficiency, hepatotoxicity, fatigue, joint swelling, discomfort, edema, hot flush, diarrhea, vomiting, cough, dyspnea, urinary tract infection, contusion, anemia, elevated alkaline phosphatase, hypertriglyceridemia, lymphopenia, hypercholesterolemia, hyperglycemia, elevated AST, hypophosphatemia, elevated ALT, muscle discomfort, dyspepsia, upper respiratory tract infection, urinary frequency, nocturia, fractures, arrhythmia, chest pain, chest discomfort, cardiac failure, non-infectious pneumonitis, myopathy, rhabdomyolysis, mineralocorticoid excess, cardiovascular disease, heart failure, myocardial infarction, ventricular arrhythmia, left ventricular ejection fraction, New York Heart Association (NYHA) Class III, IV heart failure, NYHA Class II, pyrexia, groin pain, constipation, insomnia, falls, nasopharyngitis, hematuria, rash, hypernatremia, cardiorespiratory arrest, myocardial ischemia, myocardial infarction, sudden death"
